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Abstract
The murine embryonic stem (ES) cell line, ES-D3 was used in this project as a 
model for (a) investigating controversial aspects of current protocols used for the 
derivation of (3 cell types from ES cells and (b) investigating the potential to 
regulate the differentiation of ES cells into endodermal derivatives 1 e 0-1 ike 
cells, using extra-cellular factors previously associated with various aspects of 
pancreatic development
Several groups have reported the derivation of insulin-expressing cell types from 
ES cells Many believe that these insulin-positive cells were a result of insulin 
uptake from supplements used in the culture medium Others have suggested 
that the ES-denved insulin-expressing cells may be of a neuronal or extra- 
embryonic lineage, rather than an endocrine lineage Using an adapted version of 
the Lumelsky protocol (Lumelsky et al, 2001), we demonstrated the induction of 
3-dimensional clusters similar to those described in the original study, which 
expressed a range of pancreatic, extra-embryonic and neuronal transcripts 
Insulin protein was detected in the differentiated clusters by ELISA A novel 
method developed to detect insulin biosynthesis by the cells, and analysis of C- 
peptide expression, indicated that this insulin is probably derived from the 
culture medium, not from the differentiated ES cell
Culture of ES cells in suspension leads to the formation of embryoid bodies 
(EBs) Treatment of these aggregates with retinoic acid (RA) was previously 
shown to induce endodermal differentiation We exposed RA_EBs to secondary 
treatment with agents associated with pancreatic endocrine differentiation, e g 
Activin A (AA), Sodium Butyrate (SB) and Betacellulin (BTC), with the aim of 
developing a novel protocol for the regulated derivation of insulin-expressing 
cell types The resulting differentiated populations were analysed for transcript 
expression of a range of multi-lineage markers i e neuronal, myogenic, exocrine 
and endocrine pancreas, extra-embryonic and apoptotic markers 
Immunohistochemistry methods were established and applied for the analysis of 
a selection of the chosen markers, following formal in-fixing and paraffin- 
embedding Applying 2-stage regulated differentiation protocols developed
during the course of the study, we demonstrated the derivation of an intermediate 
multi-potential population (RAJEBs) from undifferentiated ES cells that 
preferentially gave rise to pancreatic endocrine insulin-expressing cell types in 
the presence of SB and neuronal-like cell types in the presence of AA or BTC
Low passages of the MIN-6 insulinoma cell line are glucose-responsive whereas 
at high passage they become glucose non-responsive This loss in the glucose 
stimulated insulin secretion (GSIS) phenotype correlates with changes in 
morphology, increased proliferation and increased alkaline phosphatase (AP) 
activity, suggesting that the loss of GSIS may be due to de-differentiation of the 
high passage MIN6 cells To investigate this hypothesis further, gene expression 
differences between low passage and high passage MIN6 cells were investigated 
by microarray and real-time PCR (qPCR) analysis
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Section 1.0: Introduction
i
1 1 Stem Cell Biology
Stem Cells are defined as ‘clonogemc cells capable of both self renewal and 
muJtihneage differentiation’ (Berna et al, 2001) Differentiation is the process by 
which an unspecialized stem cell becomes equipped to perform specific functions 
i e hormone secretion, nerve cell communication, muscle contraction, etc The 
organs of the body are predominately composed of functional specialized cells 
that are all progeny of stem cells from the developing embryo (Figure 111)  
Stem cells are proving a useful tool in understanding the genes, molecules, 
growth factors and key events in embryonic development (Kirschtein & Skirboll, 
2001) The physiological or experimental conditions that induce stem cells to 
give rise to functional cells are of particular importance to scientists The belief 
is that in the future these cells may be a potential source of cell replacement 
therapy for degenerative diseases such as Parkinson’s disease, diabetes, multiple 
sclerosis, heart disease etc (http //stemcells mh gov/infc^asics/basicsl asp) 
They may also serve as vectors to carry and express genes in target organs in the 
course of gene therapy (Henmngson et al, 2003)
1 1 1  Differentiation
Differentiation may be symmetric or asymmetric Symmetnc differentiation will 
give rise to two daughter cells, which have both either remained as stem cells or 
which have both differentiated Asymmetric differentiation will give rise to two 
daughter cells, one that has differentiated, while the other remains as a stem cell 
(Hall & Watt, 1989, Watt & Hogan, 2000) There are a number of intermediate 
cells between the stem cell and its terminally differentiated progeny These cells 
are partially differentiated precursor/progenitor cells All multi-cellular 
organisms are an arrangement of cell types in an organised pattern that have 
descended from a single stem cell - the fertilised egg (Figure 11 1 )  (Kirschstein 
& Skirboll, 2001, Xavier Doss et al, 2004)
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Zygote
I
Blastocyst
I
Gastrula
•  Skin
•  Neural tissue
•  Adrenal medulla
•  Pituitary gland
•  Connective tissue of 
the head and face
Ectoderm A Germ CellsSperm • Egg
•  Eyes, ears
Mesoderm
•  Bone Marrow
•  Adrenal Cortex
•  Lymphatic Tissue
•  Skeletal, smooth, and 
cardiac muscle
•  Connective tissues 
(including bone, cartilage)
•  Urogenital system
•  Heart and blood 
vessels
Endoderm
•  Thymus
•  Thyroid, parathyroid glands
•  Larynx, trachea, lung
•  Urinary bladder, vagina, 
urethra
•  Gastrointestinal (Gl) organs 
(liver, pancreas)
•  Lining of the Gl tract
•  Lining of the respiratory 
tract
Figure 1.1.1 Embryonic Development and Differentiation
1.1.2 Classification of Stem Cells
Stem Cells can be broadly classified into (1) Adult Stem (AS) Cells (2) 
Embryonic Stem (ES) Cells. It is the latter, which is o f  primary importance in 
this thesis.
1.1.2.1 Adult Stem Cells
AS cells are dispersed throughout differentiated cells in tissues and organs o f  the 
body. Like all other stem cells they are capable o f  both self-renewal and 
differentiation. They can be difficult to define in that no one is entirely sure o f  
their origin. There is only a small number o f  AS cells within a tissue and they 
remain quiescent until activated by disease or injury (Robey, 2000; Fortier, 
2005). AS cells have been found in the bone marrow, brain, peripheral blood, 
blood vessels, skeletal muscle, skin and liver cells
(http://stemcells.nih.gov/info/basics/basics4.asp). It was previously thought that 
the primary function o f  these cells was to replace dead and injured cells within
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Arg*1
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Proinsulin
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Insulin
C-peptide
Figure 1.3.3 Processing o f proinsulin to insulin. Following initial cleavage by 
either PCI or PC2, trimming o f the residual C-terminal residues is carried out by 
the action o f ubiquitously expressed carboxypeptidases.
1.3.3 Glucose Sensing in the P Cell
To correctly control blood glucose levels, the p cell must be able to accurately 
sense/determine how much glucose is present in the blood. The glucose level is 
determined from the metabolism o f  the blood glucose and the subsequent 
changes in blood metabolites (Ashcroft, 1980; German, 1993). GSIS requires 
that the metabolism o f glucose can be increased within the p cell over the entire 
physiological range o f  glucose (Marshall et al, 1993; Ishihara et al, 1994). The 
most important components o f the glucose sensor are (I) glut2, which facilitates 
rapid glucose uptake regardless o f  the extracellular sugar concentration and (II)
36
the tissue of residence (Fortier, 2005) For example neural stem cells in the brain 
give rise to all 3 major cell types nerve cells (neurons), astrocytes and 
oligodendrocytes (Reynolds & Weiss, 1992, Williams et al, 1991) However, 
recent studies have suggested that an AS cell can give rise to differentiated cells 
characteristic of other tissue types, regardless whether the tissue is derived from 
the same germ layer or not The ability of AS cells to give rise to multiple cell 
types is variously referred to as plasticity, unorthodox differentiation or 
transdifferentiation (Filip et al, 2004, Fortier, 2005) The use of AS cells as a 
source of cells for replacement therapy has potential in that the expansion and 
réintroduction of a patient’s own cell type back into the body would avoid 
rejection by the immune system One of the problems associated with this is the 
lack of successful methods for expanding AS cells in culture (Hipp & Atala, 
2004)
1 1 2.2 Embryonic Stem Cells
The ES cell as defined by its origin is derived from the inner cell mass (ICM) of 
the blastocyst ES cells may be totipotent or plunpotent Totipotent stem cells 
form when a fertilised egg initially divides They are capable of generating all 
cells and tissues that form an embryo Plunpotent stem cells are isolated 
approximately 3 - 5  days after fertilisation from the blastocyst stage of the 
embryo (Figure 1 1 2) The blastocyst is composed of the trophoblast (outer 
layer of cells), the blastocoel (hollow fluid filled cavity) and ICM (cluster of cells 
on interior) (Kirschstein & Skirboll, 2001) Plunpotent stem cells are capable of 
giving rise to differentiated progeny representing all three germ layers ectoderm, 
mesoderm and endoderm, as well as extra embryonic tissue that support 
development (Reubinoff et al, 2000) Charactenstics of ES cells are
• Long term self renewal in culture
• Exhibit a stable, normal karyotype
• Maintain high levels of telomerase activity (A telomere is a repeating 
sequence of double stranded deoxyribonucleic acid (DNA) located at the 
end of a chromosome Long telomeres are associated with 
immortalization of cells)
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• Capable of giving rise to a colony of genetically identical cells 
(clonogenic)
• Expression of classical stem cell markers 1 e transcription factor Oct 4 
and AP
• ES cells are pluripotent in that they can differentiate into cells from all 
three germ layers both in vivo and in vitro and, therefore, can give rise to 
a wide range of cell types
It is these unique properties that make ES cells an attractive universal source of 
donor cells for transplantation and regeneration therapies (Kirschstein & 
Skirboll, 2001, Henningson et al, 2003) ES cell lines are currently available 
from rodents, rabbits, pigs and primates (Xavier Doss et al, 2004)
Isolated 
inner cell mass
Cleavage 
stage embryo
Cultured
blastocyst
Irradiated mouse 
fibroblast feeder cells
Cells dissociated 
and replated
New feeder cells
Established 
ES cell cultures
Figure 1.1 2 Derivation of ES cell lines (permission to use Figure received from 
Dr Jon S Odonco, M D , University of Wisconsin- Madison)
1 1 3  Mouse Embryonic Stem Cells
Pnor to the isolation of human stem cells in 1998 the majority of knowledge on 
stem cells and embryonic development was based on mouse model systems 
Mouse ES cells were first isolated in 1981 from that blastocyst, which is the 
stage of embryonic development pnor to implantation Mouse ES cells are 
derived from the ICM of the 3 5-day-old blastocyst (Evans and Kaufman, 1981, 
Martin, 1981) The multi-step process for denving stem cells is as follows -
■ Removal of the trophectoderm surrounding the ICM Cells are then 
grown in petn dishes containing a nutnent broth known as culture 
medium The medium is supplemented with fetal calf serum (FCS) 
The medium may contain cytokine leukaemia inhibitory factor (LIF) 
and if not, the petn dishes are coated in an inactivated layer of mouse 
embryonic fibroblasts (MEFs) (Cells inactivated using mitomycin C or 
gamma irradiation to prevent cell division)
■ Approximately 1 week later the cells are removed and dispersed into 
new culture dishes coated with MEF feeder layers/in presence of LIF 
ES cells aggregate to form colonies
■ Nondifferentiating single colonies are dissociated and replated into fresh 
culture dishes The replating process establishes a clonal ES cell line 
generated from a single ES cell
Mouse ES cells can be maintained in culture for two or more years (Kirschstein 
and Skirboll, 2001) In culture, mouse ES cells grow in tight rounded colonies 
with indistinct cell borders (Pera & Trounson, 2004)
1 1 3  1 Factors Involved in Maintaining Mouse ES Cells in an 
Undifferentiated State
Undifferentiated murine ES cell lines require an exogenous supply of LIF (Table 
1 1 1 )  The mouse ES cells can be propagated on mitotically inactivated MEFs 
that produce LIF or the medium can be supplemented with a relatively high 
concentration of LIF (Berna et al, 2001, Xavier Doss et al, 2004) Pathways 
mediated by LIF are critical in regulating self-renewal of mouse ES cells In 
brief, LIF binds to the LIF receptor (LIFR) and GP130 receptor-signalling 
complex, activating the JAK-STAT downstream pathways Activation of the Jak 
kinases results in the recruitment, tyrosine phosphorylation and dimenzation of
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STAT3 The activation of STAT3 is essential for ES cell self-renewal (Niwa et 
al, 1998, Burdon et al, 2002)
Recent studies have suggested that LIF is required, but not sufficient, for 
maintaining pluripotent mouse ES cell expansion The presence of serum or 
feeder layers is necessary indicating that signals are provided by the serum or 
feeders that are necessary to support self-renewal (Yamane et al, 2005) 
Components of serum l e bone morphogemc protein (BMP) are thought to act 
along with LIF in maintaining the undifferentiated state of ES cells Prolonged 
self-renewal of ES cells in serum free media supplemented with LIF and BMP 
has been demonstrated (Ying et al, 2003) The effect of BMP is dependent on the 
presence of LIF In the absence of LIF, BMP induces mesodermal 
differentiation
Oct 4 is present in the mouse blastocyst and is encoded by the PouSfl gene Its 
expression is confined to pluripotential cells and has been shown to be a 
requirement for the establishment of pluripotent cell lineages during mouse 
embryonic development (Nichols et al, 1998) Precise levels of Oct 4 are 
required in maintaining the ES cell undifferentiated state (Niwa et al, 2000) Oct 
4 is therefore a marker for undifferentiated ES cells It has been shown that Oct 
4 is negatively regulated by RA signalling, little is known as to what acts as a 
positive regulator of Oct 4 (Rao, 2004)
The interaction of LIF signalling pathways with Oct 4 signalling pathways 
remains unclear but LIF itself doesn’t appear to regulate Oct 4 Likewise Oct 4 
doesn’t appear to regulate JAK-STAT signalling The pathways may work in 
parallel whilst converging on common downstream targets (Rao, 2004) 
Although LIF is essential for in vitro murine ES cell maintenance, the 
establishment of ES cell lines from LIF receptor-null, GP 130-null embryos has 
been demonstrated providing evidence that other factors outside of LIF may be 
sufficient to maintain undifferentiated ES cells (Berger & Sturm, 1997, Gendall 
et al, 1997)
;
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More recently, a homeobox domain containing protein known as Nanog has been 
identified as a necessity in murine ES cell self-renewal It is highly expressed in 
ES cells and over expression of Nanog is sufficient to maintain Oct 4 levels 
(Chambers et al, 2003, Mitsui et al, 2003)
1 1 4  Human Embryonic Stem Cells
In 1998 human ES cells were derived from the ICM of a human blastocyst 
produced by in vitro fertilization (IVF) and donated for research purposes 
(Thomson et al, 1998) The derivation of human ES cell lines is similar to that of 
mouse ES cell lines (Figure 1 1 2) Researchers drew on animal studies i e 
mouse, to develop culturing methods LIF is not sufficient to prevent 
differentiation of human ES cells and they require continuous propagation on 
feeder layers (Odonco et al, 2001) Human ES cells are maintained in medium 
containing serum or serum replacement medium with supplemental basic 
fibroblast growth factor (bFGF) It’s been suggested that the use of bFGF 
improves cloning efficiency of human ES cells growing at low density (Amit et 
al, 2000) The population doubling time of human ES cells is 36 hours, this is 
slow in comparison to their murine counterparts (population doubling time of 12 
hours) Morphologically human ES cells differ from murine ES cells in that they 
form relatively flat loose aggregates with more distinct borders than murine cells 
(Table 1 1 1) (Kirschstein & Skirboll, 2001, Pera & Trounson, 2004) 
Differences are also noted in regard to cell surface antigen phenotype, for 
example human ES cells express stage specific embryonic antigens 3 and 4 
(SSEA-3 and SSEA-4) where as murine ES cells do not express these antigens 
but do express SSEA-1 In the absence of feeder layers and in suspension culture 
human ES cells spontaneously form EBs and can activate the expression of genes 
restricted to each of the three embryonic germ layers (Odonco et al, 2001) The 
mouse EB initially forms a bilayered structure with the extra embryonic 
endoderm on the outside and primitive ectoderm on the inside, however, it is not 
clear if human EBs display any consistent organisation (Doetschman et al, 1985) 
Human ES cells fulfil the criteria of plunpotent ES cells in that they are capable 
of indefinite self-renewal and multi lineage differentiation, both in vivo and in 
vitro They also express the classical markers of plunpotent ES cells i e Oct 4 
and AP (Table 111)  Human ES cells have been shown to differentiate in vitro
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to neural progenitors, blood cell precursors, endothelial cells, osteogenic cells, 
cardiomyocytes, insulin-producing cells, hepatocytes, keratinocytes and 
trophoblast cells (Pera & Trounson et al, 2004) When transferred into an in vivo 
environment, human ES cells can give rise to denvatives of all three embryonic 
germ layers (Odonco et al, 2001)
The data on human ES cells is still somewhat limited The understanding of 
molecular regulation of mammalian studies may provide a framework for 
differentiation of human ES cells There is high hope to use human ES cells in 
transplantation therapy and drug testing but there are still many hurdles to 
overcome in regards to this area of research The ethical debate over the use of 
human embryos in research is ongoing Large-scale culture of human ES cells is 
labour intensive and time consuming The presence of feeder layers and animal 
based ingredients incur a risk of cross-transfer of pathogens Prolonged growth 
may lead to genomic instability and cause chromosomal aberrations (Pera & 
Trounson, 2004, Stojkovic et al, 2004) The differentiation studies in this thesis 
employ mouse cell models
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Table 1.1 1 Comparison of mouse ES cell characteristics to human ES cell 
characteristics (permission to use Table received from the National Institutes of 
Health)
Marker Name Mouse ES Human ES
SSEA-1 + -
SSEA-2 - +
SSEA-3 - +
Alkaline Phosphatase + +
Oct 3/4 (known as Oct 4) + +
Telomerase Activity + +
Feeder Cell Dependent
Yes in absence of alternative 
LIF Yes
Factors aiding m stem cell self 
renewal
LIF and other factors acting 
through GP130 receptor can 
substitute for feeder layer
Feeder Cell + serum, feeder 
layer + serum-free 
medium+bFGF
Growth Charactenstics in vitro
Form compact, rounded 
clumps, can form EBs
Form, flat loose aggregates, 
can form EBs
Teratoma formation in vivo + +
Chimera Formation + +
1 1 5  Directing the Differentiation of ES Cells
The formation of organised tissue during embryonic development is controlled 
by complex inductive events and cell-cell interactions Differentiation studies 
using ES cells contribute to an understanding of the elements regulating both 
differentiation and embryonic formation (Henmngson et al, 2003) If 
differentiation is to proceed, mouse ES cells must be removed from LIF, which 
promotes the division of undifferentiated ES cells Common strategies employed 
in directing differentiation are -
(1) Addition of growth factors to the medium For example Kawamorita et 
al (2002) studied the in vitro differentiation of mouse ES cells in the 
presence of RA
(2) Altering the chemical composition of the surface on which the cells are 
propagated Adherent substrates aid in preventing cells from interacting 
and differentiating In 2005, Flaim et al used a microarray platform to
1 0
study the effect of a combination of extracellular matrix molecules on 
murine ES cellular differentiation
(3) Introduction of a foreign gene into the genetic complement of the ES 
cell, which may in turn drive the cell along a specific differentiation 
pathway Blyszczuk et al (2003) demonstrated that expression of pax 4 
in ES cells promotes differentiation of nestin-positive progenitor and 
insulin-producing cells
(4) Mimicking the naturally occurring cell-to-cell interaction of the in vivo 
environment by co-cultunng ES cells with inducer tissues/cells (Odonco 
et al, 2001, Sona et al, 2001a)
Many differentiation studies employ EBs rather than monolayer culture In the 
absence of LIF, ES cells in suspension culture spontaneously differentiate into 
multi-cellular cell aggregates over a 2 - 5 day period The theory is that cell-to- 
cell interaction within the EB mimics the natural in vivo development of the 
embryo In general the formation of these aggregates is thought to initiate 
spontaneous differentiation of ES cells to the three embryonic germ layers 
(Hennmgson et al, 2003, Xavier Doss et al, 2004) In vitro differentiation can be 
disorganised and variable from one EB to another within the one culture The 
cultures obtained using differentiation methods are relatively heterogeneous in 
that they give rise to a mixture of cell types The current strategies to isolate a 
single population of a desired cell type include -
■ genetic engineering of cells with a selection marker under the control of a 
tissue specific promoter
■ employing selective culture conditions to promote the growth of a desired 
cell type
■ Fluorescence activated cell sorting based on fluorescent-labelled 
antibodies raised against unique cell surface markers of a desired cell 
type
(Xavier Doss et al, 2004, Shufaro & Reubinoff, 2004)
Optimum protocols will be fundamental in the production of an unlimited source 
of cells for transplantation therapies Any future therapeutic application implies 
the current need to drive homogeneous differentiation of the ES cells to a desired 
cell type (Roche et al, 2003)
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Murine ES cells have been differentiated m vitro to cardiomyocytes, 
haematopoietic progenitors, yolk sac, skeletal myocytes, smooth muscle cells 
adipocytes, hepatocytes, chondrocytes, neurons, glia, pancreatic islet cells, 
primitive endoderm etc The list is ever increasing but the main hurdle 
researchers have to face is development of a desired cell phenotype rather than a 
mixed population (Xavier Doss et al, 2004)
1 1 6  ES-D3 Cell Line as an Embryonic Stem cell Model
ES-D3 is a plunpotent ES cell line derived from a murine 129/Sv blastocyst 
(Doetschman et al, 1985) ES-D3 cells are maintained in an undifferentiated state 
by
(I) frequent subculture on inactivated feeder layers of MEFs or STOs 
(STO-SNL2) Inactivation of feeder layers is achieved by mitomycin 
C treatment or irradiation Inactivation prevents the cells from 
dividing, whilst allowing them to maintain their metabolic activity 
and release LIF into the medium
or
(II) frequent subculture in media supplemented with commercially 
available LIF (in the presence of serum)
The undifferentiated cells are routinely subcultured every 2 - 3  days In the 
absence of feeder layers or LIF the cells spontaneously differentiate into 
embryonic structures i e EBs {American Type Culture Collection (ATCC) Data 
Sheet)
1 1 6  1 Differentiation Potential of ES-D3 Cells
Identifying the factors and elements that influence ES-D3 differentiation is 
necessary for studies using these stem cells to achieve a desired cell type In 
1991, Wiles & Keller used a semi-solid culture system (methyl cellulose media) 
to encourage the development of EBs These EBs contained a number of 
differentiated cell types including haematopoietic precursor cells The cells were 
exposed to both erythropoietin (Epo) and interleukin-3 (IL-3) Epo increased the 
frequency of EBs with erythropoietic activity to more than 60% whereas IL-3 did 
not increase the frequency of EBs but increased the number of erythropoietic
1 2
cells associated with them, clearly indicating that using well-defined conditions 
ES-D3 cells could give rise to haematopoietic precursors
ES-D3 cells can be genetically modified by gene targeting and transfection 
techniques In 1996 Klug et al used a genetic selection technique to derive pure 
cultures of cardiomyocytes from differentiated murine ES-D3 cells A transgene 
consisting of the a- cardiac myosin heavy chain promoter fused to a 
complementary DNA (cDNA) encoding aminoglycoside phosphotransferase was 
transfected into undifferentiated ES-D3 cells via electroporation Resulting cell 
lines underwent differentiation and drug (G418) selection Analyses showed that 
selected cardiomyocyte cultures were greater than 99% pure and were highly 
differentiated These cardiomyocytes were used to form stable intercardiac 
grafts in dystrophic mice Kolossov et al (1998) followed up this research with a 
study investigating the functional characteristics of ES-D3 cell derived cardiac 
precursor cells Once again genetic selection was used to identify the cardiac 
precursor cells A vector containing the green fluorescent protein (GFP) gene 
under the control of the cardiac a-actin promoter was successfully transfected 
into the undifferentiated ES-D3 cells by electroporation Strongly fluorescent- 
contracting regions distinguished cardiac precursor cells amongst the 
differentiated progeny Other studies use transduction techniques to introduce 
genes into ES-D3 cells that enhance the formation of a particular cell type upon 
differentiation of the ES cells In 2000, Dai et al used retrovirus mediated gene 
transfer to introduce human erythropoietin receptor (hEpoR) cDNA into ES-D3 
cells Expression of hEpoR gene in the cells was found to enhance the primitive 
and definitive erythropoiesis in differentiation of EBs
In 1999a, Li et al demonstrated that transplanted ES-D3 cells could grow in the 
eyes of nude mice with a tendency to differentiate into neurons and retina-like 
structures Ge et al, 2000 demonstrated that exposure of ES-D3 cells to RA and 
cytosine arabinoside (Ara-C), resulted in differentiated neuronal phenotypes 
Both studies demonstrate ES-D3 cell potential in giving rise to neuronal 
phenotypes
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Both Karbanova & Mokry (2002) and Toumadje et al (2003) examined the in 
vitro spontaneous differentiation potential of ES-D3 cells Karbanova & Mokry 
used histological and histochemical analysis to determine that the most distinct 
cell populations arising in spontaneously formed EBs were alpha-fetoprotein- 
positive (AFP) endodermal cells and myogenic cells that expressed desmin, 
myogenm or smooth muscle actin Toumadje at al used immunocytochemical 
and flow cytometric methods to monitor ES-D3 EB differentiation over a 21-day 
period Oct 4, SSEA-1, and EMA-1 persisted for at least 7 days, whereas the 
primitive endoderm marker cytokeratin endo-A was expressed at increasing 
levels from day 6 Localization of these antigens within the EBs indicated 
segregation of the embryonic ectoderm- and primitive endoderm-denved tissues 
Localized expression of class III beta-tubulin and sarcomenc myosin also 
indicated that representatives of all three embryonic germ layer were present in 
EBs Both studies demonstrated the usefulness of the ES-D3 cell model for 
studying early embryogenesis
In 2003, Kahan et al evaluated the ability of ES-D3 cells to differentiate into 
pancreatic and islet lineage-restricted cell types Following differentiation in 
nonselective medium containing serum, murine ES cells spontaneously 
differentiated into cells individually expressing each of the four major islet 
hormones insulin, glucagon, somatostatin (Som), and pancreatic polypeptide 
(PP) Pancreatic duodenal homeobox factor 1 (Pdxl) immuno-positive cells 
appeared first, before hormone-positive cells had emerged Hormone-positive 
cells appeared within focal clusters of cells coexpressing Pdxl and the hormone 
markers peptide YY (YY) and islet amyloid polypeptide (IAPP) in combination 
with the definitive hormones, characteristic of endocrine cells appearing during 
early pancreatic neogenesis (Section 1 2) In 2005, Milne et al used ES-D3 cells 
to present evidence that murine ES cells, which readily differentiate into cells 
displaying endodermal and 13 cell characteristics are likely to be extra-embryonic 
in origin
In 2004, Ward et al compared the differentiation properties of the ES-D3 cell line 
to 4 other murine ES cell lines All stem cell lines were cultured in defined 
medium in the absence of feeder layers The study demonstrated that all
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undifferentiated ES cell lines exhibited pluripotency, similar morphology and 
transcript expression However upon induced differentiation, the cell lines 
differed in their response to RA resulting in significant variations in cell number 
and morphology between lines Oct 4 and Neurofilament-68k messenger RNA 
(mRNA) transcripts were detected in all undifferentiated cell lines
Judging by studies carried out over the past 1 0 - 1 5  years it appears that the ES- 
D3 cells can under certain culture conditions differentiate into a range of cell 
types They are also suitable for use in studies were genetic manipulation is to 
play a key role in (a) directing differentiation and (b) selecting desired cell types 
from differentiated progeny Although research has been carried out on the 
differentiation of ES-D3 into neuronal, cardiac, haematopoietic and erythroid 
precursor cells, the derivation of endoderm derivatives from this cell line is a 
relatively new research area and only currently being studied
1 1 7  Directing the Differentiation of ES Cells towards Neuronal Phenotypes
In the mid- 1990’s neuroscientists became aware that parts of the adult brain can 
be regenerated under certain circumstances The existence of neural stem 
cells/progenitors that give rise to the three major neural lineages i e neurons 
(main message carriers in the nervous system), oligodendrocytes and astrocytes 
(crucial support cells) in the foetal and adult brain (Figure 1 1 3) (Gage, 2000) 
gave way to hope that cell replacement therapy based on the derivation of neural 
cell types from ES cells may be able to repair damage caused by degenerative 
disorders such as Parkinson’s disease, Alzheimer disease, amyotrophic lateral 
sclerosis (ALS also known as Lou Gehrig’s disease) and others (Kirschstein & 
Skirboll, 2001, Henningson et al, 2003) The formation of neural precursors and 
neural lineages from ES cells has been extensively studied over the past 20 years 
(Section 1 1 7  1) However, before neural stem cells/progenitors can be used for 
transplantation therapy, we need to learn more about the factors that control their 
expansion and proliferation as well as investigating the signalling molecules that 
direct the differentiation of their daughter cells (Gage et al, 2000, Kirschstein & 
Skirboll, 2001)
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Restriction
totipotent
nor self-renewing
piunpotent
self-renewing
broad potential 
self-renewing
l i m i t e d  p o t e n t i a l  
l i m i t e d  9 8 l f * r e n e w a i
limited division 
non-functional
Cell
zygote
Source
zygote
embryonic blastocyst
stem cell
0
miitipotent embryo or adutt 
stem cells brain, bkocK?)
neural brain or
progenitor spinal cord
committed brain subregion 
neural 
progenitor
n e u ro n a l p ro g e n ito r g lia l p ro g e n ito r
4 *
non-mitotic
functional
differentiated specific 
brain sites
n e u ro n g lu *
J
Figure 1.1.3 An illustration proposing the classes of stem cells that can give rise 
to neurons (permission to use Figure received from Prof. Fred H. Gage, The Salk 
Institute for Biological Studies)
Parkinson’s disease is a good model for studying the use of stem cell therapy in 
curing degenerative disorders. This disease is a neurodegenerative disorder 
affecting motor control and causing movement disorder. Occurrence of the 
disease is due to loss of neurons that secrete dopamine in the brain. A therapy 
for this disease requires the replacement of one cell type in a particular location 
in the brain. Other disorders such as spinal cord injury would require the 
replacement of multiple cell types. Investigations into a therapy for Parkinson’s
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disease have found that mature dopaminergic neurons do not survive direct 
transplantation and transplanted cells find it extremely difficult to establish the 
required connections within the striatum The use of fetal dopaminergic neurons 
in transplant therapies has achieved some success Limited donor supply and 
ethical concerns are major obstacles to the widespread use of these cells 
(Hennmgson et al, 2003, Shufaro & Reubinoff, 2004) ES cells may be a 
potential alternative source of these transplantable dopaminergic neurons
1 1.7 1 Protocols Used in the Derivation of Neuronal Phenotypes from 
Mouse ES Cells
Protocols for the derivation of competent neural precursors have been developed 
in the mouse ES system In 1995, the chemical induction of neuronal cell types 
from ES cells using RA was demonstrated by three independent research groups 
(Bain et al, 1995, Fraichard et al, 1995, Strubing et al, 1995) The formation of 
EBs in the presence of RA resulted in 50 -  70% surviving cells exhibiting neural 
and glial characteristics after replating into serum free-medium (Fraichard et al, 
1995, Strubing et al, 1995, Li et al, 1998), however, follow-on studies 
demonstrated that these populations were not homogeneous and contained 
contaminating cell populations (Li et al, 1998, Liu et al, 2000) RA-treated EBs 
promoted some recovery in mouse models of spinal injury suggesting a capacity 
for integration and function (McDonald et al, 1999, Liu et al, 2000)
Selective pressure during culture has been used to enrich neural progenitors 
derived from mouse ES cells An enriched population of nestin-positive 
neuroepithelial precursor cells was successfully derived from murine ES cells in 
serum free conditions These cells proliferate in the presence of bFGF and upon 
withdrawal of bFGF differentiate into both neurons and glia Subsequent 
differentiation of the cells in serum-containing medium induces expression of a 
wide variety of neuron-specific genes (Okabe et al, 1996)
The differentiation of mouse ES cells into dopaminergic neurons in vitro was 
initially achieved through selection and differentiation of nestin-positive cells 
from EBs Sonic hedgehog (Shh) and fibroblast growth factor 8 (FGF8) (both 
have key roles in midbrain development) were used to direct the neural
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precursors into dopaminergic neurons (Lee et al, 2000) Derivation of 
dopaminergic neurons from mouse ES cells has also been achieved by the direct 
transplantation of undifferentiated mouse ES cells into the midbrain of 6-OH- 
dopamine lesioned rats allowing for in situ differentiation into dopaminergic 
neurons (Bjorklund, et al, 2002) However, undifferentiated ES cell 
transplantation caused formation of teratoma tumours in situ More recently, 
Barberi et al (2003) demonstrated the derivation and engraftment of 
dopaminergic neurons from ES cells resulting in functional improvement in 
animal models of parkinsonism
1 1 7  2 Protocols Used in the Derivation of Neuronal Phenotypes from 
Human ES Cells
Most protocols for the derivation of neural lineages from human ES cells involve 
spontaneous differentiation, followed by selection of neural progenitors, and 
subsequent culture under neural stem cell promoting conditions (Shufaro & 
Reubinoff, 2004) Using this strategy Reubmoff et al (2001) reported the 
generation of an enriched population of proliferating neural progenitors isolated 
from human ES cells that were capable of differentiating in vitro into the three 
neural lineages-astrocytes, oligodendrocytes, and mature neurons In vivo, the 
transplanted progenitor cells migrated along established brain migratory tracks in 
the host brain and differentiated in a region-specific manner A subsequent study 
by Zhang et al (2001) reported the in vitro differentiation, selection and 
transplantation of neural precursor cells Upon transplantation into the neonatal 
mouse brain, these human ES cell-derived neural precursors were incorporated 
into a variety of brain regions, where they differentiated into both neurons and 
astrocytes
Perrier et al (2004) reported the differentiation of human ES cells into 
dopaminergic neurons A stromal feeder cell based differentiation system was 
used to induce neuroectodermal differentiation Regional specification was 
achieved by means of the sequential application of defined molecules that direct 
m vivo midbrain development i e Shh and FGF8 Progression toward a midbrain 
dopamine neuron fate was monitored by the sequential expression of key 
transcription factors e g pax 5, pax 2 and measurement of dopamine release
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1 1 8  Directing the Differentiation of ES Cells towards Pancreatic 
Phenotypes
Researchers studying the directed differentiation of ES cells towards pancreatic 
phenotypes are all working towards specific goals -
■ the development of a stable insulin-producing cell line with regulated 
hormone secretion
■ the development of cells constituting normal pancreatic islets 
(Roche et al, 2003, Kirschstein & Skirboll, 2001)
13 Cells, the major components of the pancreatic islets of Langerhans, secrete 
insulin in response to blood glucose levels The loss of insulin production by the 
pancreatic 13 cells is central to the development of a metabolic disorder known as 
Diabetes Mellitus (DM) Annually DM affects more people and causes more 
deaths than AIDS and cancer combined Type I diabetes is characterised by 
auto-immune destruction of 13 cells, whereas type II diabetes is characterised by 
the inefficient production or use of insulin resulting in glucose accumulation 
Treatments for diabetes such as insulin injections and controlled diets do not 
rigidly control glucose levels and do not solve serious long-term complications 
(Blyszczuk & Wobus, 2004a, Roche et al, 2005) Replacing 13 cells/islets cells 
has been a therapeutic goal for decades and could prevent the mortality 
associated with DM The success of whole pancreas and islet transplantations in 
restoring normal glycaemic control verifies that replacing the p cells is an 
effective therapy for DM Isolated islets from at least two compatible donors are 
necessary for transplantation (Shapiro et al, 2000) and as these aren’t readily 
available, the demand for donor tissue greatly outweighs it availability The self- 
replication and differentiation potential of ES cells has made them an attractive 
potential source of transplant islet/13 cells for future diabetes therapy Studies on 
the propagation and differentiation of ES cells into a pancreatic lineage are 
ongoing (Section 1 4 )  An understanding of the key factors affecting the 
differentiation programmes in endocrine pancreatic development will be central 
to the successful production of a transplantable p/islet cell line (Section 1 2) 
(Roche et al, 2003)
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1 2 Development of the Pancreas
Gastrulation is the process by which the simple structure of the blastula is 
transformed into the complex, 3-dimensionaI structure of the basic body plan by 
a series of cell shape changes and rearrangements It takes place at an early stage 
in the development of the embryo resulting in the occurrence of the three 
embryonic germ layers The embryonic endoderm serves as a template for the 
gastrointestinal tract (duodenum) from which the embryonic pancreas is derived 
(Edlund, 2001, Trucco M , 2005) In mice the pancreas is derived from two buds 
occumng on the dorsal and ventral sides of the gut at the junction of the foregut 
and the midgut at the embryonic age 9 5 days (e9 5) (Watada, 2004) As the gut 
rotates during development the dorsal and ventral buds branch and eventually 
fuse to form the vertebrate pancreas (Edlund, 2002, Watada, 2004) The 
pancreatic buds give rise to the ducts and acinar (exocrine) components of the 
pancreas The exocrine acinar cells synthesize digestive enzymes, which are 
secreted into the intestine via branched ductal epithelium (Bishop & Polack, 
1991, Madsen et al, 1996) The endocrine progenitors proliferate from the 
budding ducts and form the differentiated islets of Langerhans (Trucco, 2005) 
The endocrine pancreas represents approximately 1% of the pancreatic gland 
(Malaisse, 2005)
The early commitment of the region of the embryonic gut to dorsal and ventral 
budding is still being studied It is known that transcription factors HLXB9 
(homeobox gene HB9), Pdxl, HNF6 (hepatocyte nuclear factor 6) and HNF3(3 
(hepatocyte nuclear factor 3p) are expressed in the region of foregut endoderm 
committed to pancreatic fate (Sona et al, 2001b) Mice and human lacking Pdxl 
do not form a pancreas (Jonsson et al, 1994, Stoffers et al, 1997) However Pdxl 
must act downstream of the initial commitment signal as Pdxl knockout mice 
(Pdxv ) still form the pancreatic buds and appearance of early pancreatic markers 
is unaffected (Kim et al, 1997, Edlund, 1999) HLXB9 is similar to Pdxl in that 
it is expressed in regions of the gut that commit to pancreatic morphogenesis and 
its expression is later restricted to 13 cells (Li et al, 1999b) Phenotypic 
comparison of HLXB9 and Pdxl deficient mice indicate that HLXB9 acts 
upstream of Pdxl (Edlund, 1999) Disruption to HLXB9 expression does not
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affect Pdxl expression in the ventral bud but does diminish Pdxl expression in 
the dorsal bud as well as preventing dorsal bud morphogenesis (Chakrabarti & 
Raghavendra, 2003) HNF6 induces HNF3P (also known as foxa2) expression 
and is also required for neurogenm3 (ngn3) expression (Section 1 2 3 2) (Sona et 
al, 2001b) Deletion of HNF3P in mice causes disruption in the formation of the 
endoderm suggesting that HNF3P is necessary for endodermal patterning and 
subsequent pancreas development The targeted disruption of HNF3P in ES cells 
or P cells causes a reduction in other P cell transcription factors i e Pdxl, placing 
HNF3P at an early stage in pancreas development (Lee et al, 2002, Chakrabarti 
& Raghavendra, 2003)
The developing ventral and dorsal endoderms receive a series of inductive 
signals from surrounding tissues (Soria et al, 2001b) The dorsal endoderm is in 
direct contact with the notochord (a flexible structural organ extending over the 
length of the body) Removal of the notochord from embryonic mice prior to 
pancreatic fate specification prevents expression of Pdxl and islet 1 (Isll) and 
the dorsal bud does not form Expression of both genes is crucial in dorsal 
mesenchyme formation (Ahlgren et al, 1997) The ventral bud is unaffected by 
removal of notochord (Kim et al, 1997) Signals from the notochord such as the 
release of factors activin -beta B and FGF2 repress expression of Shh, a negative 
regulator of Pdxl, thus allowing normal morphogenesis (Hebrok et al, 2000) 
Mesenchymal tissue surrounding the dorsal pancreatic bud expresses Isll Is llv 
mutants fail to form dorsal mesenchyme and do not form the dorsal pancreatic 
bud However the expression of Pdxl and beta 2 in Isl 17 mutants indicates that 
Isll expression and thus mesenchymal factors are not initiator signals for 
embryonic foregut commitment (Alhgren, 1997)
Ngn3, nkx2 2, beta 2/Neuro d, pax 4 and pax 6 are other transcription factors 
involved in proliferation and specification of early endocrine pancreas The 
individual roles of the transcription factors will be discussed in detail in Section 
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1.2 1 Source of New Islet Cells in Adult Pancreas
The adult pancreas has demonstrated the regenerative ability following tissue 
loss and injury (Pearson et al, 1977, Bouwens 1998, Trucco, 2005) The source 
of new islet cells in adulthood is somewhat controversial The theories are
■ The existence of a bonafide endocrine progenitor located within or close 
to the pancreatic ducts Seaberg et al (2004) and Zulewski et al (2001) 
both isolated what appeared to be pancreatic multipotent precursors 
(PMPs) from both islet- and duct- derived populations
■ Pancreatic ductal cells transdifferentiate into (3 cells efficiently activated 
by increased metabolic demand and tissue injury (Bonner-Weir & 
Sharma, 2002)
■ Islet cells arise from stem cells in the blood (Kirschtein and Skirboll, 
2001)
1.2 2 Development of Pancreatic Islet Cell Types
The pancreas contains exocrine, endocrine and ductal cell types (Figure 12 1), 
which are all derived from the one region of the gut epithelium in the developing 
embryo This study is primarily focused on the development of the endocrine 
pancreas The endocnne islets of Langerhans consist of four cell types organised 
in a topological order These are (a) glucagons producing a  cells (b) insulin 
producing (3 cells (c) PP producing y cells and (d) Som producing 5 cells 
(Trucco, 2005) Knowledge of the development and order of appearance of each 
cell type is important for implementing this information in deriving replacement 
islet/p cells for diabetes therapy
2 2
Figure 1.2.1 Cross section o f  the pancreas (permission to use Figure received 
from Dr. Massimo Trucco, M.D., University of Pittsburgh School of Medicine)
1.2.2.1 Chronological Appearance of Islet Cell Types
Gittes and Rutter (1992) analysed the transcriptional expression o f  pancreatic 
hormones in microdissected mouse embryos. The study indicated that induction 
o f hormone gene expression occurred prior to formation o f ventral and dorsal 
buds. Som RNA (ribonucleic acid) was initially detected followed by insulin and 
glucagon. PP was not detected until fusion o f  the dorsal and ventral buds occurs 
during formation o f  the pancreas. The appearance o f  immuno-reactive hormone 
protein differs in the order o f appearance o f their mRNA transcripts. 
Immunohistochemistry analysis indicates that co-expressing insulin and 
glucagon cells are initially detected (e9.5). All o f the insulin cells co-express 
glucagon but there are also exclusive glucagon expressing cells at this stage 
(Teitelman et al, 1993). The pancreatic a  cells are the first differentiated cells to 
appear followed by the appearance o f  (3 cells. Som is detected at a later stage. 
The first 5 cells differentiate about e l 4 and PP cells appear shortly before birth 
(Watada, 2004). The initial belief that insulin-producing cells differentiated from 
a glucagon precursor was discredited by Herrera (2002). A Cre-loxP system 
based study helped in identifying cell lineages involved in pancreatic
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development and demonstrated that each islet cell type has a different precursor 
(Kulkami et al, 2004)
12  3 Endocrine Cell Determination through the Expression of Transcription 
Factors
The differentiation of islet cells is a complex process regulated by multiple 
transcription factors (Chakabarti & Raghavendra, 2003) Knowledge of the 
cascades and interrelationships of transcription factors can be implemented in 
differentiation studies to ascertain which lineage a specific cell is committed to 
For example the expression of Pdxl in a differentiating cell population would 
indicate pancreatic fate A selection of the most significant transcription factors 
which are strong candidates for specifying lineage commitment are discussed 
below and their interrelationship is summarised in Figure 1 2 2
12 31 Pdxl Expression in the Developing Pancreas
The homeobox transcription factor Pdxl also known as Ipfl, Stfl and Idxl was 
initially identified in mouse P tumour cells in 1991 (Ohlsson et al, 1991) and 
cloned in 1993 Pdxl is synthesised in the early rudiment that comprises the 
pancreatic buds as well as the surrounding gut epithelium The gut epithelium 
destined to dorsal pancreas commitment receives signals from the notochord to 
repress Shh expression, a negative regulator of Pdxl, thus facilitating Pdxl 
expression (Section 1 2) (Hebrok et al, 2000) Pdxl expression becomes 
restricted to p cells as the pancreas matures (Sona et al, 2001b)
A number of studies have identified Pdxl as a crucial regulator of pancreatic 
development In 1994, Jonsson et al demonstrated that transgenic mice 
homozygous for a targeted Pdxl gene mutation lacked a pancreas In 1997, 
Stoffers et al attributed pancreatic agenesis (lack of pancreas) in a patient to a 
homozygous point mutation in the Pdxl coding region, which resulted in a lack 
of functional Pdxl expression In 1998, Ahlgren et al employed the Cre-Lox 
system to disrupt Pdxl in p cells Pups were found to be normal at birth but 
became diabetic within 5 months Subsequent analysis revealed that they had 
60% less insulin-positive cells than normal animals and 17% of these cells co­
expressed Pdxl Further investigation revealed that mutant pups had a greater
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number of a  cells than normal pups Insulin/glucagon co-expressing cells were 
also found in mutant pups Using clonal populations of the rat INS-1 cell line, 
Wang et al (2001a) demonstrated that elimination of Pdxl in the transitory 
INSlaP population promoted a cell differentiation Overexpression of brain-4 
(an a cell differentiation marker) did not display a similar effect The study 
concluded that loss of Pdxl function is a prerequisite for a differentiation Pdxl 
is proposed as an a versus P cell fate determinant
Expression of pancreatic genes in particular P cell genes are dependent on Pdx 1 
expression level Pancreatic glucose transporter (glut2) expression was 
nonexistent when Pdxl was knocked out of P cells (Alhgren et al, 1998) The 
overexpression of Pdxl in INSip cells promoted expression of genes encoding 
insulin, IAPP, glut2 and nkx6 1 (Wang et al, 2001a) In 2004, Miyazaki et al 
used an ES cell line in which endogenous Pdxl expression was regulated by a 
Tet-off system to examine the effects of Pdxl expression during m vitro EB 
differentiation Pdxl expression enhanced expression of insulin II, Som, kir6 2,
j
glucokinase (gck), ngn3, p48, pax 6, prohormone convertase 2 (PC2) and HNF6 
genes in resulting differentiated cell types All are associated to pancreas 
development
Through monitoring Pdxl expression it has been observed that co-expression of 
other transcription factors is often necessary to mediate the effects of Pdxl For 
example transfection experiments demonstrate that Pdxl can stimulate insulin 
gene expression but in many cases the co-expression of beta 2 is necessary to do 
so (Serup et al, 1996, Madsen et al, 1997) Given the number of transcription 
factors involved in pancreatic development it is more than likely that Pdxl 
mediates its effects though the co-operation of the other factors (Figure 12 2)
12  3 2 Neurogenin 3 Expression in the Developing Pancreas
Ngn3 is a member of the basic helix-loop-helix (bHLH) family of transcription 
factors Ngn3 is expressed in both the developing pancreas and in neural cells 
Ngn3 is initially expressed at the time of pancreatic budding (Watada, 2004) 
Expression of the pro-endocnne ngn3 is both necessary and sufficient to drive 
progenitor cells in the developing pancreas to an endocrine fate Gradwohl et al
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(2000) demonstrated that ngn3-null mice failed to generate any pancreatic 
endocrine cells and died shortly after birth from neonatal diabetes The 
expression of Isll, pax 4, pax 6 and Neuro D was lost in these mice placing ngn3 
upstream of these targets (Chae et al, 2004) Ngn3 initiates the islet 
differentiation program but its expression is diminished before terminal 
differentiation of endocrine cells Smith et al (2005) concluded that ngn3 
functions as a transcriptional activator, initiating a cascade of gene expression i e 
nkx2 2, pax 4 events leading to endocrine differentiation However it represses 
its own expression in doing so
1 2 3 3 Beta 2 Expression in Developing Islet Cells
Neuro D/beta 2 is a bHLH transcription factor implicated in insulin gene 
expression and islet cell differentiation (Naya et al, 1997) It is also known to 
play a role in terminal differentiation of neurons (Lee et al, 1995)
Beta 2 mRNA is initially expressed in the mouse at e9 5 and continues to be 
expressed in P cells throughout maturation (Chae et al, 2004) Beta 2 is a 
downstream target of ngn3 This is based on the knowledge that the neurogenin 
family regulates protein expression of the Neuro D family during neurogenesis 
and overexpression of ngn3 in stable transfected endocrine cell lines activates 
endogenous levels of beta 2 mRNA Ngn3 deficient mice also fail to express beta
2 (Huang et al, 2000, Gradwohl et al, 2000) Pax 6 and pax 4 are both likely 
downstream targets of beta 2 within pancreatic endocrine development (Chae et 
al, 2004) Within the P cell the insulin gene was the first identified target of beta 
2 (Naya et al, 1995) Beta 2 heterodimenzes with ubiquitous bHLH proteins of 
the E2A family to regulate insulin gene transcription More recently a number of 
P cell target genes have been identified namely sulfonylurea receptor 1 (SUR1), 
islet-specific glucose-6-phosphate (G6Pase) catalytic subunit related protein 
(IGRP), and P-glucokinase (pGK) (Chae et al, 2004, Huang et al, 2000)
Newborn beta 2 null mice fail to form islets and die from hyperglycaemia within 
5 days from birth There is a significant decrease in the P cell number, as well as 
a reduction in a cells Typically in normal islets, a cells surround p cells, but in
2 6
beta 2 null mice this is not the case 1 e a and P cells are clustered separately 
along the ductal structure (Naya et al, 1997)
1 2 3 4 Islet 1 Expression in Developing Islet Cells
Isll is a LIM homeodomain factor expressed in the embryonic mesenchyme 
(surrounding the dorsal bud) and in all endocrine islet cell types (Chakrabarti & 
Raghavendra, 2003) Isll appears in glucagon positive cells at e9 5, prior to the 
appearance of differentiated insulin and Som expressing cells (Gradwohl et al, 
2000) Ahlgren et al (1997) used mice engineered with a disrupted Isll gene to 
demonstrate independent requirement of Isll in formation of pancreatic dorsal 
mesenchyme and islet cells The low level of Isll expression in p cells would 
suggest it doesn’t have a role in the regulation of insulin gene transcription 
(Habener et al, 2005) The importance of mesenchymal secretion has previously 
been discussed in Section 1 2
1 2 3 5 Pax Gene Expression in Developing Islet Cells
Pax genes are members of the paired homeobox transcription factor family 
They are similar to homeobox factors with the exception that they contain an 
additional paired domain (DBD) This additional DBD may increase specificity 
for promoter binding (Chakabarti & Raghavendra, 2003) Previous studies have 
demonstrated the necessity for pax activity in development of the eye, brain, 
kidney, thyroid gland, immune system and pancreas (Dohrmann et al, 2000) 
Both pax 4 and pax 6 are involved in pancreatic islet formation They appear to 
be strong candidates for specifying endocrine lineage differentiation (Chae et al, 
2004, Chakabarti & Raghavendra, 2003)
Pax 6 expression is detected during development of the dorsal and ventral buds 
(approx e9 0) and its expression becomes restricted to the 4 islet cell types in 
newborn animals Small eyeNtu mice (mice with a spontaneous mutation of the 
pax 6 gene) have disorganised islets and a reduced number of a, P, 5 and PP cells 
(Sander et al, 1997) Knockout pax 6 mice die within minutes of birth and fail to 
form islets (St Onge et al, 1997) Vetere et al (2003) demonstrated that 
transfection of ngn3 into RA-derived-endoderm F9 cells induced expression of
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pax 6, whilst Marsich et al (2003) proposed that Neuro D/beta 2 activates the pax 
6 gene
In contrast to pax 6, pax 4 is only required in cells destined to p and 5 cell fate 
Pax 4 is initially expressed in pancreatic precursor cells and becomes restricted to 
P and 5 cells prior to being turned off at birth (Chae et al, 2004) Mice deficient 
for pax 4 fail to develop insulin-producing P cells and Som producing 8 cells 
within their pancreas The mice have an abundance of a  cells (Sosa-Pineda et al,
1997) Pax 4 expression commits endocrine precursors towards a P and 5 cell fate 
whereas pax 6 expression promotes a cell specification (Chakrabarti & 
Raghavendra, 2003) Studies by Gradwohl et al (2000) and Smith et al (2003) 
supported the hypothesis that ngn3 functions as an upstream activator of pax 4 
Gradwohl et al demonstrated that the expression of Neuro D, pax 6 and pax 4 is 
lost in ngn3 deficient mice, whereas Smith et al demonstrated that expression of 
both ngn3 and HNFla is necessary for activation of the pax 4 gene in NIH3T3 
fibroblast cells Neuro D/beta 2 has also been proposed as a candidate upstream 
activator of pax4 but binding of Neuro D ^eta 2 to the pax 4 promoter has not 
been confirmed (Chae et al, 2004) In a study by Blyszczuk et al (2003), the 
constitutive expression of pax 4 combined with histotypic cultivation drove ES 
cell differentiation along a pancreatic lineage, leading to the formation of insulin 
secreting spheroids These islet-like spheroids normalised blood glucose levels 
when transplanted into streptozotocin-treated diabetic mice Wang et al (2004) 
suggested that the role of pax 4 in P cell differentiation is mediated via 
interaction with nkx2 2
1 2 3 6 Nkx Gene Expression and Islet Cell Determination
The nkx factors are homeobox transcription factors containing a conserved ten 
ammo acid sequence (the NK decapeptide) that interacts with transcriptional co­
repressors Nkx2 2 and nkx6 1 play crucial roles in islet cell formation 
particularly P cell lineage differentiation (Chakrabarti & Raghavendra, 2003)
The initial expression of nkx2 2 coincides with the dorsal pancreatic bud 
evagination at e9 5 The majority of pancreatic epithelial cells express nkx2 2 
however expression of the gene becomes more restricted to a subset of ngn3
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expressing islet precursors Unlike ngn3, nkx2 2 continues to be expressed in the 
mature endocrine cells a, p and PP cells (Watada, et al, 2003, Habener et al, 
2005) Nkx2 2 is a downstream target of ngn3 Neuro Dfteta 2 may act to 
maintain nkx2 2 expression after the disappearance of ngn3 (Watada, 2004, 
Smith et al, 2005) Mice deficient for nkx2 2 have no insulin-producing P cells 
and have a reduced number of a and PP cells There is a population of 
incompletely differentiated cells within these mutants, which express some P cell 
markers i e Pdxl and IAPP but do not express other definite P cell markers i e 
nkx6 1 (Sussel et al, 1998)
Expression of nkx6 1 is widely distributed in the pancreas until elO 5 but 
specifically expressed in P cells by the end of gestation (Chakrabarti & 
Raghavendra, 2003) Mice with a targeted disruption of the nkx6 1 gene form 
islets with minimal to absent P cell content, whereas all other cell types within 
these islets develop normally (Sander et al, 2000)
Expression of nkx2 2 immediately precedes that of nkx6 1 in the developing 
pancreas and it appears to be a requirement for the maintenance of nkx6 1 
expression (Sussel, et al, 1998, Sander et al, 2000) Both nkx6 1 and nkx2 2 play 
crucial roles in the final differentiation of P cells The insulin promoter contains 
binding sites for both nkx genes leading to speculation that these factors may 
cause p cell differentiation through direct activation of insulin in precursor cells 
(Chakrabarti & Raghavendra, 2003)
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Figure 1.2.2 Model for the role o f  transcription factors during cellular 
differentiation within the developing pancreas. Data was accumulated from 
transgenic and knockout mice, as summarized within the previous text. The 
positioning o f each transcription factor is based on the predominant timing o f  its 
function and not necessarily the timing o f  its synthesis. Although some factors 
act at more than one point during differentiation, for simplicity a single point is 
indicated for each (permission to use Figure received from Dr. Raghu G. 
Mirmira, MD, PhD, University o f Virginia Diabetes Center).
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1 3 The Islet P Cell
The primary function of P cells to produce insulin was first recognised in 1922 in 
studies carried out on dogs (Banting & Best, 1990) P cells are located adjacent to 
blood vessels These cells quantitively synthesize and secrete bioactive insulin in 
response to nutrients, hormones and nervous stimuli Blood glucose level is the 
primary modulator of insulin secretion Insulin facilitates the uptake of glucose 
into the tissues of the body In adjusting the insulin production in response to 
blood glucose concentrations P cells maintain glucose levels within a tight 
physiological range allowing for optimal functioning of all tissues in the body 
(Kirschstein & Skirboll, 2001, Kulkarm, 2004) As previously discussed in 
Section 1 2 the differentiation to pancreatic p cells is quite complex 
Furthermore, within the P cell there is a highly regulated complex network 
controlling cell function
1 3.1 The Insulin Gene
Insulin mRNA is initially expressed in the mouse embryo at e9 0 in the foregut 
from which the pancreas originates (Gittes & Rutter, 1992) In postnatal life it is 
widely accepted that insulin gene expression is restncted to P cells although there 
is some evidence of insulin expression in the central nervous system (CNS) and 
in the retina (Alpert et al, 1988, Devaskar et al, 1993, Budd et al, 1993) The 
human insulin gene is located on the short arm of chromosome 11 whereas the 
two mouse insulin genes are located on individual chromosomes i e Insulin I on 
chromosome 19 and insulin II on chromosome 7 The ancestral rodent insulin II 
and human insulin genes contain three exons whereas rodent insulin I lacks the 
second exon (Wentworth et al, 1986, Melloul et al, 2002)
13 11 Regulation of Insulin Gene Transcription
Tissue specific regulation is controlled by 55 flanking regulatory regions of the 
insulin gene Insulin genes share a number of conserved DNA motifs within the 
5’ flanking region suggesting that they may be regulated by similar factors 
(German et al, 1995) Deletion and mutational analysis of various insulin 
promoter regions in transgenic mice and transfected cell lines and have led to the 
identification of critical cis-acting elements in insulin gene transcription
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Positive and negative regulation of insulin gene transcription relies on the 
interaction of sequence motifs in the promoter with specific transcription factors 
(Figure 13 1) These interactions also determine the inducibility of the insulin 
gene by physiological stimuli 1 e glucose, glucagon-like peptide 1 (GLP-1) 
(Melloul et al, 2002)
Systematic mutagenesis of the rat insulin I promoter and transfection studies led 
to the identification of two regulatory sequences within the 5’ region namely El 
and E2 Disruption of these E boxes led to abolishment of transcriptional activity 
(Karlsson et al, 1987, Philippe, 1991) E boxes bind bHLH proteins, which 
function as transcriptional activators of tissue specific genes by forming 
heterodimers between ubiquitous and cell restricted members (Section 1 2 3 3) 
For example IEF1 is a heterodimer of the ubiquitous E2A gene product(s) E47 
and beta 2, which binds to the insulin promoter activating transcription
AT rich A boxes (A1-A5) are additional regulatory elements within the insulin 
promoter These A boxes with the exception of A2 contain a core TAAT 
sequence, which binds homeodomain transcription factors le  Isll and HNF1 
(Melloul et al, 2002, Chakrabarti & Raghavendra, 2003) Pdxl is known to 
directly bind to the A box elements and leads to the activation of the insulin 
promoter in conjunction with other transcription factors (Peshavana et al, 1997) 
Pdxl is present in about 91% of p cells and a subpopulation of 8 cells In the 
presence of glucose, Pdxl is activated through phosphorylation and translocates 
to the nucleus of the P cell where it transactivates the insulin gene, gck, glut2 and 
IAPP (Mac Farlane et al, 1999, McKinnon & Docherty, 2001, Serup et al, 1996, 
Melloul, 2002) p cell specific inactivation of Pdxl results in fewer insulin 
positive cells and reduced insulin and glucagon expression causing diabetes in 
mice (Ahlgren at al, 1998)
Hedgehog signalling has previously been discussed in relation to pancreatic 
development (Section 1 2) but it also appears to play a role in insulin gene 
transcription Indian hedgehog (Ihh) and desert hedgehog (Dhh) were both 
shown to positively regulate insulin gene transcription in cultured INS1 and
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MIN6 cell lines, and administration of the hedgehog inhibitor, cyclopamine, 
caused a decrease in insulin promoter activity (Thomas et al, 2000).
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Figure 1.3.1 Major transcription factor complexes that activate the insulin 
promoter in |3 cells (permission to use Figure received from Dr. Raghu G. 
Mirmira, MD, PhD, University o f Virginia Diabetes Center).
1.3.1.2 Glucose Regulation of Insulin Gene Expression
Glucose homeostasis requires tight regulation of insulin production and 
secretion. Glucose must be metabolized within the B cell to stimulate insulin 
release. The first indication of a glucose effect on the insulin gene was reported 
over 35 years ago (Jarret et al, 1967) and since then the complexity of molecular 
elements regulating this effect has been studied (Melloul et al, 2002). It was 
initially believed that the short-term effects of glucose were predominately at a 
post-transcriptional level i.e. stabilisation of insulin mRNA. In 1998, Leibiger et 
al demonstrated that short-term exposure of HIT-T15 B cells to stimulatory levels 
of glucose led to significant increases in insulin gene transcription. Direct 
interaction of glucose with the insulin enhancer through the Z element of the 5’ 
flanking region of the human insulin gene has been observed (Sander et al,
1998).
Inducible transcription of the insulin gene appears to depend on the same 
regulatory sequences within the promoter/enhancer region that control the cell 
tissue specificity of the insulin gene. Thus glucose responsiveness is mediated 
by cis-elements within the 5’ flanking region of the gene (Section 1.3.1.1). It 
appears that glucose regulates a number of transcription factors interacting with
E47 Lmx1.1 
NeuroDI
NeuroDI
P300
HNF4a
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the insulin promoter For example it has been shown that extracellular glucose 
concentrations regulate the binding of Pdxl to the A3 element within the 5’ 
region of the insulin gene (Melloul et al, 2002) Glucose also effects insulin gene 
transcription through the action of cyclic adenosine monophosphate (cAMP) 
response elements Glucose and other hormones such as GLP-1 increase 
intracellular cAMP (Melloul et al, 2002, Charles et al, 1975, Nielsen et al, 1985, 
Hammonds et al, 1987, Inagaki et al, 1992) There are 4 cAMP responsive 
elements (CRE) within the insulin gene contributing to cAMP-inducibility of 
insulin transcription (Inagaki et al, 1992) The interaction of cAMP with these 
elements is mediated by a CRE binding protein (CREB) Thus cAMP could 
almost be described as a form of second messenger for glucose activation of the 
insulin gene (Melloul et al, 2002)
Glucose stimulates initiation of insulin translation and causes increased transfer 
of initiated ribosome bound RNA from the cytoplasm to the rough endoplasmic 
reticulum (RER) (Welsh et al, 1987)
13 13  GLP-1 Regulation of Insulin Gene Expression
GLP-1 is a physiological incretin hormone secreted from enteroendocnne L-cells 
of the intestine GLP-1 is derived from post-translational processing of 
proglucagon and is released from the gut in response to nutnent ingestion GLP- 
1 is known to stimulate insulin gene transcription, expand P cell mass and 
augment GSIS The effect of GLP-1 on insulin gene expression is mediated via 
the CRE in the promoter region of the insulin gene (Section 13 12) The effects 
of GLP-1 on 13 cell function are in part attributed to increases in cAMP 
concentration with concomitant activation of protein kinase A (PKA) (Melloul et 
al, 2002) The effects of GLP-1 on insulin transcription and cell proliferation 
have also been attributed to an upregulation of Pdxl (MacDonald et al, 2002) 
Pdxl translocation to the nucleus in RIN 1046-38 cells has shown to be 
dependent on cAMP/ PKA (Wang et al, 2001b)
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1.3.2 Insulin Biosynthesis and Processing
The insulin mRNA is translated as a single chain 11.5 kDa precursor 
preproinsulin (PPI). The removal of PPI’s signal peptide during insertion into 
the endoplasmic reticulum generates proinsulin. The proinsulin (9 kDa) consists 
of three domains: an amino terminal B chain, a carboxyl terminal A chain and a 
connecting peptide in the middle known as the C-peptide fragment. Disulphide 
bond formation occurs within the Golgi apparatus. Proinsulin is then passed 
through the Golgi cisterne to the trans-Golgi network (TGN) where it is 
packaged into immature secretory granules. The C-peptide aligns the proinsulin 
for cleavage to mature insulin (Howell, 1991; Docherty, 1997). The immature 
secretory granules can either form part of a constitutive pathway or regulated 
pathway of protein secretion. If constitutively secreted, the immature granules 
are transported immediately to the P cell membrane and a mixture of insulin and 
proinsulin is released. During regulated secretion the proinsulin is stored in 
secretory granules where it is converted to mature insulin via the action of 
endoproteases and carboxypeptidase (Figure 1.3.2). The endoprotease PC2 and 
PCI (prohormone convertase) are enzymes that are restricted to neuroendocrine 
cells (Smeekens et al, 1991; Bennet et al, 1992; Docherty et al, 1997). PCI 
cleaves the sequence at the B-chain C-peptide junction and PC2 cleaves at the A- 
chain C-peptide junction. These two intermediate molecules are converted to 
mature insulin and C-peptide by carboxypeptidase action (Figure 1.3.3). Insulin 
(6 kDa) and C-peptide (3 kDa) is released from the P cell in eqimolar amounts by 
exocytosis upon stimulation of insulin secretion by glucose. The large 
concentration of protein/hormone in the storage granules facilitates the secretion 
of large amounts upon stimulation by a secretagogue (Halban & Irmanger, 1994).
Insulin B chain y C-Peptide y Insulin A chain
PC1 PC2
Figure 1.3.2 Cleavage Points for PCI and PC2
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Figure 1.3.3 Processing of proinsulin to insulin. Following initial cleavage by 
either PCI or PC2, trimming of the residual C-terminal residues is carried out by 
the action of ubiquitously expressed carboxypeptidases.
1.3.3 Glucose Sensing in the p Cell
To correctly control blood glucose levels, the p cell must be able to accurately 
sense/determine how much glucose is present in the blood. The glucose level is 
determined from the metabolism of the blood glucose and the subsequent 
changes in blood metabolites (Ashcroft, 1980; German, 1993). GSIS requires 
that the metabolism of glucose can be increased within the P cell over the entire 
physiological range of glucose (Marshall et al, 1993; Ishihara et al, 1994). The 
most important components of the glucose sensor are (I) glut2, which facilitates 
rapid glucose uptake regardless of the extracellular sugar concentration and (II)
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glucokinase (gck), the activity of which is the rate-limiting step for glucose 
metabolism (Schuit et al, 2001).
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Figure 1.3.4 Glucose stimulated secretion from B cells depends on the presence 
of correct glucose sensing, insulin storage and regulated secretion pathways.
The relative importance of the two components of the glucose sensor were 
compared by the overexpression of their low Km counterparts i.e. glutl and 
hexokinase I in the MIN6 cell line. Expression of hexokinase I increased glucose 
utilisation and release at concentrations below 10 mM. Glutl expression had no 
effect on GSIS (Ishihara et al, 1994). Patients with maturity onset diabetes of the 
young (MODY) exhibit impaired GSIS due to a point mutation in the gck gene. 
A similar disruption of gck gene in transgenic mice causes the same phenotypic 
effect (Bali et al, 1995). It has also been demonstrated that mutations in the glut2 
gene abolishes glucose transport in a patient with non-insulin dependent diabetes 
mellitus (NIDDM) while the expression of glut2 antisense has led to diabetes in 
transgenic mice (Mueckler et al, 1994; Valera et al, 1994). The presence of gck is
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the main rate limiting glucose sensor but a combination of glut2 and gck is 
required for effective glucose sensing For example MIN7 insulinoma cells 
(isolated at same time as MTN6) were found to be glucose insensitive due to a 
combination of high levels of hexokinase I and Glutl (Miyazaki et al, 1990)
13 4 Stimulated Insulin Secretion from (3 Cells
Insulin injections do not provide the minute-to-minute control of blood glucose 
level and are therefore not efficient at maintaining glucose homeostasis In 
contrast, P cells use highly regulated secretion pathways to provide a 
proportional release of stored insulin in response to the blood glucose level
13 41 Regulated Pathways of Protein Secretion
The majority of secretory proteins from eukaryotic cells originate in the RER and 
are then transferred to the Golgi apparatus The TGN plays a crucial role in 
directing proteins in the secretory pathway to the appropriate cellular destination 
The proteins may enter a constitutive pathway of secretion or a regulated 
secretion pathway (Kelly, 1985, Traub & Komfeld, 1997)
Secretion via the regulated pathway allows the release of protein to be controlled 
by secretagogues The action of the secretagogue occurs at the level of 
exocytosis and allows the discharge of protein from mature secretory granules at 
an appropriate moment The earliest form of granule is clathenn coated The 
bulk of prohormone conversion occurs as the clathenn-coated granule matures 
The clatherin coat is eventually lost Secretion via the constitutive pathway 
results in continuous exocytosis meaning that protein availability is the main 
modulator of this pathway and thus is only regulated at the level of biosynthesis 
(Halban & Irminger, 1994) When cDNA encoding proinsulin was transfected 
into a mouse cell line secreting adrenocorticotropic hormone (ACTH) via the 
regulated pathway, storage, processing and secretion of the proinsulin upon 
stimulation occurred (Moore et al, 1983, Motoyoshi et al, 1998) Thus, it seems 
that regulated proteins such as proinsulin have structural determinants, which 
cause them to be sorted in to the regulated secretion pathway (Halban & 
Irminger, 1994, Traub & Komfeld, 1997)
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1 3.4 2 Glucose Stimulated Insulin Secretion
Insulin secretagogues can be divided into two groups l e initiators and 
potentiators Initiators can stimulate secretion on their own where as potentiators 
can enhance insulin secretion in the presence of an initiator Glucose is the most 
important initiator of insulin secretion 13 cells are sensitive to changes in glucose 
from approx 5-8 mM to 20 mM (Knaack et al, 1994, Poitout et al, 1996, Best, 
2000) l e there is no glucose stimulation below 5 mM and maximum stimulation 
insulin secretion occurs at 20 mM approximately
Knowledge of the mechanisms involved in insulin stimulus-secretion has 
increased remarkably in the last 15 years Studies have demonstrated that 
stimulation by glucose triggers characteristic electrical responses at the P cell 
membrane (Ullrich et al, 1996) These changes in membrane potential are due to 
knock-on effects from glucose metabolism Increased blood glucose leads to 
increased glucose metabolism, determining the extent of insulin secretion 
Increased glucose metabolism results in an increase in the ATP/ADP (adenosine 
tnphosphate/adenosine diphosphate) ratio within the P cell causing the closure of 
ATP sensitive potassium channels on the cell membrane Once these channels 
are closed membrane depolarisation occurs i e the cell becomes less negative a 
result of the build up of K+ ions Membrane depolarisation results in the opening 
of the voltage gated Ca2+ channels in the P cell membrane, thus allowing Ca2+ 
ions to flow into the cell This increase in intracellular calcium results in 
translocation of the insulin storage granules to the cell membrane and facilitates 
release of stored insulin In resting p cells the K+ channels are open allowing a 
steady flow of K+ ions out of the cell, holding the membrane potential of the cell 
at a negative level of approx -70 mV(Ashcroft & Gribble, 1999, Best, 2000, 
Howell, 1991, Ullrich et al, 1996) See Figure 1 3 4
Evidence for an alternative Ca2+ independent mode of secretion has been also 
been reported Glucose has been shown to augment insulin secretion in Ca2+ - 
depleted rate islets in the absence of both extracellular Ca2+ and a rise in [Ca24^  
This augmentation effect operates best when PKA and PKC are maximally 
activated in the 13 cell (Komatsu et al, 1997, Bratanova-Tochkova et al, 2002) In 
MIN6 cells it was observed that adenylate cyclase activator forskolin (increases
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intracellular cAMP) caused an increase in insulin secretion without an increase in 
intracellular calcium This and other observations involving glucose, leucine and 
argmine in Ca2+ -free systems indicate that there is another mechanism of 
secretion that involves cAMP and cellular alkinalization (Sakuma et al, 1995)
1 3 4 2.1 Factors affecting GSIS
The response of 13 cells to glucose is heterogeneous in nature both at the level of 
insulin biosynthesis and secretion (Moitoso de Vargas et al, 1997, Giordano et al, 
1993) It was discovered that the GSIS response from 13 cells is heterogeneous 
due to differing 13 cell size, and not as a result of individual cell metabolism of 
glucose The release of insulin in response to glucose is also dependent on cell- 
to-cell contacts within the islets When the insulin levels, secretion rates and 
GSIS capabilities of intact islets, dispersed islet cells and re-aggregated islet cells 
were compared, it was found that the single cells and aggregates had a reduced 
response to glucose signals in perfusion assays This was considered to be, at 
least partly, due to disruption of cell-to-cell signalling due to loss of gap 
junctions (Linzel et al, 1988) Homologous contact between (3 cells rather than 
with other islet cell types is critical to effective GSIS (Bosco et al, 1989) Gap 
junctions are cell-to-cell channels, which allow direct transfer of ions and 
metabolites e g  cAMP, calcium between cells Channels are formed by the 
interaction of hemichannels on one cell with the open channel of another 
(Willecke et al 1991)
1 3.4 2 2 The Effect of GLP-1 on GSIS
GLP-1 binds to a G protein-coupled receptor on 13-cells to stimulate insulin gene 
transcription, GSIS and 13 cell growth (Section 13 13) GLP-1 is proposed to 
modulate GSIS by regulating the activity of the ion channels involved in 
depolarization of the 13 cell membrane It has been observed that GLP-1 inhibits 
13 cells K At p  channels (previously referred to as ATP sensitive potassium 
channels in Section 1 3 4 2) resulting in membrane depolarization triggering Ca2+ 
influx and subsequent exocytotic release of insulin The inhibitory effect of 
GLP-1 on K Atp  channels is thought to be cAMP/PKA-dependent (MacDonald et 
al, 2002, Melloul et al, 2002)
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1 3 4 2.3 M1N6 Insulinoma Cell Line as a B cell Model to Study GSIS
The potential use of replacement P cells/islets as a cell therapy for type 1 
diabetes relies on the ability to culture such cells/islets in vitro, whilst 
maintaining their functional status The GSIS phenotype is relatively unstable in 
long-term culture and current research is focused on understanding the factors 
affecting functional GSIS The MIN6 cell line is an attractive model for studying 
phenotypic and genomic changes associated with the loss of GSIS in culture
MTN6 cells, originally isolated from insulinomas generated within SV40 T 
antigen-expressing mice and shown to share many characteristics with freshly 
isolated P cells (Miyazaki et al, 1990), have been described as a rare example of 
a transformed mouse P cell line that has retained many relevant aspects of a P 
cell, including GSIS (Lilia et al, 2003) MIN6 cells are also known to express 
glucagon, Som and IAPP (Ohgawara et al, 1995, Kanatsuka et al, 1992)
The reported stability of MIN6 in culture varies MIN6 cells have been 
characterised as being stable for 30-40 passages le  with an intact GSIS 
response MIN6 can exhibit an increase in insulin secretion of almost 10-fold 
upon stimulation with 25 mM glucose (Miyazaki et al, 1990) Other researchers, 
however, have noted only moderate GSIS responses (approximately 1 2 fold) 
from MIN6 cells by passage 16 (Kayo et al, 1996)
In a study of low/early passage (passage 17-19) MIN-6 cells, Webb et al (2000) 
investigated expression profile of P cells exposed to high (25 mM, continuously) 
and low (5 5 mM, for 24 hours) glucose to identify genes involved in insulin 
secretion (using the Affymetnx Mu6500 oligonucleotide array) The two largest 
clusters of genes differentially expressed between low and high glucose 
conditions were those encoding secretory pathway components and enzymes of 
intermediary metabolism It must be considered that optimised conditions for 
culturing P cells are typically supra-physiological / e MIN6 -  25 mM (Miyazaki 
et al, 1990, Lilia et al, 2003, O’Driscoll et al, 2004a) Following isolation of 
glucose-responsive (m9) and a non-responsive (m l4) MIN6 clonal populations at 
passage 18, Minami et al (2000) reported 10 genes (from 216 combinations of
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anchored and arbitrary primers) to be differentially expressed, using differential 
display techniques These included gck (involved in glucose phosphorylation, 
levels in m9>ml4), stanniocahn/STC (involved in calcium regulation, levels in 
m9>ml4), and delta-like homologue 1 (dlk) /Pref-1 (involved in (3 cell 
differentiation and growth, levels in m9>ml4) Other gene transcripts, including 
glut2, were unchanged Two clonal populations of MIN6 (01 responsive to 
insulin and other secretagogues, C3 non-responsive) were isolated by Lilla et al 
(2003), using the same approach, and differentially expressed genes were 
identified using suppression subtractive hybridisation techniques and 
oligonucleotide (Affymetnx, MG-U74) microarrays Genes clustered as being 
involved in metabolism, intracellular signalling, cytoarchitecture, and adhesion 
were identified as being of potential interest MIN6-P1 cells, however, tend to 
lose their GSIS beyond approximately 30 passages also (V Lilia, pers comm )
13 4 2 31  Loss of GSIS in the MIN6 maybe attributed to De-differentiation
Loss of GSIS is accompanied with a decrease in proinsulin processing enzymes 
PCI and PC2 with a concommitment increase in furin that was linked to MIN6 
adopting a de-differentiated state with increasing passage number (Kayo et al, 
1996)
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1 4 Advances in Stem Cell Therapy for Diabetes Mellitus (DM)
Stem cell therapy for DM implies the replacement of diseased or lost functional 
insulin-producing pancreatic cells, with pancreas or islet-cell transplants As 
previously stated (Section 1 1 8) there is a shortage of donor organs, which has 
spurred on the current research into alternative means of generating P-cells/islets 
Table 1 4 1 summarizes the studies to date that have reported the generation of 
ES-denved insulin-expressing cell types
14 1 Protocols Used in the Derivation of Pancreatic Phenotypes from Mouse 
ES Cells
A number of studies reporting the derivation of insulin-secreting structures from 
mouse ES cells have been published within the last 6 years Some of the more 
interesting findings are discussed below
In February 2000 Bernat Sona and his research team derived insulin-secreting 
cells from R1 mouse ES cells that normalised glycemia in streptozotocin induced 
diabetic mice Researchers used a cell trapping technique that involved 
transfecting the mouse ES cells with a construct, which coupled the regulatory 
region of the human insulin gene to a neomycin resistance gene i e those cells 
which expressed insulin would also express neomycin resistance This chimeric 
gene was also fused to the hygromycin resistance gene (pGk-hygn) to allow for 
the selection of transfected cells The hygromycin resistant mouse ES cells were 
grown in suspension culture in medium lacking supplemental LIF The 
differentiated cells underwent a final maturation step based on the use of 
nicotinamide (NIC) and non-stimulatory glucose concentrations Over 3 weeks 
the insulin content of the cells increased 20 fold and the overall yield of glucose 
responsive insulin-positive cells was high Clusters of the resulting clone were 
transplanted into the spleen of streptozotocin induced diabetic mice The mice 
corrected hyperglycemia within 1 week and restored body weight within 4 
weeks 12 weeks after transplantation 40% of the mice developed 
hyperglycaemia and it was thought that this was due to the short lifespan of the 
transplanted cells Whilst further studies were needed to characterise the clones 
developed by Sona et al, the study was an encouragement to other scientists in
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the pursuit of a diabetes therapy using ES cells (Sona et al, 2000, Sona et al, 
2001a)
In 2001, Lumelsky et al used a 5-stage protocol based on the enrichment of ES 
derived nestin-positive cells to yield islet-like clusters containing 15% msulin- 
positive cells Glucagon, Som and PP expressing cells were also present in these 
clusters In vitro the clusters demonstrated GSIS whilst in vivo the clusters 
managed to extend the lifespan of diabetic mice but had no effect on 
hyperglycaemia (Lumelsky et al, 2001) In 2002, a study using a modified 
version of the Lumelsky protocol (addition of a P13K inhibitor i e LY294002) 
gave rise to structures similar in topology to the pancreatic islets of Langerhans 
These cells produced insulin at levels greater than previously reported and 
completely rescued survival in diabetic mice, whilst improving glycemic control 
(Hon et al, 2002) Both Miyazaki et al (2004) and Blyszczuk et al (2003) 
modified the Lumelsky protocol by introducing transcription factors (l e Pdxl 
and pax 4) to generate pancreatic-phenotypic cells demonstrating variable insulin 
release
Kahan et al (2003) used a different approach to demonstrate the ability of ES 
cells to differentiate into pancreatic and islet lineage restncted stages (Section 
1 1 6 1) ES cells grown and differentiated in non-selective medium containing 
serum gave rise to differentiated cell types individually expressing insulin, 
glucagon, Som and PP Antibodies that specifically distinguish between C- 
peptide cleaved from proinsulm I and proinsulin II were used to determine 
whether differentiated cell types were producing insulin I and insulin II
14 2 Protocols Used in the Derivation of Pancreatic Phenotypes from 
Human ES Cells
The techniques used to differentiate human ES cells towards pancreatic cell types 
are somewhat different than those used for murine ES cells In 2000 Schuldiner 
and his colleagues carried out a study to look at the effects of eight growth 
factors (GFs) on the differentiation of human ES cells (H9 clone 1) The growth 
factors tested were as follows bFGF, transforming growth factor (31 (TGF-(31),
44
activin A (AA), BMP-4, hepatocyte growth factor (HGF), epidermal growth 
factor (EGF), P nerve growth factor (PNGF) and RA 5-day old EBs (in 
suspension) were tested for the presence of the growth factor’s respective 
markers to ensure that the growth factors could have an effect on the human ES 
cells As expected with pluripotent cells a broad range of receptors for the 
growth factors was detected EBs were then dissociated and plated After a 10 
day exposure to the GFs, differentiated cells became more homogeneous and 
resembled specific cell types Reverse transcriptase polymerase chain reaction 
(RT-PCR) gene expression results indicate that treatment with NGF and HGF 
activates transcription of a variety of liver and pancreas restricted genes during 
differentiation of ES cells Both untreated EBs and those treated with NGF 
expressed Pdx-1 (gene that controls insulin transcription and is associated to the 
formation of B cells) Prior to the formation of EBs Pdx-1 was not detectable 
These results suggested that (a) islet cells maybe one of the cell types present 
after spontaneous differentiation into EBs and (b) NGF may be a significant 
signalling factor in directing differentiation towards P cells (Schuldiner et al, 
2000)
A study by Assady and colleagues (2001) complemented the above findings by 
further charactensing insulin-producing cells in EBs The researchers allowed 
human ES-H9 cells to spontaneously differentiate in vitro in both adherent and 
suspension cultures Immunohistochemistry using anti-insulin antibody indicated 
that 1 -  3% of the cells present in EBs were insulin producing P-cells Islet 
specific gck and glut2 mRNAs, which play important roles in p cell function, 
were detected after but not before differentiation Although the investigators did 
not demonstrate glucose responsiveness, they did show that cells cultured in 
glucose containing medium secrete insulin into the culture medium Evidently 
EBs contained a subset of cells that have many of the characteristics of a 
functioning P cell
In 2004, Segev et al presented a protocol for the differentiation of human ES 
cells into insulin-producing clusters The protocol consisted of several steps 
EBs were cultured and plated in lnsuhn-transferrin-selemum-fibronectin medium
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(ITSFn), followed by medium supplemented with N2, B27, and bFGF Next, the 
glucose concentration in the medium was lowered, bFGF was withdrawn, and 
NIC was added Dissociating the cells and growing them in suspension resulted 
in the formation of clusters which exhibited higher insulin secretion and had 
longer durability than cells grown as monolayers RT-PCR analysis revealed an 
enhanced expression of pancreatic genes in the differentiated cells 
Immunofluorescence and in situ hybridization analyses revealed a high 
percentage of insulin-expressing cells in the clusters In addition to insulin, most 
cells also coexpressed glucagon or Som, indicating a similarity to immature 
pancreatic cells
14  3 Controversy Surrounding Published Protocols
Several authors have successfully shown differentiation of ES cells into p cell 
types, however, subsequent studies have been unable to confirm these results 
(Sipione et al, 2004 Kama et al, 2004) The most common criticism of these 
studies is the lack of evidence to support de novo insulin synthesis Both 
Rajagopal et al and Sipione et al found that the reported detection of insulin 
mRNA in ES-derived insulin-positive cells was inconsistent and weak 
Exogenous insulin (in the form of supplements i e B27, N2 e tc ) was added to 
the culture medium in several protocols ES-denved cells had small condensed 
nuclei and appeared to be undergoing apoptosis Thus, uptake of insulin and 
release by cells undergoing apoptosis contributed to the illusion of msulin- 
expression and secretion It has been suggested that demonstration of C-peptide 
biosynthesis and secretion is necessary to confirm insulin production within ES- 
derived progeny (Rajagopal et al, 2003, Hansson et al, 2004, Sipione et al, 2004)
i
Both pancreatic and neuronal cells were generated by the majority of published 
protocols (Lumelsky et al, 2001, Hon et al, 2002, Rajagopal et al, 2003, Sipione 
et al, 2004, Miyazaki et al, 2004, Hansson et al, 2004) In the study by Sipione et 
al, the ES-denved insulin-positive cells rarely showed immunoreactivity for C- 
peptide and were mostly apoptotic The mam insulin producers within the 
differentiated culture were those with a neuronal phenotype Kama et al (2004) 
suggested that the selection for nest in-positive cells and the use of bFGF within
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published protocols induced commitment to a neuronal fate rather than a 
pancreatic fate In 2005, Milne et al demonstrated that insulin-positive cells 
derived by spontaneous differentiation of ES cells appeared to be extra- 
embryonic in origin Whilst these cells expressed insulin, they also expressed 
increased levels of Oct 4, Pdxl and AFP mRNA which is consistent with extra- 
embryonic lineage specification
In summary, current protocols yield a small fraction of immature and/or 
apoptotic insulin-expressing cell types within a heterogeneous population that 
may be of a neuronal, extra-embryonic or endocrine lineage Studies such as 
those by Sipione et al (2004), Rajagopal et al (2003), Hansson et al (2004) and 
Milne et al (2005) highlighted the need for stringent entena in defining P cell 
identity i e the evaluation of transcript expression of both target and non-target 
cell types, expression of key P cell proteins and demonstration of de novo insulin 
synthesis
14 4 Nestin-Positive Pancreatic Progenitors
B cells in the pancreas have a life span of approximately 50 days at which time 
they are replaced by neogenesis of progenitor cells Identification of these 
progenitors is essential in understanding islet cell regeneration A number of 
studies in recent years have proposed that cells expressing nest in represent 
multipotent progenitor cells of the pancreas (Hunziker et al, 2000, Zulewski et al, 
2001, Wiese et al, 2004) Nestin is an intermediate filament protein normally 
found in neural precursors but is more recently emerging as a potential marker of 
intra-islet stem cells
Zuleweski et al (2001) isolated nestin-positive cells from adult rat and human 
pancreas and differentiated these cells ex vivo into pancreatic endoenne, exocrine 
and hepatic phenotypes Treatment of nestin-positive cells with GLP-1 induces 
differentiation to insulin secreting cells through the activation of Pdxl (Abraham 
et al, 2002) During embryogenesis nestin expression has been shown to precede 
the appearance of B cells (Abraham et al, 2002, Huang & Tang, 2003) In 2005, 
Wang et al demonstrated that a heterogeneous population of nestin progenitors 
could be expanded from islet-derived epithelial monolayers A subpopulation of
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nestin/Pdx 1 progenitors identified within these progenitors could yield msulin- 
producing cells
Despite these findings, controversy still exists over the use of nestin as a 
pancreatic progenitor marker Studies reporting nestin immunoreactivity in 
ductal epithelium (a pancreatic compartment known to harbour islet progenitors) 
were challenged by others reporting that nestin is only a marker of mesenchymal 
or endothelial cell types (Klein et al, 2003, Lardón et al, 2002, Selander & 
Edlund, 2002) Kama et al (2004) presented a detailed comparison of protocols 
used to generate pancreatic phenotypes and concluded that the selection of ES- 
denved nestin-positive cells should be omitted as these cells are already 
committed to a neural fate prior to pancreatic differentiation
As discussed previously in Sections 1 4 1 and 14 2 the selection for nestin- 
positive cells (by ITSFn) has become a common step in protocols developed to 
generate insulin-expressing cell types
14  5 Endodermal/Ectodermal Multipotential Progenitors9
Research into pancreatic and neuronal development has indicated a close 
relationship between neural and pancreatic cell types Some of the 
characteristics shared between pancreatic endocrine cells and neuronal cells are 
electrical excitability, neuronal adhesion molecules (i e NCAM), communication 
between cells through specialized molecules (i e cadherins), expression of 
neuropeptide-processing enzymes and expression of glucose transporters 
Transcription factors implicated in the development and function of islet cells i e 
Isll, ngn3, Neuro D, pax 6, pax 4, nkx2 2, are also implicated in the development 
of the CNS (Hunziker & Stem, 2000, Kama et al, 2004, Montoh et al, 2003) 
Nestin-positive progenitors are also common to both neuronal and pancreatic 
development (Section 1 4 3) The hypothesis that similar mechanisms are 
involved in the development of both neuronal and P cells, has led to attempts to 
generate insulin-producing cells from ES cells using modifications of a protocol 
originally developed to generate neurons e g Lumelsky et al, 2001
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Studies supporting the existence of neuroendocrine progenitors have been 
published Seaberg et al (2004) reported the isolation of endodermal/ectodermal 
multi-potential precursors from adult pancreatic tissue Induced differentiation 
of these cells resulted in neural and pancreatic cell types, including neuronal and 
glial cells, pancreatic endocrine 0-, a- and 5- cells and pancreatic exocrine and 
stellate cells More recently Burns et al (2005) reported the in vitro 
differentiation of rat neural stem cells into an insulin-expressing phenotype 
These insulin-positive cells express functional responses typical of pancreatic P 
cells, including glucose-dependent increases in metabolism and rapid elevations 
in intracellular Ca2+ in response to tolbutamide or to increased glucose 
concentration
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Table 1 4.1 A summary of studies relevant to the derivation of insulin-expressing cells from ES cells
Author Year Cells Genetic
Modification
Treatment Analysis [Insulin ] Comment
Sona 00 mES 1B/3X-99 
(no feeder)
Ins Prom-cell 
trap
EB + Nicotinamide + 
low glucose
GSIS RIA/ In Vivo 16 5 ng/|ig content 
318 pg/jig release
Human 
insulin gene
Lumelsky 01 mES E14 1/B5 5 Stage ICC (ms, glue, som, 
PP)/GSIS ELISA
145 ng/mg content 
2 87 ng/mg release
Nestin + 
selection
Assady 01 hES H9 Spontaneous (EB 
formation versus 
monolayer culture)
IHC (ins)/GSIS ELISA 315 jiU/ml 
release (not in 
response to 
glucose)
Hon 02 mES
JMI/ROSA
Modified 5 Stage EHC (ms, C-pep, glut2, 
gck, Pdxl)/GSIS 
ELISA 
In vivo
11300 ng/mg 
content
+ Ly294002 
= PI3K 
inhibitor
Blyszczuk 03 mES R1 Pax 4+/Pdxl + Modified 5 Stage IF (ms, glue, som, PP) 
/ELISA GSIS 
In vivo
98 7 ng/mg Pax 4 
important
Kahan 03 mES D3 Spontaneous->EBs 
plated on gelatin
IHC(ins, C-pep, glue, 
som, PP)
Data not shown Very low % 
spontaneous 
Ins+ cells
Rajagopal 03 mES E14/R1 & 
hES H9
5 Stage IF (ins, C-pep) Data not shown Insulin
absorption
Montoh 03 mES EB3 (Oct 
4 Prom-cell 
trap)
Ins Prom- 
LacZ
(no feeder)
Modified 5 Stage Bgal/IHC(ins, glue, 
Pdxl)/GSIS ELISA
3 255-4 725 pg/mg 
release
Exo+endo 
w/o pdxl 
induction
Blyszczuk 04 mES R1 
(Pax4+)
Pax 4+ Multi-stage, no nestin 
selection
IF(C-pep/ins)/GSIS 
ELISA Un vivo
168 ng/mg content 
27 ng/mg release
C-pep+/ins+
cells
generated
Miyazaki 04 mES EB3 
(no feeder)
Tet+/-Pdxl Modified 5 stage 
(±dox)
IHC(C-pep/ins)/GSIS
ELISA
8-10 ng/mg release 
(not in response to
Timing of 
Pdxl
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glucose) induction
important
Segev 04 hES H9 Modified 5 Stage IF(C-pep, ins, glue, 
som)/GSIS ELISA
225
uU/ml/l 0A5 cell s/hr 
release
Sipione 04 mES
AB1/D388/J1
Ins Prom-GFP 5 stage ICC(ins, C-pep, 
gluc)/GSIS RIA
75-150 ng/10A6 cell 
content
(Released insulin 
but not in response 
to glucose)
Nestin+ cells 
do not lead to 
beta cells
Leon-
Quinto
04 mES D3 
(no feeder)
Nkx6 1 Prom­
cell trap
Reduced
serum/Nicotinamide/
Anti-Shh/Pancreas
rudiments
ICC(ins/Pdxl,
nkx6 1),/GSIS RIA//«
vivo
150-200 ng/mg 
content
Pancreatic 
rudiments 
most effective
Micallef 05 mES W9 5 Pdxl-GFP RA GFP Fluorescence/ 
Flow Cytometry
Data not shown Pancreatic
Endoderm-
>Pdxl
Yan-Shi 05 mES R1 
(no feeder)
Ins Prom-GFP AA/RA EBs->B27, 
NIC, N2, bFGF
IHC(C-pep/ins)/GSIS 
ELISA//« vivo
1 25 ng/mg release Difficult
treatment1
Milne 05 mES D3, CCE 
(no feeder)
High density growth 
(no EB formation)
IF(Oct 4 only)/Ca++ 
microfluonmetry
Data not shown Ins+ cells are 
from 
primitive 
endoderm
Note ELISA, Enzyme Linked Immunosorbent Assay, RIA, radioimmunoassay, IF, immunofluorescence, ICC, immunocytochemistry, IHC,
immunohistochemistry, mES, mouse embryonic stem cell, hES, human embryonic stem cell, GSIS, glucose stimulated insulin secretion, C-pep, 
C-peptide (connecting peptide), Ins, insulin, EB, embryoid body, Pdxl, pancreatic duodenal homeobox factor 1, PP, pancreatic polypeptide, 
som, somatostatin, glue, glucagons, Shh, some hedgehog, RA, retinoic acid, AA, activin A, bFGF, basic fibroblast growth factor, GFP, green 
fluorescent protein, exo, exocrine, endo, endocrine, w/o, without
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1 5 Common Agents Employed in Directing the Differentiation of ES cells
Spontaneous differentiation of ES cells can give rise to numerous cells types Current 
research is focused on enriching differentiated populations for a desired cell type As 
previously mentioned in Section 1 1 5 the addition of differentiating agents/growth 
factors to the culture media is one of the current methods employed in directing the 
differentiation of ES cells The success achieved with some of these agents is 
discussed below
15  1 Retinoic Acid
RA is a powerful morphogemc derivative of vitamin A It plays a role in embryonic 
development in particular neural differentiation and specification in the developing 
CNS (Moms-Kay & Sokolova, 1996, Maden et al, 2000, MacCaffery & Dragner, 
2000) The formation of neural lineages from pluripotent ES cells m response to RA 
was previously discussed in Section 1 1 7  1
RA has also been identified as an inducer of endodermal and endocrine differentiation 
using a variety of mouse models Both Vetere et al (2003) and O’Drtscoll et al 
(2004b) used RA to induce differentiation of endodermal derivatives from the mouse 
embryonic teratocarcinoma cell line, F9 These cells were further manipulated to 
express pancreatic transcription factors and endocrine cell markers All-trans-RA 
stimulated an up-regulation of Pdxl coinciding with induced endocrine differentiation 
in the embryonic pancreas (Tulachan et al, 2003) Micallef et al (2005) also 
demonstrated that RA regulates the commitment of mouse ES cells to form Pdxl- 
positive endoderm
15  2 Activin A
AA is a member of the transforming growth factor (TGFP) family of secreted 
proteins Treatment of AR42J cells with AA resulted in neuronal-like differentiation 
However these cells also expressed glut2 and PP and displayed what appeared to be 
sulphonurea receptors and calcium channels, characteristic of p cells In a subsequent 
study on the treatment of AR42J cells with a wider range of differentiation agents it 
was found that a combination of betacelluhn (BTC) and AA resulted in 10% of 
treated cells expressing insulin (Ohmshi et al, 1995, Mashima et al, 1996) A 
combination of AA and BTC promoted regeneration of pancreatic p cells and
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improved glucose metabolism in neonatal streptozotocin (STZ)-treated rats (Li et al, 
2004) AA increases pax 4 gene transcription and 13-cell proliferation in rat islets 
(Brun et al, 2004) The transcription factor pax 4 plays an important role in islet cell 
development (see Section 1 2 3 5)
Previous studies have presented evidence of a possible 
neurotrophic/neurodifferentiation role for AA (Kos et al, 1997, Trudeau et al, 1997) 
It has been suggested that exogenous AA can rescue striatal interneurons and striatal 
projection neurons in an animal model of human Huntingdon’s disease (Hughes et al,
1999) The effects of AA were examined on the multipotent neural stem cell line 
MEB5 and the astrocyte progenitor cell line AP-16 (both established from the murine 
CNS) Treatment with AA induced glial fibrillary acidic protein (GFAP) in AP-16 
cells but not in MEB5 cells GFAP is a marker of astrocytic cells LIF-induced 
astroglial differentiation of MEB5 cells, however, was enhanced by treatment with 
AA (Satoh et al, 2000) Bao et al (2005) presented data suggesting that AA may work 
with bFGF in the development of tyrosine hydroxylase (TH)-positive neurons
1.5 3 Betacellulm
BTC is an epidermal growth factor, which was initially discovered in the conditioned 
medium of 13 tumours (Shing et al, 1993) It has mitogemc activity on Balb/c 3T3 
fibroblasts (Watanabe et al, 1994) and on foetal pancreatic tissue in culture 
(Demeterco et al, 2000) It was shown to have potent effects on the proliferation of 
cultured 13 cells (INS 1), with no effects on insulin levels (Huotan et al, 1998) BTC is 
capable of differentiating small percentages (<5%)' of AR42J cells into msuhn- 
secreting cells (Mashima et al, 1996) Pdxl-transfected epithelial cells and a cell- 
derived lines only expressed insulin after BTC treatment (Watada et al, 1996, Yoshida 
et al, 2002) Islet-like clusters, predominately composed of 0 cells were generated in 
the ducts of glucose intolerant mice after injections of BTC (Yamamoto et al, 2000) 
Neuro D-betacellulin gene therapy induces islet neogenesis in the liver and reverses 
diabetes in mice (Kojima et al, 2003) BTC exerts a similar effect to AA on rat islets 
i e increases pax 4 gene transcription and 6-cell proliferation in rat islets (Section 
1 5 2) (Brun et al, 2004) Jiang et al (2005) demonstrated that Lammin-1 and EGF 
family members i e BTC etc co-stimulate fetal pancreas cell proliferation and colony 
formation
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BTC is known to be growth factor of vascular smooth muscle cells (VSMCs) Mifune 
et al (2004) demonstrated that BTC promotes growth and migration of VSMCs 
through activation of EGFR, ErbB2, and downstream senne/threomne kinases The 
study also suggested a critical role for BTC in vascular remodelling
15  4 Sodium Butyrate
SB is a short chain aliphatic acid that occurs naturally in the colon through 
fermentation of dietary fibre (Otonkoski et al, 1999) SB was identified as a 
differentiation agent for insulinoma cells in a study relating cessation of proliferation 
with differentiation (Philippe et al, 1987) SB increased both insulin and glucagon 
levels in RIN cell lines through the recruitment of hormone negative cell to 
differentiate (Powers et al, 1998) A combination of SB and NIC resulted in the 
increased content of insulin in both INS 1 cells and porcine fetal islet-like cell clusters 
(ICCs) (Huotan et al, 1998, Otonkoski et al, 1999) The effects of exposure to NIC 
and SB both alone and in combination on p cell function were investigated in cultured 
rat insulin-secreting BRIN-BD11 cells NIC and/or SB caused a decrease in growth, 
insulin content and basal insulin secretion SB also reduced cell viability whilst NIC 
had no significant effect Treatment with either agent abolished p cell glucose 
sensitivity but increased insulin secretory responsiveness to a wide range of P cell 
stimulators e g protein kinase C, were enhanced (Liu et al, 2004) SB is a member of 
a class of compounds known as histone deacetylase (HDAC) inhibitors, this inhibition 
leads to increased histone acetylation Highly transcribed genes are associated with 
highly acetylated core histones (Marks et al, 2000, Wade et al, 1997) This possibly 
infers the mechanism by which SB operates
15  5 Nicotinamide
NIC is a metabolite of the vitamin niacin (vitamin B3) NIC was shown to be a potent 
inducer of P cell regeneration following partial pancreatectomy in rats, this appears to 
be due to its role in inhibiting poly (ADP-nbose) synthetase (Yonemura et al, 1984) 
Experimental states of diabetes can be instigated by administration of streptozoticin to 
cause breaks in the DNA strand of p cells which induces poly (ADP-ribose) 
synthetase, resulting in reduced nicotinamide adenine dinucleotide (NAD), thus 
causing inhibition of P cell function (Yamamoto & Okamoto, 1980) ICCs isolated 
from the pancreata of fetal pigs are of limited use as they secret low amounts of
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insulin, however upon exposure to NIC containing medium these clusters synthesise 
and secrete more insulin (Sjoholm et al, 1994, Otonkoski et al, 1999) The increase in 
(3 cell number and insulin content could be correlated with increased poly amine levels 
(i e spermidine, putrescine and spermine) Inhibitors of polyamine synthesis blocked 
the effect of NIC (Sjoholm et al, 1994) This is consistent with the observations 
regarding the requirement of polyamines for P cell function (Sjoholm et al, 1990, 
Welsh & Sjoholm, 1988)
NIC has been found to have a potent msuhnotropic effect on fetal pancreatic tissue 
(resulting in p cell outgrowths) and on cultured P cells (Otonkoski et al, 1993, 
Ohgawara et al, 1995, Huotan et al, 1998) Lumelsky et al (2001) used NIC in the 
final stages of differentiation of mouse ES cells into insulin-secreting structures 
(Section 14 1)
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1 6 Aims of Thesis
The aims of this study were
• to investigate whether an adapted version of the original Lumelsky 
protocol (Lumelsky et al, 2001), applied to a different ES cell line, 
could yield msulin-producing cells
• to develop novel assays for the determination of de novo insulin 
synthesis that could be applied to insulin-positive ES-denved 
differentiated cell types
• to further characterize cell types derived from an adapted version of 
the Lumelsky protocol (2001) by evaluating multi-lineage marker 
expression within the differentiated population
• to identify extra-cellular factors capable of inducing endocrine 
pancreas differentiation (without the use of exogenous insulin), in 
order to improve on existing protocols or to establish a novel, 
simplified, protocol for the derivation of pancreatic endocrine cell 
types
• to determine the effects of these extra-cellular factors on temporal gene 
expression and lineage specification using an m vitro 3-dimensional 
EB differentiation system
• to investigate models of directed differentiation, in parallel with a 
model of spontaneous differentiation, with particular emphasis placed 
on the successful derivation of pancreatic endocrine cell types within 
complex differentiated cultures
• to use microarray, bioinformatics and real-time PCR technologies to 
investigate gene expression changes associated with the loss of the 
GSIS phenotype, after continuous culture of MIN6 cells
• to assess the possible functional significance in GSIS of the observed 
changes in gene expression
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Section 2.0: Materials and Methods
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2 1 CELL CULTURE METHODS
2 11 Water
Ultra high pure water (UHP) was used in the preparation of all media and 
solutions This water was punfied by a reverse osmosis system (Millipore Milli- 
RO 10 Plus, Elgastat UHP) to a standard of 12 -18 MD/cm resistance
2 12  Treatment of Glassware
All solutions for use in cell culture and maintenance were prepared and stored in 
sterile glass bottles Bottles (and lids) and all other glassware used for any cell- 
related work were prepared as follows - all glassware and lids were soaked in a 
2% (v/v) solution of RBS-25 (AGB Scientific) for at least 1 hour This is a 
deproteimsing agent, which removes proteineous material from the bottles 
Glassware was scrubbed and rinsed several times in tap water, the bottles were 
then washed by machine using Neodisher detergent, an organic, phosphate-based 
acid detergent The bottles were then rinsed twice with distilled water, once with 
UHP water and sterilised by autoclaving
2 13  Sterilisation
Water, glassware and all thermostable solutions were sterilised by autoclaving at 
121 °C for 20 minutes (min) under pressure of lbar Thermolabile solutions were 
filtered through a 0 22/im sterile filter (Millipore, millex-gv, SLGV-025BS) 
Low protein-binding filters were used for all protein-containing solutions
2 14  Media Preparation
Medium was routinely prepared and sterility checked by Mr Joe Carey 
(technician) as in SOP NCTCC 003-02 lOx media were added to sterile UHP 
water, buffered with HEPES (N-[2-Hydroxyethyl]-N’-[2-ethanesulphonic 
acid])and NaHC0 3  and adjusted to a pH of 7 45 - 7 55 using sterile 1 5M NaOH 
and 1 5M HC1 The media were then filtered through sterile 0 22|im bell filters 
(Gelman, 121-58) and stored in 500 ml sterile bottles at 4°C The basal media 
used during routine cell culture were prepared according to the formulations
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shown in Table 2 1 1 Sterility checks were carried out on each 500 ml bottle of 
medium as described in Section 2 2 8
The basal media were stored at 4°C up to their expiry dates as specified on each 
individual lOx medium container Working stocks of culture media were 
prepared as 100 ml aliquots and supplemented as required These were stored for 
up to 3 weeks at 4°C, after which time, fresh culture medium was prepared
Table 2 11 Preparation of basal media
DMEM
(Gibco, 12501-029)
Hams F12
(Gibco, 21700-109)
10X Medium 500 ml Powder
Ultrapure H2O 4300 ml 4700 ml
1M HEPES* 
Sigma, H-9136
100 ml 100 ml
7.5% NaHCOj 
BDH, 30151
45 ml 45 ml
HEPES = N-(2-Hydroxyethyl) piperazme-N'-(2-ethanesulfonic acid)
ES-D3 cells were cultured in Dulbecco’s Minimal Essential Medium (DMEM) 
supplemented with 10% FCS (ATCC, 30-2020), 0 1 mM P-mercaptoethanol 
(Sigma, M6250), 1400 units/ml LIF (Chemicon, LIF2010) and 1% penicillin 
streptomycin (Gibco, 15070-063) MIN6 cells were routinely grown in DMEM 
supplemented with 20% FCS (heat inactivated for 30 min at 56°C) 4TI cells 
were cultured in DMEM supplemented with 5% FCS and 800 ng/|il G418 
(Sigma, G5013) FVB#c cells were cultured in DMEM supplemented with 10% 
FCS
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2 2 MAINTENANCE OF CELL LINES
2 2 1 Safety Precautions
All cell culture work was earned out in a class II down-flow re-circulating 
laminar flow cabinet (Nuaire Biological Cabinet) and any work, which involved 
toxic compounds, was earned out in a cytoguard (Gelman) Stnct aseptic 
techniques were adhered to at all times The laminar flow cabinet was swabbed 
with 70% industnal methylated spirits (IMS) before and after use, as were all 
items used in the cabinet Each cell line was assigned specific media and waste 
bottles and only one cell line was used at a time in the cabinet, which, was 
allowed to clear for 15 mm between different cell lines The cabinet itself was 
cleaned each week with industrial detergents (Virkon, Antec International, 
TEGO, TH Goldschmidt L td ), as were the incubators
2.2.2 Culture of Adherent Cell Lines
The cell lines used during the course of this study, their sources and their basal 
media requirements are listed in Table 2 2 1 Lines were generally maintained in 
vented 25 cm2 (Costar, 3056) and 75 cm2 (Costar 3376) and fed every 1-2 days
ES-D3 cells were maintained on a layer of 0 1 % gelatin (Sigma, G1890) Coating 
of flasks was earned out by adding enough gelatin to cover the tissue culture 
surface of the flask, these were then placed at 4 °C for at least 2 hours (usually 
overnight) The flasks were then nnsed 3X in stenle UHP These coated flasks were 
stored at room temperature until required
MIN6 cells, 4TI and FVB#c cells were maintained in vented T75 cm2 flasks
6 0
Table 2.2 1 Cell lines used in this thesis, including sources, growth conditions 
and types
Cell Line Source of Cell Line Medium Cell Type co2
Requirement
ES-D3 'ATCC (CRL-1934) DMEM Undifferentiated Murine ES 
Cell Line
5% CO2
MIN6 Dr Per Bendix Jeppesen DMEM Munne ß Cell Line 5% CO2
4TI Dr Sharon Glynn 
NICB
DMEM Murine Breast Cell Line 5% CO2
FVB#c NICB Culture 
Collection
DMEM Munne Ear Fibroblast Cell 
Line
5%C02
1ATCC = American Type Culture Collection
2 2 3 Subculture of Adherent Cell Lines
During routine sub-culturing or harvesting of adherent lines, cells were removed 
from their flasks by enzymatic detachment
2.2 3 1 Subculture of ES-D3/4TI/FVB#c cell line
Waste medium was removed from the flasks and rinsed with a pre-warmed 
(37°C) trypsin/EDTA (TV) solution (0 25% trypsin (Gibco, 25090-028), 0 01% 
ethylene diamine tetraacetic acid (Sigma, E5134) solution in phosphate buffered 
saline (PBS) (Oxoid, BR14a)) The purpose of this was to eliminate any naturally 
occurring TV inhibitor, which would be present in residual serum Fresh TV was 
then placed on the cells (1 ml/2 5 cm2 flask or 2 ml/75 cm2 flask) and the flasks 
were incubated at 37°C until the cells were seen to have detached (2 min) The 
TV was deactivated by addition of an equal volume of growth medium 
(containing serum) The entire solution was transferred to a 30 ml sterile 
universal tube (Stenlin, 128a) and centrifuged at 1,000 rpm (revolutions per 
minute) for 5 mm The resulting cell pellet was re-suspended in pre-warmed 
(37°C) fresh growth medium, counted (Section 2 2 5) and used to re-seed a flask 
at the required cell density or to set up an assay Cells were never re-seeded back 
into the same flask
61
2 2 3 2 Subculture of MEV6 Cell Line
MIN6 flasks were emptied of conditioned medium and the cells were rinsed in 
pre-warmed IX Ca2+/Mg2+- free PBS (Gibco 14200-067) TV was then added (1 
ml/ 25cm2 flask and 2 ml/75cm2 flask) and incubated at 37°C for 2 min exactly 
The flask was tapped sharply to dislodge the cells and then 5 ml of culture 
medium was added to inhibit the TV The cell suspension was aspirated gently 
and with care to avoid separating the cells in to a single cell suspension 
Following this the cells were centrifuged at 900 rpm for 5 min The resulting 
pellet was re-suspended in pre-warmed culture medium, counted (Section 2 2 5) 
and re-seeded to flasks or assay plates MIN6 cells were never re-seeded back in 
to the same flask
2 2 4 Subculture of Suspension Embryoid Bodies
Culture of ES-D3 cells in mim/petn bactenological-grade dishes (Greiner, 
627102/633183), resulted in the formation EBs These cells grew in suspension and 
thus did not require enzymatic detachment Subculture was performed by gentle 
removal of the cells to a universal using a Pasteur pipette (Copan, 200CS01) The 
EBs were separated from the medium using gentle centrifugation at 700 rpm for 10 
mm Following centrifugation the umversals were treated gently as the pellet was 
quite loose and the waste medium removed carefully using a Pasteur pipette The 
pellet was gently re-suspended in pre-warmed medium and the EBs were 
transferred to new petn dishes EBs were trypsinzed for cell counting, lysis and re- 
plating for immunofluorescence analysis
2 2 41 Trypsmization of Embryoid Bodies
EBs were separated from the medium using gentle centrifugation at 700 rpm for 10 
mm Following centrifugation the waste medium was removed carefully using a 
Pasteur pipette The pellet was re-suspended in PBS and re-spun at 100 rpm for 10 
min The EBs were transferred to 2 mM EDTA for 10 mm at room temperature 
followed by TV for 10 mm at 37°C (2 ml/pellet) 2 ml media was added to inhibit 
TV The cell suspension was centrifuged at 700 rpm for 10 min and the resulting 
pellet was washed in PBS (2X) before being counted, lysed or re-plated
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2 2 5 Cell Counting
Cell counting and viability determinations were earned out using a trypan-blue 
(Gibco, 15250-012) dye exclusion technique
An aliquot of trypan-blue was added to a sample from a single cell suspension at 
a ratio of 1 5 After 3 min incubation at room temperature, a sample of this 
mixture was applied to the chamber of a haemocytometer over which a glass 
covershp had been placed Cells in the 16 squares of the four outer comer gnds 
of the chamber were counted microscopically An average per comer gnd was 
calculated with the dilution factor being taken into account Final cell numbers 
were multiplied by 104 to determine the number of cells per ml (volume occupied 
by sample in chamber is 0 1cm x 0 1cm x 0 01cm / e 0 0001cm3 therefore cell 
number x 104 is equivalent to cells per ml) Non-viable cells were those, which 
stained blue while viable cells excluded the trypan-blue dye and remained 
unstained
2 2 6 Cell Freezing
To allow long term storage of cell stocks, cells were frozen and cryo-preserved in 
liquid nitrogen at temperatures below -180°C MIN6 cells were also stored at - 
80°C
2 2.6 1 Freezing of ES-D3/4TI/FVB#c Cells
Cells were frozen using the standard freezing method as follows Cells to be 
frozen were harvested in the log phase of growth (/ e actively growing and 
approximately 60-70% confluent) and counted as described in Sections 2 2 5 
Pelleted cells were re-suspended in serum and an equal volume of a dimethyl 
sulphoxide (DMSO)/serum (1 5 v/v for ES-D3, 1 10 v/v for 4TI) freezing 
solution (pre-chilled on ice as were cryovials (Greiner, 122 278)) The freezing 
solution was slowly added (drop-wise) to the cell suspension (as DMSO is toxic 
to cells) The suspension was diluted to a final concentration of at least 4 x 106 
cells/ml The suspension was then aliquoted into cryovials, which were then 
quickly placed in the vapour phase of liquid nitrogen containers (approximately -
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80°C) After 3 to 4 hours, the cryovials were lowered down into the liquid 
nitrogen where they were stored until required
2 2 6 2 Freezing of MIN6 Cells
Prior to trypsmization of MIN6 cells, a freezing medium containing DMSO and 
culture medium was prepared (1 5) and filter sterilised The freezing medium 
was then placed on ice until ready The cryovials were also placed on ice at this 
point MIN6 cells were trypsmized as outlined previously (Section 2 2 3 2) The 
pellet was re-suspended in culture medium to give a cell density of 5 x 106-  1 x 
107 cells/ml To this suspension, an equal volume of freezing medium was added, 
drop wise This suspension was aliquoted to cryovials The cryovials were cooled 
on ice for 10 min, and then transferred to a -20°C freezer in a Boehringer 
Mannheim enzyme box for 30 mm Following this, the cells were placed at -  
80°C for at least 12 hours Reserve stocks were placed in liquid nitrogen 
containers
2 2 7 Cell Thawing
2.2 7 1 Thawing ES-D3 Cells
Prior to thawing ES-D3 cells, 5 ml of culture medium was placed in a gelatin 
coated T25 cm2 flask (vented) and conditioned for temperature and pH in a CO2 
incubator for at least 30 min The frozen ES-D3 cryovial was then thawed and 
the contents were transferred directly into the medium A sample was taken for 
cell counting, viability (Section 2 2 5) and for sterility checks (Section 2 2 8) 
This medium was changed 12-24  hours later
2 2 7 2 Thawing MIN6/4TI/FVB#c Cells
Immediately prior to the removal of a cryovial from the liquid nitrogen stores for 
thawing, a sterile universal tube containing 5 ml growth medium was prepared 
This allowed for the rapid transfer and dilution of thawed cells to reduce their 
exposure time to the DMSO freezing solution (it is toxic at room temperature) 
The cryovial was partially thawed and its contents were transferred to the 
universal The suspension was centrifuged at 1,000 rpm for 5 min (900 rpm for
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MIN6), the DMSO-contaimng supernatant was removed and the pellet was then 
re-suspended in fresh growth medium Viability counts were carried out (Section 
2 2 5) to determine the efficacy of the freezing/ thawing procedures A sample 
was also taken for sterility analysis (Section 2 2 8) Thawed cells were placed 
into tissue culture flasks with the appropriate volume of medium (10 ml/25cm2 
flask and 15 ml/75cm2 flask) and allowed to attach overnight Medium was pre­
warmed and conditioned in a vented flask in the presence of 5% CO2 for at least 
30 min prior to thawing 24 hours after thawing, the cells were re-fed with fresh 
medium to remove any residual traces of DMSO
2 2 8 Sterility Checks
Sterility checks were routinely carried out on all media, supplements and TV 
used for cell culture Samples of basal media were inoculated into Columbia 
(Oxoid, CM331) blood agar plates, Sabauraud (Oxoid, CM217) dextrose and 
Thioglycollate (Oxoid, CM173) broth’s which should between them detect most 
contaminants including bacteria, fungus and yeast Growth media (/ e 
supplemented with serum) were sterility checked at least 3 days prior to use by 
incubating samples at 37°C These were subsequently examined for turbidity and 
other indications of contamination Freshly thawed cells were also subjected to 
sterility checks
2 2 9 Mycoplasma Analysis
Mycoplasma examinations were carried out routinely (at least every 3 months) 
on all cell lines used in this study This analysis was preformed by Aine Adams 
and Michael Henry at the National Institute of Cellular Biotechnology (NICB)
2 2 9 1 Indirect Staining Procedure
In this procedure, Mycoplasma-negative NRK cells (a normal rat kidney 
fibroblast line) were used as indicator cells and incubated with supernatant from 
test cell lines to test for Mycoplasma contamination NRK cells were used for 
this procedure because cell integrity is well maintained during fixation A 
fluorescent Hoechst stain was utilised which binds specifically to DNA and so 
will stain the nucleus of the cells in addition to any Mycoplasma DNA present A
65
Mycoplasma infection would thus be seen as small fluorescent bodies in the 
cytoplasm of the NRK cells and occasionally outside the cells
NRK cells were seeded onto sterile coverslips in sterile Petn dishes (Greiner, 633 
185) at a cell density of 2x103 cells per ml and were allowed to attach overnight 
at 37°C in a 5% CO2, humidified incubator 1 ml of cell-free (cleared by 
centrifugation at 1,000 rpm for 5 mm) supernatant from each test cell line was 
then inoculated onto a NRK coverslip and incubated as before until the cells 
reached 20 - 50% confluency (4-5 days) After this time, the waste medium was 
removed from the petn dishes, the coverslips (Chance Propper, 22 x 22 mm) 
were washed twice with sterile PBS, once with a cold PBS/Camoys (50/50) 
solution and fixed with 2 ml of Camoys solution (acetic acid methanol - 1 3) for 
10 mm The fixative was then removed and after air drying, the coverslips were 
washed twice in deionised water and stained with 2 ml of Hoechst 33258 dye 
(BDH) (50 ng/ml) for 10 min
From this point on, work proceeded in the dark to limit quenching of the 
fluorescent stain
The coverslips were rinsed three times in PBS They were then mounted in 50% 
(v/v) glycerol in 0 05 M citric acid and 0 1 M disodium phosphate and examined 
using a fluorescence microscope with a UV (ultraviolet) filter
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2 3 SPECIFIC CELL CULTURE TECHNIQUES EMPLOYED IN THIS 
THESIS
2 3 1 Directed Differentiation of ES-D3 Cells towards Insulin-Expressing 
Structures (based on the Lumelsky protocol (2001))
Stage 1 Undifferentiated ES-D3 cells were cultured in pre-coated gelatin 
T75cm2 tissue culture flasks in the presence of LIF for at least 3 passages 
Stage 2 Culture of ES-D3 cells in media without LEF at a cell density of 2 x 105 
cells/ml in mini bactenological-grade petn dishes (Greiner, 627102), resulted in the 
formation of aggregates called EBs These cells grew in suspension and thus did not 
require enzymatic detachment After 5 days the EBs were separated from the 
medium using gentle centrifugation at 700 rpm for 10 min Following 
centrifugation the umversals were treated gently as the pellet was quite loose and 
the waste medium removed carefully using a Pasteur pipette (Section 2 2 4) The 
pellet was gently re-suspended in pre-warmed medium and the EBs were 
transferred to new tissue culture 6-well plates (Costar, 3516) Cells from one mim- 
dish were seeded per well and allowed to attach overnight in ES-D3 media (-LIF) 
Stage 3 The attached EBs were fed with ITSFn (IX neurobasal media 
(Biosciences, 21103-049) supplemented with insulin @ 5 |ig/ml (Sigma, 11882), 
transferrin @ 50 jag/ml (Sigma, T0665), sodium selenite @ 30 nM (Sigma, S9133) 
and fibronectin @ 5 |ig/ml (Sigma, F2006)) 1 5 ml of medium is sufficient to cover 
the well The EBs were re-fed twice over a 7-day interval
Stage 4 Each well was fed with 1 5 ml of IX neurobasal media supplemented 
with IX N2 Supplement (Biosciences, 17502-048), IX B27 Supplement 
(Biosciences, 17504-044) and 10 ng/ml bFGF Cells were re-fed twice over a 7- 
day interval
Stage 5 Each well was fed with 1 5 ml of IX neurobasal medium supplemented 
with IX N2 Supplement, IX B27 Supplement and 10 mM NIC (Sigma, N0636) 
Cells were re-fed twice over a 6-day interval
Cells/EBs were taken down at the end of each stage for RT-PCR (Section 
2 3 3 1) Stage 1 and stage 5 cells were dissociated (Section 2 2 4 1) and re­
plated for analysis of protein expression by immunofluorescence (Section
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2 3 3 3), assayed for protein/insulin content (Section 2 3 3 4) and GSIS capability 
(Section 2 3 5) and were also earned through to the radio-active labelling assay 
(Section 2 3 4) Western blot analysis was preformed on stage 1, stage 5 and 
control cells (Section 2 3 3 5)
2 3 2 Differentiation Studies
Differentiation Studies were carried out using the differentiation agents listed in 
Table 2 3 1
Table 2 3 1 Differentiation agents used in the course of this work
Differentiation Agent Supplier Stock
Concentration
Working
Concentration
All trans Retinole Acid 
(RA)
Sigma (R2625) 1 mM 100 nM
Activin A 
(AA)
Sigma
(A4941)
20 |ig/ml 2nM
Betacellulin
(BTC)
Sigma (B3670) 2 (ig/ml 1 nM
Sodium Butyrate 
(SB)
Sigma
(B5887)
1 M 1 mM
Pentanoic Acid 
(PA)
Sigma
(V9759)
9 2 M 1 mM
Tnchostatin A 
(TSA)
Sigma
(T8552)
3 3 mM 30 nM
Nicotinamide
(NIC)
Sigma
(N0636)
122 12 M 10 mM
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2 3 21  Two-Stage Differentiation Studies
2.3 2 1 1 Reconstitution of Activin A, Betacellulin and Sodium Butyrate
RA was reconstituted in 95% ethanol to a final concentration of 1 mM RA was 
aliquoted and wrapped in tinfoil as it is light sensitive, it was routinely stored at -  
80°C The stock solutions of the recombinant proteins AA and BTC were made 
up in PBS-0 1% bovine serum albumin (BSA) (Sigma, A2153) to the desired 
concentration These were aliquoted in working volumes and stored at -20°C 
until required SB stocks solutions were made up in UHP The stock solution of 
SB was stored at 4°C immediately prior to the differentiation assay, these stock 
solutions were diluted in complete medium to reach working concentration and 
filter sterilised using a 0 22 |im filter
2 3 2 1 2 Stage 1 Differentiation
EB experiments were carried out in mini/petri dishes On day 1 ES-D3 EBs were 
generated as follows,
ES-D3 cells were seeded at 2 x 105 cells/1 5 mis/mini dish or 1 4 x 106 cells/10 5 
mls/petn dish in media (-LEF) and incubated overnight On day 2 the EBs were 
treated with RA (100 nM) The cells were exposed to this compound for 72 hours 
at 37°C in a 5% CO2 atmosphere The plates and dishes were wrapped in tinfoil 
as RA is light sensitive Untreated EBs were used as a control
2 3 2 13  Stage 2 Differentiation
On days 5 and 7, RA solution was removed and EBs were re-fed with one of the 
following compounds AA, BTC or SB as listed in Table 2 3 1 Untreated EBs 
were used as a control Day 9 marked the endpoint of the treatment Samples of 
the EBs and conditioned media were taken at day 5 and day 9 for RT-PCR, 
immunohistochemistry, immunofluorescence and insulin/protein content analysis 
(See Figure 2 3 1 and Section 2 3 3)
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ESD3 cells maintained in feeder 
free culture system (+LIF)
+ Retinole Acid . .p
(RA) LIF
RA CO_5d
5 Day EBs 5 Day EBs
+ Activin A + Betacelluhn + Sodium 
(AA) (BTC) Butyrate
(SB)
RA_AA RA_QTC RA_SB CO_9d
9 Day EBs
Figure 2 3 1 Two-stage differentiation protocol used in differentiation studies 
LIF, leukaemia inhibitory factor, CO, control, RA, retinoic acid, AA, activin A, 
BTC, betacelluhn, SB, sodium butyrate, EBs, embryoid bodies
2 3.2 2 Time Course Assay on Transcript Expression in the RA SB Culture
The RA SB differentiation study was preformed as previously described in 
Sections 2 3 2 1 Samples were taken at 2 day intervals for RT-PCR analysis 
(Section 2 3 3 1) Samples were also taken for RT-PCR analysis at 2 and 4 days 
after removal from treatment Cell counts were preformed on day 1, day 5 and 
day 9 to ascertain the effects of treatment on proliferation (Section 2 2 5) The 
cell numbers are approximate as some cells are lost through dissociation of EBs 
(Section 2 2 4 1)
2 3 2 3 Investigation of Alternative RA_SB Differentiation Protocols
The RA_SB differentiation study was performed as previously described in 
Sections 2 3 2 1, however, the following protocol adjustments were tested as a 
means of improving cell yields from the RA_SB differentiation study
(a) shortening the SB part of the treatment to 48 hours instead of 96 hours
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(b) removing the RA step and allowing spontaneous formation of EBs prior 
to secondary differentiation in the presence of SB
(c) culturing the cells in 10 mM NIC after the removal from RA_SB 
treatment
(d) using alternative SB treatments such as pentanoic acid (PA) and 
Tnchostatin A (TSA) (Table 2 3 1), which are known to have similar 
effects as SB See Figure 2 3 2
Samples were taken for RT-PCR analysis at day 1, day 6, day 7 and day 9 
(Section 2 3 3 1) Samples were taken for protein extraction and quantification 
on day 6, day 7 and day 9 (Section 2 3 3 4) Protein derived from cell lysates 
was used to determine effects of treatments on cell yields
2 3 2 3 1 Reconstitution of Tnchostatin A, Pentanoic Acid and Nicotinamide.
TSA was reconstituted in ethanol to a final concentration of 3 3 mM and stored 
at -80°C until required PA and NIC stocks were stored at room temperature and 
ready for use Immediately prior to assay, these stock solutions were diluted to 
working concentrations in complete medium (Table 2 3 1)
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Undifferentiated ESD3 (Day 1)
+ Media (-LIF) + RA (10 7 M)
EB
Day 5
+ Media (-LIF) + SB
CO_EB SB_EB
Day 6 Day 6
I 1
CO_EB SB_EB
Day 7 Day 7
SB
RA_EB
Day 5
+ PA TSA
I I
RA_SB_EB RA_PA_EB R A T S A E B
Day 6
I I 1
RA_SB_EB RA_PA_EB RA_TSA_EB
Day 7 Day 7
N IC
RA_SB_EB
Day 9
Figure 2.3.2 Alternative RA SB differentiation protocols. LIF, leukaemia 
inhibitory factor; CO, control; RA, retinoic acid; SB, sodium butyrate; EBs, 
embryoid bodies; PA, pentanoic acid; TSA, trichostatin A; NIC, nicotinamide.
2.3.3 Sampling Differentiation Studies 
2.3.3.1 Taking Samples for RT-PCR Analysis
Pellets were generated by directly centrifuging the EBs/cells from solution as 
during subculture (Sections 2.2.3 and 2.2.4). Pellets washed 2X in PBS. Pellets 
were then dissolved in TriReagent™ (Sigma, T9424). These samples were then 
stored in pre-autoclaved eppendorf tubes (Eppendorf, 0030 121 023) at -80°C 
until required for RNA isolation (Section 2.4.1.2).
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2 3 3 2 Fixing Samples for Immunohistochemistry
Pellets were generated by directly centrifuging the EBs/cells from solution as 
during subculture (Sections 2 2 3 and 2 2 4) Pellets washed 2X in PBS 
EBs/cells were resuspended in 10% buffered formalin (Serosep L td) Fixed 
samples were then stored at room temperature pnor to paraffin embedding 
Embedding, slicing and immunohistochemistry are described in Section 2 4 2 2
2 3 3 3 Fixing Samples for Immunofluorescence
Pellets were generated by directly centrifuging the EBs/cells from solution as 
during subculture (Sections 2 2 3 and 2 2 4) EBs were dissociated into single 
cell suspension (Section 2 2 4 1) and re-plated onto poly-l-omithine (15 |ig/ml in 
PBS) coated chamber slides Cells were allowed to attach before being fixed in 
4% paraformaldehyde (Sigma, P6148) (45 min at 4°C) Immunofluorescence 
(Section 2 4 2 3) was usually carried out on samples immediately, but samples 
could be stored at -20° C until required
2 3 3 4 Taking Samples for Insulin Content ELISA/Protem Quantification
Cells/EBs were trypsinized (Sections 2 2 3 and 2 2 4) and the resulting pellet was 
washed 2X in PBS PBS washes were followed by centrifugation at 1000 rpm 
(to ensure a firm pellet) The excess PBS was allowed to drain off and the pellets 
were lysed in chilled 0 1 M NaOH The amount of lysis buffer varied depending 
on size of pellet Lysed samples were stored at -20°C until required for protein 
quantification (Section 2 4 2 1) and ELISA (Section 2 4 2 6)
2 3 3 5 Taking Samples for Western Blot
Cells/EBs were trypsinized (Section 2 2 4 1) and the resulting pellet was washed 
2X in PBS PBS washes were followed by centrifugation at 1000 rpm (to ensure 
a firm pellet) The excess PBS was allowed to drain off and the pellets were 
lysed in chilled IX Protease Inhibitor Cocktail (Roche, 16974978) in UHP The 
amount of lysis buffer varied depending on size of pellet Samples were then 
sonicated (Labsomc U) Number of pulses varied with sample Cell debris was 
removed from the lysed samples by centrifugation at 2000 rpm Lysed samples
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were stored at -20°C until required for protein quantification (Section 2 4 2 1) 
and western blot (Section 2 4 2 4)
2 3 4 Radio-Active Labelling Assay
2 3 4 1 35S-L-cysteine Labelling
Control cells were plated at lx l06 cells per well overnight in a 6 well plate In 
the case of the ES-derived cells from the Lumelsky based protocol (Section 
2 3 1), the 35S-L-cysteine labelling was performed on differentiated cell cultures 
on the final day of the protocol Growth medium was removed from cell cultures 
and cells were washed with PBS 1 ml of cysteine" medium (DMEM lacking 
cysteine and 10% dialysed FCS (Sigma)) was added to each well and incubated 
at 37°C for 20mins to deplete intracellular cysteine levels This was removed and 
replaced with 1 ml of the same medium supplemented with 100 - 250 uCi/ml 35S- 
L-cysteine (Specific Activity >1000 Ci/mmol) Control ‘cold’ cultures received 
complete, normal growth medium The cultures were then incubated at 37°C for 
6 hours in 5% C 02 Cells were lysed, after removing the labelling medium and 
washing twice with cold PBS, by addition of 400 \i\ 0 1 M NaOH These extracts 
were stored at -80°C before analysis (Section 2 4 2 5 and 2 4 2 6)
2 3 5 Insulin Secretion Assays for Monolayer Cells
2 3 5 1 Glucose Stimulated Insulin Secretion Analysis of Cultured Cells
MIN6s were seeded at a cell density of 2 x 105 cells/well in a 24 well plate 
(taking care not to generate a single-cell suspension (Section 2 2 3 2)) These 
cells were allowed to grow for 72 hours pnor to the GSIS assay In the case of 
the ES-denved cells from the Lumelsky based protocol (Section 2 3 1), the GSIS 
assay was preformed on differentiated cell cultures (on a 6 well plate) on the 
final day of the protocol On the day of the assay IX Krebs Ringer Buffer (KRB) 
was prepared from an aliquot of frozen 10X stock (36 525g NaCl, 2 2g KC1, 
0 941g CaCl2 2H20 , 1 22g MgCI2 6H20 , 29 8g HEPES dissolved in 500 ml 
H20 )  BSA was added to a final concentration of 0 1% The KRB-BSA was pH 
adjusted to 7 36 exactly with 1 M NaOH This was heated to 37°C and the pH
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was maintained in a 37°C incubator with a 5% CO2 atmosphere (30 mm) 
Glucose concentrations of 0, 3 3, 10, 16 7 and 26 7 mmol/1 were constituted in 
the conditioned IX KRB and were then placed at 37 °C and 5% CO2 for 30 min 
After this, the conditioned medium was removed carefully from the MIN6 wells 
and the wells were rinsed (twice) in IX KRB The MTN6 cells were then 
equilibrated at 3 3 mM glucose for 30 min at 37°C After equilibration, the 3 3 
mM glucose was removed, and the glucose containing stimulation medium was 
administered (1 ml/well) GSIS was earned out over 60 mm and was stopped by 
placing the entire plate on ice 500 jal of conditioned medium was removed from 
each well and placed in an ice-cold eppendorf These were spun at 2000 rpm for 
2 min and 200 \x\ of the supernatant was taken and stored at -20°C until analysis 
(Section 2 4 2 6) The attached cells were lysed in 200 - 400 [il/well 0 1 M NaOH 
(depending on well size) and stored at -20°C for later protein quantification 
(Section 2 4 2 1) and insulin content analysis (Section 2 4 2 6)
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2 4 ANALYTICAL TECHNIQUES AND ASSAYS
2 4 1 RNA Analysis
2.4 1 1 Preparation for RNA Analysis
RNA is easily degraded by RNase (nbonuclease) enzymes, which are ubiquitous, 
thus the following precautions were taken prior to RNA work
All solutions for RNA related work, i e that would come in to contact with the 
test-RNA, were prepared from sterile UHP that had been treated with 0 1% 
diethyl pyrocarbonate (DEPC) (Sigma, D5758) before autoclaving All 
eppendorfs PCR (polymerase chain reaction) tubes etc were RNase free and pre- 
autoclaved prior to use as were Gilson pipette tips Disposable mtnle gloves were 
worn at all times during RNA work (to protect the operator and to prevent RNA 
degradation) and changed frequently
2 4 12 RNA Isolation
2 4 12  1 RNA Isolation using TnReagent
RNA was extracted from cultured cells and cells following differentiation 
treatment In all cases the cells were initially trypsmized (Sections 2 2 3 and 
2 2 4) to pellet form, lysed in TriReagent (Section 2 3 3 1) and stored at -80°C 
until required
The following protocol outlines the method whereby pure RNA was isolated 
from TriReagent The frozen TriReagent samples were allowed to thaw at room 
temperature and upon thawing, were allowed to sit for at least 5 min to ensure 
complete dissociation of nucleoprotein complexes 0 2 ml of chloroform per ml 
of TnReagent was added into the sample This was shaken vigorously for 15 
seconds and the samples were allowed to stand for 15 min at room temperature 
The samples were then centrifuged at 13,000 rpm for 15 mm at 4°C Following 
centrifugation, the sample separated into three layers, the upper aqueous layer 
containing the RNA, the interphase (DNA) and the red layer containing the 
protein The upper layer was carefully removed to a fresh eppendorf and 0 5 ml
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of isopropanol (Fluka, 59304) per ml of TriReagent used initially, was added 
The tubes were mixed well and allowed to stand at room temperature ( 1 5 - 2 0  
min) to let the RNA precipitate After centrifugation at 13,000 rpm for 10 min 
the RNA was washed (2X) in 75% ethanol and air dried for 5 - 10 mm The 
recovered RNA pellets were then dissolved in 12-20 jil DEPC treated H2O with 
repeated pipetting To aid re-suspension of the RNA, the samples were heated to 
55°C for 10 min followed by cooling on ice RNA solution was aliquoted and 
stored at -80°C until required
2 4 1 2 2 Qiagen Kit RNA Isolation
Alternatively, high quality RNA used for microarray studies was isolated from 
cells using the Rneasy mini-kit (Qiagen, 74104) Cell pellets for RNA extraction 
(pellets had been flash frozen in liquid nitrogen upon harvesting and stored at -  
80°C) were re-suspended in 1 2 ml of buffer RLT (supplemented with 10 (al/ml 
of P-mercaptoethanol) and vortexed to loosen the pellets The lysed pellets were 
aspirated a number of times and vortexed until the samples were completely 
homogenised 1 volume (12  ml) of 70% ethanol was added to the homogenised 
samples and mixed well by pipetting This mixture was then loaded in 700 (il 
aliquots on to an RNeasy mini column which was placed in a collection tube and 
centrifuged at 8,000 x g for 15 seconds (this was continued until the entire 
mixture had been passed through the column) Once all the homogenised cells 
had been passed through the column, the washes were carried out Initially 700 
|il RW1 was loaded on to the column and centrifuged at 8,000 x g for 15 
seconds This was closely followed by 2 washes in buffer RPE (also followed by 
centrifuging at 8,000 rpm for 15 seconds) To completely dry the spin column, it 
was placed in a fresh collection tube and centrifuged at full speed for 1 mm The 
RNA was eluted by passing two lots of 25 |il RNase free water (supplied) 
through the column by centrifuging it at 8,000 rpm for 1 min The eluted RNA 
was then quantified (Section 2 4 13)
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2 4 13 RNA Quantification
RNA (like DNA) was quantified using an ND-1000 spectrophotometer The ND- 
1000 software automatically calculated the quantity of RNA in the samples using 
the OD260
1 e OD260 x 40 x Dilution Factor/1000 = RNA content (|ag/|il)
The software simultaneously measured the OD28o of the samples allowing the 
purity of the sample to be estimated
Punty = OD260/OD280
This was typically in the range of 18-2 0 A ratio of <1 6 indicated that the RNA 
may not be fully in solution The RNA was diluted to 1 ¿ig/|il stocks for the 
reverse transcription (RT)
2 4 14  Reverse-Transcnption Polymerase Cham Reaction Analysis
2 4 14  1 Reverse Transcription of RNA (cDNA Synthesis)
To form cDNA the following components were mixed in a 0 5 ml eppendorf tube 
(Eppendorf, 0030 121 023) and heated at 70°C for 10 min followed by cooling 
on ice
1 ¿il Oligo dT 12-18 primers (0 5 ^g/|il)
1 |il RNA (1 |ig/|al)
3 \xl DEPC H20
This step gets nd of RNA secondary structures and allows the oligo dT to bind 
the poly (A)+tail of the RNA
While this mixture was incubated, the following reaction mix was generated (all 
volumes listed in master mix assume 1 ng total RNA)
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2 \i\ of a lOx buffer (Sigma, B 8559)
1 \x\ RNasin (ribonuclease inhibitor) (40U/|il) (Sigma R2520)
1 \x\ dNTPs (deoxynucleotide triphosphate) (10 mM of each dNTP) (Sigma 
DNTP100)
10 |il DEPC -treated water
1 nl MMLV-RT (200U/|al) (Sigma, M l302)
Once the RNA mixture had cooled (-2 min) 15 |il of the master mix was added 
and mixed by flicking The mixture was centrifuged to collect the material in the 
bottom of the tube and then incubated at 37°C for 1 hour The resultant cDNA 
was stable at 4°C but for prolonged storage it was maintained at -20°C
2 4 1 4 2 Polymerase Chain Reaction
The cDNA was analysed for the expression of genes of interest by PCR
The standardised PCR mix is listed below and did not change significantly with 
any of the PCRs carried out in this thesis
2 5 \x\ cDNA was added to the following reaction mixture
12 25 j^ l H20
2 5 |il 10X PCR buffer (Sigma, P2317)
1 5 jal 25 mM MgCl2 (Sigma, M8787)
4 nl 1 25 mM dNTP
0 5 |nl each of the forward and reverse primers (250 ng/|il) for the target gene 
(Eurogentec Ltd /MWG)
0 5 |il each of the forward and reverse primers to the housekeeping gene of 
interest i e P Actin (25 -  50 ng/jal) or GAPDH (glyceraldehyde-6-phosphate 
dehydrogenase, 10-25 ng/|il), (also synthesised by Eurogentec Ltd )
0 25 |il Taq Polymerase (5 U/|al) (Sigma, D4545)
The samples were mixed and centrifuged before being placed on the 
thermocycler (Biometra)
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A typical PCR protocol is outlined below however annealing temperatures can 
vary from primer set to primer set therefore a frill list of the primers used in this 
thesis and the annealing temperatures are listed in Table 2 4 1
95°C for 3 min (Denaturation step)
followed by 
25-30 cycles of
- 95°C for 30 seconds (Denaturation)
- 52-60°C for 30 seconds (Annealing)
- 72°C for 30 seconds (Extension) 
and
- 72°C for 7 min (Extension)
PCR products were stored at 4°C until they were analysed by gel electrophoresis 
2 4 1 4 3 Gel Electrophoresis of PCR Products
Typically, 2% agarose (Sigma, A9539) gels were used for PCR gel 
electrophoresis, which were prepared and run in IX TBE (10 8g Tns base, 5 5 g 
Bone Acid, 4 ml 0 5 M EDTA (pH 8 0) and made up to 1 L with UHP) and 
melted in a laboratory microwave Upon cooling, the gel was supplemented with 
5 [i\ ethidium bromide (10 mg/ml) to allow visualisation of the DNA The gel 
was then poured in to the electrophoresis unit (Biorad) and allowed to set 
Sample wells were formed by placing a comb into the top of the gel prior to 
hardening
To run the samples, 2 \x\ of 6X loading buffer (50% Glycerol, 1 mg/ml 
bromophenol blue, 1 mM EDTA) was added to 10 pil PCR product and the 
mixture was loaded to the gel with an appropnate size marker (Sigma, D0672) 
The gels were electrophoresed at 120-150 mV for 1 - 2 hours (depending on size 
of the target gene, i e to get adequate separation) Once the internal control and 
target bands have migrated to the required extent, the gel was taken to the gel 
analyzer (an EpiChemi II Darkroom, UVP Laboratory Products), photographed 
and densitometncally analysed using Labworks software (UVP)
80
2.4 1 5 Real-Time PCR
cDNA synthesised according to Section 2 4 14 1 was amplified using an ABI
\
7500 Real-Time PCR System (Applied Biosystems, Foster City, CA) Two
chemistries were used to detect PCR products
- TaqMan Chemistry (uses a fluorogemc probe to enable the detection of a 
specific PCR product as it accumulates during the PCR cycles)
- SYPR Green dye Chemistry (uses SYBR Green dye, a highly specific, 
double stranded DNA binding dye, to detect PCR product as it accumulates 
during the PCR cycles)
2 4 1 5 1  TaqMan PCR
Relevant probes and primer pairs were designed for this purpose (Table 2 4 1)
using Primer Express 2 0 software
Standardised Taqman PCR mix
cDNA 2 5 \il
2X Master Mix 12 5 \i\
Forward Primer (10 |iM) 2 fil
Reverse Primer (10 nM) 2 111
Probe (5 i^M) 1 25 \i\
H20 4 75 nl
The temperature profile of the reaction was 50°C for 2 min, 95°C for 10 mm and 
40 cycles of 95°C for 15 seconds and 60°C for 1 min Expression levels were 
normalized using the GAPDH/p-actin signal (internal control) compared to 
reference sample (set to 1) Individual samples were run in triplicate
2 4 1 5 2 SYPR Green PCR
Relevant primer pairs were designed for this purpose (Table 2 4 1) using Primer 
Express 2 0 software
Standardised SYBR Green PCR mix
cDNA 2 5 nl
2X Master Mix 12 5 p.1
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Forward Primer (10 ^M) 
Reverse Primer (10 ^M) 
H20
2  jllI 
2 Hi 
6 i^l
The temperature profile of the reaction was 95°C for 10 min, 35 cycles of 
denaturation at 95°C for 40 seconds, annealing (see Table 2 4 1 for specific 
temperatures) for 40 seconds, and extension at 72°C for 40 seconds Expression 
levels were normalized using the GAPDH/p-actin signal (internal control) 
compared to reference sample (set to 1) Individual samples were run in 
triplicate
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Table 2 4 1 Primer sequences used during the course of this work These 
primers sequences were used in both semi-quantitive PCR analysis and qPCR 
analysis
Gene Sequence (51 to 3’) Annealing 
Temp (°C)
Fragment 
Size (bp)
Ref Seq
Gene ID
Pdxl ggtggagctggcagtgatgtt
accgcccccactcggggtcccgc
60 125 NM_008814 18609
gck gatgctggatgacagagccaggatg
agatgcactcagagatgtagtcga
54 392 NM 010292 103988
pax 4 tggcttcctgtccttctgtgagg
tccaagacacctgtgcggtagtag
52 242 N M 011038 18506
pax 6 aagagtggcgactccagaagt
accatacctgtattcttgcttcagg
60 545 NM _013627 18508
Ihh aaggcccacgtgcattgctct
tgtccgcaatgaagagcaggtg
60 298 NM 010544 16147
Shh ggaagatcacaagaaactccgaac
ggatgcgagctttggattcatag
60 354 NM_009170 20423
Islet 1 acgtctgatttccctgtgtgttgg
tcgatgtggtacaccttagagcgg
60 276 NM _021459 16392
nkx2 2 cggagaaaggtatggaggtgac
ctgggcgttgtactgcatgtgctg
60 188 NM_010919 18088
beta2 cttggccaagaactacatctgg
ggagtagggatgcaccgggaa
60 229 NM _010894 18012
GAP43 gctgctaaagctaccactga
taggtttggcttcgtctaca
56 223 NM_008083 14432
npy tgaccctcgctctatctctg
aagggtcttcaagccttgtt
58 249 NM_023456 109648
cck gatggcagtcctagctgctg
ccaggctctgcaggttctta
60 167 NM _031161 12424
egrl atggacaactaccccaaact
attcagagcgatgtcagaaa
56 240 NM_007913 13653
pldl tcttatcccttcctgctacc
ccaccttgttgaacacaact
56 250 NM_008875 18805
scg3 ggatactggtgttggtgctc
tttctgttattgccctcagc
58 234 NM_009130 20255
chgb atccaagtccagtgttccaa
tctcattgcctaccttcgtc
58 227 NM_007694 12653
CEACAM1 aatctgcccctggcgcttggagcc 60 246 NM _011926 26365
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aaatcgcacagtcgcctgagtacg
sgnel ttcagtgaggatcaaggcta
ctgggtagtcatgttctgga
56 157 NM 009162 20394
trp53 agctttgaggttcgtgtttg
ggaacatctcgaagcgttta
58 220 NM _011640 22059
Gadl aaggatgcaaccagatgtgt
ttggcgtagaggtaatcagc
58 205 NM_008077 14415
tjpi acgacaaaacgctctacagg
gagaatggactggcttagca
58 213 NM_009386 21872
claudin 11 caagagtgcccatgtctaag
tgggcattaactgagctaga
56 234 NM 008770 18417
dll-1 agccctccatacagactctc
cagaacacagagcaaccttc
56 201 NM_007865 13388
ODC ctgccacatccttgatgaag
cgttactggcagcatacttg
60 349 N M 013614 18263
nestin ggctacatacaggattctgctgg
caggaaagccaagagaagcct
60 85 NM _016701 18008
GATA4 cgccgcctgtccgcttcc
ttgggcttccgttttctggtttga
60 193 NM_008092 14463
Amylase caggcaatcctgcaggaacaa
cacttgcggataactgtgcca
58 484 NM_009669 11723
AFP cctgtgaactctggtatcag
gctcacaccaaagcgtcaac
58 406 NM_007423 11576
PCI atctgatgatgatcgtgtga
tgtctgtgtgattccactcc
56 260 NM _013628 18548
PC2 cacagatgactggttcaaca
tcacagttgcagtcatcgta
56 359 NM 008792 18549
PPI agcgtggcttcttctacacacc
ggtgcagcactgatccaccatg
54 158 NM_008386/
N M 008387
16333/
16334
insulin I tagtgaccagctataatcagag
acgccaaggtctgaaggtcc
62 288 NM_008386 16333
insulin II ccctgctggccctgctctt
aggtctgaaggtcacctgct
62 212 NM 008387 16334
insulin I gtgaagtggaggacccacaagt 
atgctggtgcagcactgatc 
Probe (5TA M -3TA M ) 
acctccaacgccaaggtctgaaggt
60 NM_008386 16333
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insulin II gtgaagtggaggacccacaagt 
atgctggtgcagcactgatc 
Probe (5’FAM-3’TAM) 
cacctccagtgccaaggtctgaaggt
60
i
NM_008387 16334
glut2 Taqman 60 N K NM_031197 20526
dlkl Taqman 60 N K NM^O 10052 13386
NF-L cgccgaagagtggttcaagag
gtaggagctgctctgcaagcc
60 472 NM_010910 18039
MBP aagcacacagcagacccaaagaa
aaggatgcccgtgtctctgt
58 309 NM _010777 17196
GFAP ctttctctccaaatccacac
ctccttgtctcgaatgactc
58 457 NM _010277 14580
P III tubulin ctcagtcctagatgtcgtgcg
gcggaagcagatgtcgtaga
58 294 NM_023279 22152
desmin gacgctgtgaaccaggagtt
acgagctagagtggctgcat
62 384 NM _010043 13346
myogenm cctgccctgagttgagagag
cggcagctttacaaacaaca
62 141 NM_031189 17928
Oct4 ggcgttctctttggaaaggtgttc
ctcgaaccacatccttctct
60 293 NM _013633 18999
bax tgcagaggatgattgctgac
gatcagctcgggcactttag
60 173 NM_007527 12028
caspase3 agtctgactggaaagccgaa
taacggcgagtgagaatgtgc
60 270 NM_009810 12367
glucagon actcacagggcacattcacc
ccagttgatgaagtccctgg
60 353 NM_008100 14526
somatostatin ccgtcagtttctgcagaagt
cagggtcaagttgagcatcg
60 356 NM_009215 20604
PP aggatggccgtcgcatactg
gagctgcactccaggaagtc
60 249 NM_008918 19064
P-actin , gaaatcgtgcgtgacattaaggagaagct
tcaggaggagcaatgatcttga
AR 383 NM_001101 11461
P-actin Taqman 60 N K NM_007393 11461
P-actin acggccaggtcatcactattg 
caagaaggaaggctggaaaaga 
Probe (5’JOE-3 TAM ) 
caacgagcggttccgatgccc
60 70 NM_007393 11461
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IGAPDH catgaccacagtccatgccatc
caccctgttgctgtagccgtattc
AR 451 NM_001001303 407972
GAPDH tgtgtccgtcgtggatctg 
accaccttcttgatgtcatcatactt 
Probe (5’JOE-3’TAM) 
tgccgcctggagaaacctgcc
60 68 NM_001001303 407972
Note qPCR, real-time PCR, P d x l, Pancreatic duodenal hom eobox factor 1, gck, 
glucokinase, Ihh, Indian hedgehog, Shh, sonic hedgehog, G A P43, grow th  a sso c ia ted  
protein  4 3 , npy, neuropeptide Y , cck, cholecystokinin, eg r l, early growth response 1, 
p ld l, phospholipase D l ,  scg3, secretogramn III, chgb, chromogramn B, sgne 1, 
secretory granule neuroendocrine protein 1 (7B 2 protein), trp53, transformation related 
protein 53, G ad l, glutamate decarboxylase, tjp l, tight junction protein, dll-1, delta-like 
1, ODC, ornithine decarboxylase, GATA4, gata binding protein 4, AFP, alpha-feto 
protein, P C I, prohormone convertase 1, PC2, prohormone convertase 2, PPI, 
preproinsulin, glut2, glucose transporter 2, bax, bcl2-associated x  protein, dlk, delta-like 
hom ologue 1, NF-L, neurofilament light, M BP, m yelin basic protein F am /T am /Joe, 
com b in ation al flu o rescen ce  en ergy  transfer tags
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2 4 1.6 Affymetnx GeneChips®
The microarray gene expression experiments of this study were performed using 
Affymetnx® Murine Genome U74A GeneChips® Affymetnx GeneChip probe 
microarrays are manufactured using technology that combines photolithography 
and combinatonal chemistry Tens to hundreds to thousands of different 
oligonucleotide probes are synthesised and each of these oligonucleotides is 
located in a specific area on the microarray slide, called a probe cell Each probe 
cell contains millions of copies of a given oligonucleotide and each feature size 
on the Affymetnx U74A GeneChip is 24 microns
The most important aspect in efficient probe design is the quality of the sequence 
information used Probe selection and array design are two major factors in 
reliability, sensitivity, specificity and versatility of expression probe arrays 
Probes selected for Affymetnx gene expression arrays are generated from 
sequence and annotation data obtained from multiple databases such as 
GenBank, RefSeq and dbEST Sequences from these databases are collected and 
clustered into groups of similar sequences Using clusters provided by UniGene 
database as a starting point, sequences are further subdivided into subclusters 
representing distinct transcripts
This categonsation process involves alignment to the mouse genome, which 
reveals splicing and polyadenylation variants The alignment also extends the 
annotation information supplied by the databases pinpointing low quality 
sequences These areas are usually trimmed for subsequent generation of high 
quality consensus sequences or alternatively Affymetnx employ quality ranking 
to select representative sequences, called exemplars, for probe design
In general, Affymetnx use 11 to 16 probes which are 25 bases in length for each 
transcript The probe selection method used by Affymetnx for their U74A 
GeneChips takes into account probe uniqueness and the hybridisation 
characteristics of the probes which allow probes to be selected based on probe 
behaviour Affymetnx use a multiple linear regression (MLR) model in the 
probe design that was derived from thermodynamic model of nucleic acid duplex 
formation This model predicts probe binding affinity and linearity of signal
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changes in response to varying target concentrations An advantage of this type 
of model-based probe selection system is that it provides a physical and 
mathematical foundation for systematic and large-scale probe selection Also, an 
essential criterion of probe selection by Affymetnx for quantitative expression 
analysis is that hybridisation intensities of the selected probes must be linearly 
related to target concentrations
A core element of Affymetnx microarray design is the Perfect/Mismatch probe 
strategy For each probe that is designed to be perfectly complimentary to a 
given target sequence, a partner probe is also generated that is identical except 
for a single base mismatch in its center These probe pairs, called the Perfect 
Match probe and the Mismatch probe, allow the quantitation and subtraction of 
signals caused by non-specific cross-hybridisation The differences in 
hybridisation signals between the partners, as well as their intensity ratios, serve 
as indicators of specific target abundance
2.4 16  1 Sample and Array Processing
After RNA isolation, quantification and purification using the Qiagen Rneasy 
isolation method (Section 2 4 1 2 2), cDNA was synthesised using the GeneChip 
T7-01igo (dT) Promoter Pnmer Kit (Affymetnx, 900375) from 10|ig total RNA 
First strand cDNA synthesis was then performed using the SuperScnpt Choice 
Kit (BioSciences, 11917-010) First strand cDNA synthesis involved ‘primer 
hybridisation’ where the T7-01igo (dT) pnmer was incubated with the RNA and 
DEPC-treated H2O at 70°C for 10 mins, followed by a short incubation in ice, 
‘temperature adjustment5 where 5X first strand buffer, DTT and dNTP mix were 
added to the RNA mix and incubated at 42°C for 2 mins, and ‘First Strand 
synthesis5 where SuperScnpt II RT was added to the mix and incubated at 42°C 
for 1 hour Second strand cDNA synthesis was performed and purified using 
GeneChip Sample Cleanup module (Affymetnx, 900371) as recommended by 
the manufacturers instructions
Complimentary RNA (cRNA) was then synthesised and biotin-labelled using the 
Enzo BioArray HighYield RNA Transcript Labelling Kit (Affymetnx, 900182)
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Biotin-labelled cRNA was purified using the GeneChip Cleanup Module Kit 
(Affymetrix, 900371) and quantified. The value obtained was adjusted to reflect 
carryover of unlabelled total RNA. A sample of biotin-labelled cRNA was taken 
for gel electrophoresis analysis. The labelled cRNA was then fragmented before 
hybridisation onto the Affymetrix GeneChip probe microarrays. The aliquot of 
fragmented sample RNA was stored at -20°C until ready to perform the 
hybridisation step.
Hybridisation of cRNA onto the Affymetrix GeneChip probe murine microarrays 
(Affymetrix, U74A) was performed in the Conway Institute, University College 
Dublin, where the Affymetrix Hybridisation Oven and Fluidics Station is set up 
along with the Affymetrix GeneChip Scanner, which exported the data directly 
into the Affymetrix analysis software, Micro Array Suite 5.1 (MAS 5.1).
2.4.1.6.2 M icroarray Data Normalisation
The purpose of data normalisation is to minimise the effects of experimental and 
technical variation between microarray experiments so that meaningful 
biological comparisons can be drawn from the data sets and that real biological 
changes can be identified among multiple microarray experiments.
2.4.1.6.2.1 Probe Logarithmic Intensity Error Estimation (PLIER)
All the data from the MIN6 biological triplicates assessed were normalised using 
the PLIER algorithm within the GREX package (Affymetrix). The PLIER 
algorithm (http://www.affymetrix.com) is a new tool introduced by Affymetrix 
for the use in data analysis of their GeneChips and has replaced the need to 
normalise microarray data by using the ‘per chip’ and ‘per gene’ normalisation 
methods. This algorithm incorporates model-based expression analysis and non­
linear normalisation techniques. PLIER accounts for differences in probes by 
means of a parameter termed “probe affinity”. Probe affinity is a measure of 
how likely a probe is to bind to a complimentary sequence, as all probes have 
different thermodynamic properties and binding efficiencies. Probe affinities 
determine the signal intensities produced at a specific target concentration for a 
given probe, and are calculated using experimental data across multiple arrays. 
By accounting for these observed differences, all the probes within a set can be
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easily compared An example of how the PLIER algorithm works is if one probe 
is consistently twice as bright as other probes within a set, PLIER appropriately 
scales the probe intensities In the case of a probe set, this enables all set 
numbers to be compared and combined accurately
PLIER also employs an error model that assumes error is proportional to the 
probe intensity rather than that of the target concentration At high 
concentrations, error is approximately proportional to target concentration, since 
most of the intensity is due to target hybridisation signal However, at the low 
end, error is approximately proportional to background hybridisation intensity, 
which is the largest component of the observed intensity Due to this effect, it is 
inaccurate to treat errors as a proportion of target concentration in all 
circumstances The PLIER error model smoothly transitions between the low 
end, where error is dependent upon background, and the high end, where error is 
dependent on signal
The PLIER algorithm supports a multi-array approach that enables replicate 
sample analysis PLIER ensures consistent probe behaviour across experiments 
to improve the quality of results in any one given experiment and helps to 
discount outliers Benefits of this algorithm include an improved coefficient of 
variation of signals from probe sets while retaining accuracy Also higher 
differential sensitivity for low expressers maybe achieved using PLIER
2 4 1 6 3 Bioinformatics Criteria for Selecting Induced/Suppressed Genes 
and Functional Assignment
Following data normalisation, gene lists were generated using a students t-test 
with a P value cut-off of 0 01, to identify genes that were statistically 
differentially expressed between the three high passage arrays and low passage 
arrays (used as the reference/“controP’) These gene lists were segregated into 
lists containing genes, who’s expression was either significantly higher or lower, 
in the high passage MIN6 cells compared to the low passage MIN6 cells A 2- 
fold cut-off (increase or decrease) was then applied
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2 4 1 6  4 Quality Control Clustering using the Spearman Correlation
The Spearman correlation is a non-parametric test for the strength of the 
relationship between pairs of variables Using a GeneSprmg (Affymetnx) 
interpretation, gene lists from 3 samples each representing the “control” (low 
passage MIN6) and the “test” (high passage MIN6) were used to develop a 
condition tree investigating their similarity Using the All Samples (log) 
interpretation and the Spearman (rank-based) correlation, the six samples were 
clustered Samples with a similar expression profile were grouped together
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2 4 2 Protein Analysis
2 4 21  Protein Quantification
Lysed samples were removed from the freezer and placed on ice A BSA 
standard curve ( 0 - 1  mg/ml) was prepared in UHP 5 \i\ of standard and 5 1^ of 
sample were placed in triplicate wells on a 96 well plate (Costar, 3596) The 
Biorad Dc Protein Assay was used for protein quantification 25 jil of Reagent A 
(containing 20 1^ Reagent S (Biorad, 500-0115) per ml of Reagent A (500-0113)) 
followed by 200 1^ of Reagent B (500-0114) were added to each test well The 
plate was kept at room temperature for 15 min prior to reading on the Spectra 
Max Plus using a softmax Lowry protein assay (750 nm) program
2 4 2 2 Immunohistochemical Analysis of Paraffin Embedded Samples
2 4 2 2 1 Plasma Clotting and Paraffin Embedding of Samples
The samples were fixed in 10% formalin (Section 2 3 3 2) and stored at room 
temperature Samples were spun down at 10,000 g for 15 seconds to form pellet 
The pellet was resuspended in 1% Fibrinogen (Sigma, F4753) prepared in 
DMEM Samples spun at 10,000 g for 15 seconds and resuspended in 100 (il 1% 
Fibrinogen solution 2 drops of thrombin solution (Sigma, T6884) was added to 
the sample to form a clot The clot was removed and placed in an embedding 
tray The clot was then exposed to 10% formalin for 30 - 60 min
Clots were soaked in 95% ethanol (2 x 10 min), 100% ethanol (2 x 10 min), 
xylene (2 x 10 min), paraffin/wax (2 x 10 min) The clots were embedded in 
paraffin (BDH, 298682F) and allowed to dry overnight
2 4 2 2 2 Sectioning of Paraffin Embedded Samples
The paraffin embedded samples were placed on ice for 30 - 60 min prior to 
cutting Four-micron thick slices were cut using the Reichert-Jung 2030 Biocut 
Slices were placed in 1% ethanol, followed by removal to warm water Slices 
were mounted onto poly-l-lysine coated slides (slides treated with ethanol and
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coated with 10% poly-l-lysine) The mounted samples were placed at 37°C for 2 
hours before stonng at 4°C
2 4 2 2.3 Immunohistochemistry Analysis
The avidin-biotin complex (ABC) immunoperoxidase technique combined with 
the diaminobenzidine (DAB) visualisation procedure was used in all 
immunocytochemistry experiments The ABC method involves application of a 
biotin-labelled secondary antibody to cells probed with a primary antibody, 
followed by the addition of avidin-biotin-peroxidase complex, which results in a 
high staining intensity due to the formation of an avidin-biotin lattice, which 
contains peroxidase molecules The peroxidase enzyme then reacts with a DAB 
solution to give an insoluble, brown-coloured precipitate The formation of this 
brown coloured precipitate is indicative of primary antibody reactivity
The following procedure was used
The sections were dewaxed in Xylene ( 2 x 3  mm), 100% ethanol ( 2 x 3  min), 
90% ethanol ( 2 x 3  min) and 70% ethanol ( 2 x 3  min) Sections were washed 
with tns buffered saline (TBS) (Sigma, T5912)/0 1% Tween (Sigma, T1379) and 
incubated with 10 mM sodium citrate buffer, pH 6, (DAKO, S2369) in a 
microwave (7SOW, 2 x 5  mm) Sections were washed with TBS/0 1% Tween 
and endogenous peroxidase was blocked by incubation in 3% H2O2 (BDH, 
101284N) for 7 mm Sections were rinsed with UHP and placed in TBS for 5 
min Sections were incubated at room temperature with the corresponding serum 
(depending on antibody host) diluted 1 10 in TBS to block non-specific binding 
After removal of serum 50-100 \x\ of optimally diluted primary antibody was 
added The sections were placed on a tray and incubated overnight at 4° C The 
primary antibodies used in these studies are shown in Table 2 4 2
The next day sections were washed in TBS/ 0 1% Tween, 3x for 5 mm, and 
incubated for 30 min with a biotinylated secondary antibody diluted in TBS 
(Table 2 4 2) The sections were washed with TBS/0 1% Tween, incubated with 
ABC complex (Vector, PK-7100) for 30 min at room temperature and rinsed 3x 
with TBS/ 0 1% Tween The sections were incubated with a DAB solution
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(Vector, SK-4100) for 7 min Excess DAB solution was rinsed off with UHP 
water The sections were counter stained with hematoxilin (Vector, H-3404), 
washed with UHP and dehydrated using 70% ethanol, ( 2 x 3  min), 90% ethanol 
( 2 x 3  min), 100% ethanol ( 2 x 3  min) and Xylene ( 2 x 3  mm) Sections were 
mounted using a commercial mounting solution (DAKO, S3023) Controls for 
immunospecificity were included in all experiments by replacing the primary 
antibody with TBS and matching concentrations of serum
2 4 2 3 Immunofluorescence Analysis of Dissociated EBs and Monolayer 
Cells
Samples were fixed as previously described in Section 2 3 3 3 Fixed samples 
were permeabilized with 0 2% Triton X I00 in PHEM buffer ((60 mmol/1 PIPES, 
25 mmol/1 HEPES, 10 mmol/1 EGTA, 2 mmol/1 MgCl, pH 6 9) for 2 - 4 hours 
and free aldehyde groups were reduced with 0 1% (w/v) sodium borohydnde in 
PBS Samples were blocked in relevant serum overnight (Table 2 4 2, diluted 
1 10 in 5% BSA, 0 2% Triton X I00 in PHEM buffer) The following morning 
the serum was removed and the primary antibody was applied (antibodies and 
dilutions are listed in Table 2 4 2) This was incubated overnight at 4°C in a 
moist environment The following day, the primary antibody was removed and 
the slides were washed three times in PHEM-0 2% Tween at 5 mm per wash 
The fluorescent secondary antibodies (light sensitive) were prepared in the dark 
room under dim conditions and were coated in foil The cells were incubated 
with secondary antibodies (Table 2 4 2) for 60 min and the slides were wrapped 
in tinfoil All work from this point onwards was earned out in the dark to prevent 
‘quenching5 fluorescent signal After 60 mm incubation the antibodies were 
removed and the slides were washed three times in PHEM-0 2% Tween The 
slides were then mounted using vectashield containing a DAPI (4', 6-diamidino- 
2-phenylindole) nuclear stain (Vector, H I000) and covered with covershps 
(Chance Propper) Slides were examined by confocal laser scanning microscopy 
using Leica TCS AOBS
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Table 2 4 2 Antibodies used in Immunofluorescent/Immunocytochemical studies 
including the labelled secondary antibodies (FITC, Fluorescein isothiocyanate,
TRITC, Tetramethylrhodamine Isothiocyanate)
Antibody Host Supplier Dilution
Serum for 
Blocking
C-peptide 1 rabbit
Dr S Heller 
Hagedorn Research Institute
1 1200-1 2000 swme/goat
C-peptide 2 rabbit
Dr S Heller 
Hagedorn Research Institute
1 1200-1 2000 swine/goat
glucagon mouse
Sigma
(G2654)
12000 rabbit
glut2 rabbit
Chemicon
(AB3412)
1300 swme/goat
gck rabbit
Abgent
(AP7901c)
1 50-100 swme/goat
AFP rabbit
NeoMarkers
(RB-315-R7)
Ready for Use
swine
insulin rat
R&D systems 
(MAB1417)
1 50 - 1 200 rabbit
somatostatin rabbit
DAKO
(A0566)
1400 swine
PP rabbit
DAKO
(A0619)
1600 swine
Pdxl rabbit
Gift from C V E  Wnght 
Vanderbilt, TN
1 500 Swine
Oct4 rabbit
Chemicon
(AB3209)
1 300 swine/goat
nestin mouse
Chemicon
(MAB353)
1600 rabbit
desmin mouse
Sigma
(dl033)
1 40 rabbit
myogemn mouse
Sigma
(m5815)
1 500-1 1000 rabbit
NF-L mouse
Abeam
(AB4572)
1 500 rabbit
GFAP mouse
Chemicon
(MAB360)
1400 rabbit
P-m tubuhn mouse
R&D systems 
(MAB1195)
1 100 rabbit
04 mouse
R&D systems 
(MAB1326)
1 150 rabbit
Anti Rat rabbit Sigma 1 30 swine
95
(TRITC) (T4280)
Anti Mouse (FITC) rabbit
DAKO
(F0261)
1 30 N/A
Anti Rabbit (TRITC)
goat DAKO
(R0156)
140 N/A
Anti Rat 
(Alexa Fluor 488)
goat
Molecular Probes 
(A 11006)
8 jig/ml N/A
Anti Mouse 
(Biotm)
rabbit
DAKO
(E0354)
1 300 N/A
Anti Rabbit 
(Biotm)
goat
DAKO
(E0432)
1300 N/A
Anti Rat 
(Biotm)
rabbit
DAKO
(E0468)
1 300 n/a
2 4 2 4 Western Blot Analysis
An aliquot of lysed cells (Section 2 3 3 5) was mixed with an equal volume of 
2X Laemmh sample buffer (Sigma, S3401) and boiled for 3 min 10 - 20 fig of 
protein was loaded to each well of a 12% bis-tns gel (NuPAGE, NP0341) The 
samples were run in parallel with multimark multi-coloured standard (Invttrogen, 
LC5725) The electrophoresis conditions were 200 V and 90 mA The gels were 
run for 40 mm Following electrophoresis, gels were equilibrated m IX tns/gly 
transfer buffer (Biorad, 161-0734) for 15 min with agitation Protein gels were 
transferred to a PVDF (polyvinylidene fluoride) membrane (Boehringer 
Mannheim, 1722026) using semi-dry electroblotting (using a semi-dry transfer 
cell (Biorad)) For this, 8 sheets of Whatman 3 mm filter paper (Whatman, 
1001824) were soaked in transfer buffer and placed on the cathode plate of a 
semi-dry blotting apparatus Excess air was removed from between the filters by 
rolling a glass pipette over the filter paper PVDF, cut to the same size of the gel, 
was soaked in transfer buffer and placed over the filter paper, making sure there 
were no air bubbles The acrylamide gel was placed over the PVDF and 8 more 
sheets of pre-soaked filter paper were placed on top of the gel Excess air was 
again removed by rolling the pipette over the filter paper The proteins were 
transferred from the gel to the PVDF at a current of 34 mA at 15 V for 20 mm 
All incubation steps from now on, including the blocking step, were earned out 
on a revolving apparatus (Stovall, Bellydancer) to ensure even exposure of the 
PVDF blot to all reagents
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The PVDF membranes were blocked for 2 hours at room temperature with fresh, 
filtered, 5% non-fat dried milk (Cadburys, Marvel skimmed milk) in IX TBS 
(Sigma, T5912)/ 0 1% Tween (Sigma, P1379) After blocking, the membranes 
were rinsed with TBS-tween and incubated with primary antibody (Table 2 4 3) 
overnight at 4°C The primary antibody was removed and the membranes rinsed 
3 times with TBS/0 1% Tween The membranes were then washed for 15 min, 
and then twice for 5 min in TBS/Tween Bound antibody was detected using 
enhanced chemiluminescence (ECL) Following chemi-luminescent detection, 
blots were again washed and blocked as described and re-probed for an internal 
standard e g GAPDH This was carried out as before
Table 2 4 3 Antibodies used for western blotting
ANTIBODY H O ST SU PPLIER D IL U T IO N  *
C-peptide 1 rabbit
Dr S Heller 
Hagedorn Research Institute
1 5000
C-peptide 2 rabbit
Dr S Heller 
Hagedorn Research Institute
1 5000
GAPDH mouse
Abeam 
(AB9484)
1 5000 -  1 10000
Mouse IgG sheep
Sigma
(A6782)
1 1000
Rabbit IgG goat
Sigma
(A4914)
1 5000
*All antibodies were diluted in IX TBS
2 4 2 5 Quantification of 35S Labelled Insulin and Proinsulin
Cell lysates were thawed and spun for 5 mins at 12,000 rpm at 4°C An aliquot of 
the supernatants was kept aside for total protein determination (Section 2 4 2 1) 
and quantification of total insulin content (Section 2 4 2 6) The remainder was 
passed through a 50 kDa cut-off spin filtration unit (Centncon, YM50) to remove 
high molecular weight proteins For Competitive RIA analysis of the samples, 
an ELISA kit (Mercodia, 10-1124-10) was used with the following 
modifications
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Blocking 50 pi of Conjugate Buffer was added to each well and 25pi of a 1 in 10 
dilution of ‘cold’ matched sample lysate (1 e MIN6 wells blocked with 
‘unlabelled’ MIN6 lysate), followed by 1 hour incubation at room temperature on 
a shaker at 100 rpm
Competitor The blocking solution was removed and the wells were washed (6X) 
with 1 X Washing Solution (supplied in kit) 50 pi Binding Buffer was added to 
each well followed by 25 pi of a dilution series of pure insulin (Sigma, 11882) 
ranging from 250 ng/pl down to 2 5x105 ng/pl The plate was again incubated at 
room temperature for 1 hour on a shaker at 100 rpm to allow equilibration 
Sample Binding 25 pi of a 1 in 5 dilution of the radio-labelled, ultra-filtered 
lysate was added to each well and incubated at room temperature for 2 hours on a 
shaker at 100 rpm
Measurement Unbound protein was removed by discarding the binding solution 
and washing the wells (6X) with Washing Buffer Bound protein was eluted from 
the plate by proteolytic cleavage of the capture antibody with 100 pl/well of 
papain-digestion buffer at 37°C overnight (200 mM sodium phosphate, pH7, 2 
mM EDTA, 10 mM L-cysteine and 0 2 mg/ml papain (Sigma, P3125) The 
amount of radio-labelled material released from each well was measured in a 
Beckman-Coulter scintillation counter (100 pi digestion buffer in 5 ml Ecolite 
scintillation fluid, 1 min reading time on 35S-channel)
2 4 2 6 ELISA Analysis for Insulin and Proinsulin
Insulin secretion studies have already been described (Section 2 3 5) Analyses
on MIN6 cells and conditioned media were carried out using a proinsulin ELISA
kit (Mercodia, 10-1124-10) and ES-denved cells were analysed using a mouse 
ultra-sensitive insulin ELISA kit (Mercodia, 10-1150-01) The kits were fully 
inclusive and all reagents, standards etc were supplied The generalised protocol 
for their use is outlined below Samples were diluted with the 0 standard supplied 
and mixed well by vortexing Standards and samples were added directly to the 
test plate (in duplicate) 50 pi conjugate solution (stock conjugate diluted 1 + 10 
in conjugate buffer) was then applied to the samples and standards The plate was 
wrapped in foil (to prevent debris falling into the wells) and incubated at room 
temperature for 2 hours on a belly dancer set to maximum speed Following this,
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the conjugate/sample mixes were tapped off in to a sink and the wells were 
washed 6X using the washing solution (stock diluted 1 + 20 in UHP prior to use) 
Washing was carried out using a wash bottle with a wide bore nozzle and care 
was taken not to overflow wells during washing (to prevent cross contamination 
between samples) After washing, the plate was tapped firmly on tissue to 
remove the excess wash solution At this point 200 |al peroxidase substrate was 
added to each well This reaction was allowed to develop in the dark (the plate 
was wrapped in tinfoil) for 15 - 30 min and stopped by adding 50 [x\ stop solution 
per well The plates were mixed gently and any bubbles were burst manually 
The plates were read at 450 nm on a plate reader (Labsystems Multiskan Ex) and 
the data was processed using Genesis™ software
2 4 2 7 Alkaline Phosphatase Determination
AP determination was carried out on fresh cells cultured on 6 well plates AP 
activity was measured by adding the assay components (16 5(j.l BCIP (5 Bromo- 
4chloro-3-indoly 1-phosphate, 4 toluidine salt (X-phosphate, 4 toluidine salt)) 
(Roche, 1383 221) and 33 \i\ NBT (mtro blue tetrazolium chloride) (Roche, 
1383, 213)) to 5 ml alkaline phosphatase buffer (100 mM Tns, 100 mM NaCl, 50 
mM MgCh in 100 ml UHP) In this system, BCIP was used as a substrate for 
alkaline phosphatase and being transformed to 5 bromo-4 chloro-3 indoxyl, 
which generates an insoluble purple dye Nitro blue tetrazolium chloride was 
used as an electron acceptor to enhance the colour reaction
The staining solution was applied directly to the test wells and the colour was 
allowed to develop Once the colour had developed the wells were washed 3X in 
UHP and the plates were photographed
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Section 3.0: Results
3.1 AN INVESTIGATION INTO THE DERIVATION OF INSULIN- 
EXPRESSING CELL TYPES USING AN ADAPTED VERSION OF THE 
ORIGINAL LUMESLKY PROTOCOL
Since 2000, several important and exciting reports have been published 
describing the derivation of insulin-positive cells from both mouse and, to a 
lesser extent, human ES cell lines (Table 14 1) Many of these studies have been 
based on the derivation of insulin-producing cells using modified protocols that 
were originally designed to generate neurons, on the premise that the pancreas 
and central nervous system share developmental pathways (Section 14 5) A 
study published by Lumelsky et al (2001) described a 5-stage protocol that gave 
rise to 3-dimsional clusters which stained for insulin in addition to the other 
pancreatic endocrine hormones The cells secreted insulin in response to glucose 
but did not correct hyperglycemia when injected into diabetic mice Several 
further studies modified this protocol resulting in the generation of transplantable 
insulin-producing cells (Hon Y et al, 2002, Blyszczuk et al, 2003) The success 
of these protocols, and others, in generating authentic p cells has been questioned 
due in part to uncertainty regarding cell lineage but also due to controversy 
regarding de novo insulin synthesis (Section 14 3) It is apparent that stringent 
criteria are necessary to define P cell identity This might include (a) measuring 
transcript expression of p cell-associated genes as well as genes associated with 
other lineages, (b) measuring expression of key p cell marker proteins and (c) 
demonstrating functional de novo insulin synthesis
In the present study we attempted to address some of the more controversial 
issues associated with the identification of ‘p-like’ cells derived from mouse ES 
cells We devised a novel assay for detection of de novo insulin synthesis, in 
order to identify functional, insulin-producing cells in vitro The murine 
insulinoma cell line, MIN6, was used to develop the assay (This assay was 
developed in collaboration with Dr Niall Barron) The assay was applied to cells 
derived via a slightly modified version of the original Lumelsky protocol which 
reported insulin-producing cells containing 145 ng of insulin per milligram of 
protein (Figure 3 11) In addition, we investigated alternative means for 
determining C-peptide expression which does not rely on immunostaining alone 
We also measured expression of a range of multi-lineage markers to further
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characterize the complex mixture of cell types derived from the protocol used in 
this and other studies.
We found that cells derived via a modified version of the Lumelsky protocol 
expressed a broad range of multi-lineage markers indicating the derivation of a 
mixed population. Insulin was detected in this ES-derived culture by both 
immunofluoresence and ELISA; however, we conclude that the insulin content is 
a result of insulin uptake from the feed medium rather than de novo synthesis. 
We present evidence suggesting that immunostaining methods for C-peptide 
reactivity may not be definitive proof of, and may over-estimate, P cell 
differentiation in ES-derived cultures and should be performed only in 
conjunction with other analysis methods. We also report the development of a 
novel assay that can identify de novo insulin synthesis.
expanded as attached cells 
(+LEF) (2-3 days) 
generation of embryoid bodies
(-) U F  (4 days)
+insulin+transferrin+selenium 
chloride+fibronectin 
(to select nestin+ cells) (6-7days) 
medium (+N2+B27>+- FGF (6
days)
medium (+N2+B27) (-) FGF + 
nicotinamide (6 days)
Figure 3.1.1 5-Stage Differentiation of ES Cells (Section 2.3.1). Stages 3 -  5 are 
serum-free.
1 0 2
3 11 Morphological Changes Occunng over the 5 Stages of the Lumelsky- 
Based Protocol
ES-D3 cells cultured on gelatin grew in tight multi-layered colonies (Figure 3 12 
A & B) Embryo id body (EB) formation occurred during stage 2 of the protocol 
(Figure 3 1 1) EBs in suspension tended to be heterogeneous in size and 
appeared individually or as aggregates (Figure 3 1 2 C & D) Stage 3 ITSFn 
serum-free medium has been reported to enrich for nestin-positive cells 
(Lumelsky et al, 2001) The EBs attached to gelatin coated tissue culture plates 
and adopted a flattened morphology (Figure 3 1 2 E & F) Cell clusters 
expanded and differentiated during stage 4 and stage 5 Neuronal-like 
projections became more visible and dense clusters adopted a 3-dimensional 
topology (Figure 3 1 2 G - J) These findings were broadly in keeping with what 
was reported elsewhere (Lumelsky et al, 2001, Sipione et al, 2004)
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Figure 3.1.2 Light microscopy images of stage 1 ES-D3 cells (A & B), stage 2 
EBs (C & D), stage 3 cultures (E & F), stage 4 cultures (G & H), stage 5 cultures 
(I & J). Scale bar = 100 urn. (A, C, E, G & I = 10X) (B, D, F, H & J = 20X)
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3.1.2 Alkaline Phosphatase Activity in ES-D3 cells and Stage 2 EBs
AP activity is a characteristic of undifferentiated ES cells (Lumelsky et al, 2001; 
Berrill et al, 2004). AP activity is decreased following differentiation. Using 
BCIP as a substrate for alkaline phosphatase, Figure 3.1.3 A indicates that the 
majority of the stage 1 ES-D3 culture stained for alkaline phosphatase activity. 
Stage 2 EBs consisted of both stained and unstained cells. The stained cells were 
at the centre of the EB surrounded by a halo of unstained cells. The pattern of 
staining demonstrates that the cells constituting the outer layer of the EB had a 
decreased level of alkaline phosphatase activity indicating that these cells had 
differentiated (Figure 3.1.3 B).
Figure 3.1.3 AP activity at stage 1 (A) and stage 2 (B) of Lumelsky based 
protocol. In stage 1 undifferentiated cells stained positive for AP. In stage 2 (B), 
embryoid bodies (EBs) consisted of both stained (undifferentiated) cells and 
unstained (differentiated) cells.
3.1.3 Analysis of Transcript Expression in Stages 1 -  5 of the Lumelsky 
Based Protocol
Cultures at stages 1 - 5 were analysed by semi-quantitive RT-PCR and qPCR 
analysis for expression of an extensive list of target genes representative of a 
number of lineages (Table 3.1.1 & Table 3.1.2).
A number of early developmental markers i.e. GAT A 4 and nestin were detected 
at low levels in stage 1 ES-D3 cells (Figure 3.1.4 I & J). Germ-line specific 
transcription factor Oct 4 was down-regulated between stage 1 and stage 5. 
Multi-lineage marker expression was detected in stage 5 cultures (Table 3.1.1). 
Induced expression of pancreatic transcription factors Pdxl (stage 2 - 5 )  and pax 
4 (stage 5) occurred during the differentiation protocol (Figure 3.1.4 E & F). The
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stage 5 culture expressed pancreatic P cell markers, type 2 glucose transporter 
(glut2), insulin I, insulin II (Figure 3 1 5 A - C) and alpha cell marker, 
somatostatin (Figure 3 1 4 C) Pancreatic polypeptide (PP) was detected at a low 
level in stages 1, 2 and 4 (Figure 3 1 4 B) However, this result varied from one 
biological repeat to the next (Table 3 1 1 )  Glucagon mRNA was not detected at 
any stage (Stage 3 1 4 D) Increased expression of the neuronal marker, myelin 
basic protein (MBP) and induced expression of glial fibrillary acidic protein 
(GFAP) was observed between stage 1 and stage 5 (Figure 3 1 4 L & M) 
Differentiated stage 5 cells also expressed extra-embryonic markers GAT A 4, 
Oct 4 and alpha-feto protein (AFP) (Table 3 1 1) Apoptotic marker expression 
i e bcl-2 associated X protein (bax) and caspase 3 remained unchanged between 
stage 1 and stage 5 (Figure 3 1 4 N, O)
We found that ES-denved stage 5 clusters expressed markers representative of 
the neuronal/glial lineage (GFAP, MBP, p III tubulin), extra-embyromc lineage 
(GATA 4, AFP, Pdxl) and pancreatic endocrine lineage (pax 4, insulin I, insulin 
II, glut2) indicating the presence of multiple cell types in stage 5 clusters
1 0 6
Table 3.1.1 Data shown is the relative quantity (RQ) of gene expression in stage 
1 -  5 cultures from 2 independent experiments (repeat 1, black; repeat 2, red). 
Refer to Figure 3 .1.4 A -  O for representative gels. RQ was determined using 
densitometry analysis. The RQ in the stage 1 ES-D3 cells was set to 1. In cases 
where there was no target detected in the ES-D3 cells, the stage at which 
expression was first induced was set to 1. A, Absent; ND, not determined; P,
present.
Target Stage
1 2 3 4 5
Pluripotent
Octamer 4
Endocrine
Pancreas
1 1 0.95 0.85 0.69 0.71 0.79 0.72 0.85 0.84
PP 1 1 A 0.473 A A 0.456 A A A
Som
Glucagon
Transcription
Factors
A
A
A 1
A
1 44.09
A
48.80 14.03
A
30.53 15.62
A
15.71
Pdxl A A 1 1 0.36 0.61 1.31 1.77 1.565 2.47
Pax 4
Exocrine
Pancreas
A A ND ND ND ND ND ND P P
Amylase
Extra-
embryonic
A A A A A A A 1 P 0.893
AFP A A 1 1 0.27 0.11 0.51 0.73 3.83 1.42
GATA4 1 1 0.73 0.87 1.26 1.34 1.53 1.358 1.70 2.16
Neuronal/Glial
Nestin 1 1 1.66 1.71 1.86 2.06 1.17 2.02 1.39 1.36
B III Tubulin 1 1 0.88 0.86 1.19 1.01 1.05 1.00 0.94 0.86
GFAP A A A A A A 1 1 1.05 2.46
MBP 1 1 1.49 1.70 1.69 3.46 2.23 2.90 2.72 3.69
Apoptotic
Bax 1 1 0.93 1.11 0.94 1.11 0.96 1.02 1.08 1.00
Casp3 1 1 1.08 0.94 1.49 0.99 0.82 1.02 1.01 1.07
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Figure 3 14  Semi-quantitive RT-PCR analysis of differential gene expression in 
Stage 1 -  5 Cultures Individual transcript analysis labelled A -  O
Pluripotent Markers
GAPDH 
Oct 4
1 2 3 4 5
Stages
(A) Oct 4 was expressed in cultures from all stages of the differentiation 
protocol There was an overall decrease in expression between stage 1 
and stage 5
Endocrine Pancreas Markers
(B) Low level expression of PP was detected in the stage 1 culture PP 
expression was also detected at low levels in cultures from other stages of 
the differentiation protocol, however, this varied from one biological 
repeat to another The third band visible on the gel is perhaps due to a 
splice variant amplified by the PP pnmer set
PP
GAPDH
2 3 4 5 +ve
Stages
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GAPDH
Som
1 2 3 4 5 +ve
Stages
(C) Somatostatin expression was detected at a very low level in the stage 2 
culture An up-regulation in expression was observed in the stage 3 
culture, however, expression was subsequently down-regulated at stage 4 
and 5
GAPDH 
Glucagon
1 2 3 4 5 +ve
Stages
(D) Glucagon was not expressed in cultures at any stage of the differentiation 
protocol
Transcription Factors
GAPDH
Pdxl
+ve 1 2 
Stages
(E) Pdxl was expressed in cultures at stages 2 to 5 Highest Pdxl 
was observed in the stage 5 culture
expression
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GAPDH
Pax 4
1 5 +ve
Stages
(F) Pax 4 was absent in the stage 1 culture and present in the stage 5 culture
Exocrine Pancreas Markers
Amylase
ßactm (s)
(G) Amylase was expressed at a low level in the stage 5 culture
Extra-Embryonic Markers
2 3
Stages
4 5
AFP
ßactm (s)
(H) AFP was expressed in cultures at stages 2 to 4 with highest expression 
observed in the stage 5 culture
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1 2 3 4 5 +ve
Stages
(I) GATA 4 was expressed in cultures at stages 1 to 5 Expression was up- 
regulated between stage 1 and stage 5
GAPDH
GATA 4
Neuronal/Glial Markers
GAPDH
NesUn
(J) Nest in expression was detected at a low level in the stage 1 culture and
up-regulated in cultures at stages 2 to 5
GAPDH 
P III Tubulin
(K) P HI Tubulin was expressed at a similar level in cultures at stages 1 to 5
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GFAP
GAPDH
(L) GFAP was expressed in cultures at stage 4 and 5 with the highest level of 
expression observed in the stage 5 culture
GAPDH
MBP
1 2 3 4 5
Stages
(M) MBP was expressed in cultures at stages 1 to 5 An up-regulation in 
MBP expression was observed over the 5 stages of the differentiation 
protocol
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Apoptotic Markers
Stages
(N) Bax was expressed at similar level in cultures at stages 1 to 5
GAPDH
Caspase3
(0)
3
Stages
Caspase 3 was detected in all cultures at stages 1 to 5 There was 
significant change in expression levels over the 5 stages
Table 3.1.2 Data shown is the relative quantity (RQ) of gene expression in stage 
1 -5  cultures from 2 independent repeats (repeat 1, black; repeat 2, red). Refer to 
Figure 3.1.5 for representative graphs. The RQ in the stage 1 ES-D3 cells was set 
to 1. A, absent; ND, not determined.
Target Stage
1 2 3 4 5
Insulin I 1 1 14.91 7.77 5.53 13.23 37.8 37.83 41.05 83.85
Insulin II 1 1 18.45 7 99 34.5 31.64 101.95 65.71 176.02 114.99
Glut2 1 1 ND ND ND ND ND ND 61.29 65.67
Stages
I Repeat 1 
I Repeat 2
Figure 3.1.5 Graphs representative of qPCR results shown in Table 3.1.2. (A) 
insulin I, (B) insulin II and (C) glut2.
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3 14  Analysis of Insulin/C-peptide Protein Expression in ES-derived Stage 
5 cultures
Immunofluorescence staining was used to identify insulin, C-peptide 1 and C- 
peptide 2 positive cells in the differentiated stage 5 culture Stage 1 ES-D3 cells 
and the murine insulinoma cell line, MIN6, represented negative and positive 
biological controls, respectively Stage 1 ES-D3 cells were negative for insulin 
(Figure 3 1 6 A) but positive for C-peptide 1 (Figure 3 1 7 A) and C-peptide 2 
(Figure 3 1 8 A) C-peptide 2 staining localised to the nucleus MIN6 cells 
stained positive for insulin (Figure 3 1 6 D), C-peptide 1 (Figure 3 1 7 C) and C- 
peptide 2 (Figure 3 1 8 C) The staining had a distinct punctate pattern for all 
proteins tested and was localised to the cytoplasm An isolated population of 
stage 5 differentiated clusters displayed a similar msuhn-staming pattern to that 
of the MIN6 ‘P-cell’ phenotype (Figure 3 1 6 B & C) Immunoreactivity for C- 
peptide 1 and C-peptide 2 was detected in a significant proportion of stage 5 
differentiated cultures (Figure 3 1 7 B and Figure 3 1 8 B) In most cases, the 
anti-C-peptide antibodies stained in a cytoskeletal-like pattern Unexpectedly, 
immunoreactivity for C-peptide 1 and C-peptide 2 was also observed in the 
mouse mammary cell line, 4TI, which was thought to be a negative control 
(Figure 3 1 7 D and Figure 3 1 8 D)
Specificity of the C-peptide antibodies was checked by western blot (Figure 3 1 7 
E and Figure 3 1 8 E & F) MIN6 cells were used as a positive control Stage 1 
ES-D3, 4TI and FVB#C (fibroblast cell line derived from mouse ear) were used 
as negative control cell lines A band for C-peptide 1 was not detected at the 
appropnate size (3 kDa) by western blot in any of the cell lines including the 
positive control cell line, MIN6, however, a number of non-specific bands were 
detected at > 17 kDa (Figure 3 1 7 E) The C-peptide 2 antibody recognised a 
specific band for the C-peptide 2 protein at the expected size, 3 kDa, in the MIN6 
cell line (Figure 3 1 8 E) Multiple non-specific higher molecular weight bands 
were observed in both positive and negative control cell lines A band for C- 
peptide 2 was not detected in stage 5 differentiated cell types (Figure 3 1 8 F 2 
repeats, S5A and S5B)
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These results suggest that the stage 5 differentiated clusters may contain a very 
small number of insulin-expressing cell types C-peptide staining may be 
overrepresented significantly in relation to actual levels in ES-derived cell 
populations Hence, C-peptide reactivity may not be definitive proof of, and may 
overestimate, P-cell differentiation in ES-denved cultures The C-peptide 2 
western blot is a more reliable, quantitive method for detecting C-peptide 2 
expression
t
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Figure 3 1.6 Insulin (A) Stage 1 ES-D3 cells were negative for insulin (B & C) 
Punctate insulin staining was visible in an isolated population of stage 5 
differentiated cells Diffuse background staining was visible throughout culture
(D) MIN6 cells, positive control, Insulin was expressed in a high proportion of 
cells (Insulin, green, DAPI nuclear stain, blue) Scale bar = 10 [im (A, C, D) and 
20 jim (B)
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Figure 3 17  C-peptide 1 stage 1 ES-D3 cells (A), stage 5 differentiated cell 
types (B), positive control MIN6 (C) and negative control 4TI (D) were positive 
for C-peptide 1 The staining pattern indicative of granular staining exhibited in 
the MIN6 positive control (C) differed from the staining pattern exhibited by all 
other samples (A, B & D) Scale bar = 10 ^m (A -  C) and 30^m (D) Antibody 
specificity was subsequently checked by western blot (E) A band was not 
detected at the appropriate size by western blot in any of the cell lines including 
the positive control cell line MIN6, however, there was a number of non-specific 
bands detected at > 17 kDa 15^g protein loaded on western blot in all cases
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Figure 3 18  C-peptide 2 stage 1 ES-D3 cells (A), stage 5 differentiated cell 
types (B), positive control MIN6 (C) and negative control 4TI (D) were positive 
for C-peptide 2 The granular staining pattern indicative for positive staining 
exhibited m MIN6 (D) differed from the staining exhibited by all other samples 
Scale bar = 10 |im (A -  C) and 30|xm (D) Antibody specificity was subsequently 
checked by western blot (E) A band was detected at the appropriate size in the 
positive control cell line MIN6, however, a number of non-specific bands were 
detected by western blot in the negative control cell lines ES-D3, 4TI and 
FVB#c A C-peptide 2 western blot was also performed on stage 5 differentiated 
cell types (2 repeats, S5A and S5B) (F) Both were negative for C-peptide 2 
expression 15 jig protein loaded on western blot in all cases
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3 15  Intracellular Insulin Content and In Vitro Glucose-Stimulated Insulin 
Secretion
Stage 1 ES-D3, positive control MIN6, stage 5 differentiated cells, repeat 1 
(S5A) and stage 5 differentiated cells, repeat 2 (S5B) were exposed to 3 3 mM, 
16 7 mM and 26 4 mM stimulatory glucose concentrations for 1 hour Cells 
were lysed (one well of a 6 well plate) and analysed for insulin/protein content 
(Figure 3 1 9) The glucose buffers removed from the cells were also tested for 
insulin content to check for glucose stimulated insulin secretion (GSIS) (Figure 
3 1 10) Stage 1 ES-D3 cells did not contain insulin when assayed by ELISA 
Stage 5 differentiated cultures contained approximately 36 ng insulin per mg 
protein (Figure 3 19) These ES-derived cultures also secreted insulin although 
they did not exhibit a significant increased secretory activity in response to 
glucose (Figure 3 1 10) The intracellular content and quantity of insulin 
released from ES-derived cultures varied between biological repeats of the 
experiment MIN6 cells demonstrated functional GSIS by increasing insulin 
release approx 4-fold over the glucose range tested (3 3 -  26 7 mmol/1)
S1
r  4500
-- 3600 ?
+ 1800 o
-  900
S5A S5B MIN6
Figure 3.1 9 Intracellular insulin content Insulin content was normalised to the 
amount of protein in each sample Stage 1 ES-D3 (SI) and MIN6 represent 
negative and positive biological controls, respectively Stage 5, repeat 1 (S5A) 
and stage 5, repeat 2 (S5B) contained 33 7 and 39 ng insulin/mg protein, 
respectively
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(MIN6 data plotted on secondary axis)
S5A S5B MIN6
Figure 3.1.10 Insulin secretion was measured by ELISA and normalised to total 
cellular protein. Stage 5 differentiated clusters were pre-incubated for 1 hour with 
Krebs buffer containing 3.3 mM glucose. Cells were subsequently incubated with 
Krebs buffer containing 3.3 mM (grey), 16.7 mM (red) and 26.4 mM (black) 
glucose. Data is representative of two independent experiments, stage 5A (S5A) 
and stage 5B (S5B). MIN6 represented a positive biological control. (MIN6 data 
plotted on secondary axis)
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3 16  Demonstration of De Novo Insulin Synthesis
The novel assay we designed to identify de novo insulin synthesis consisted of 
metabolic labelling (ML) of total cellular protein over a 6 hour time period 
followed by a modified radio-immunoassay (MRIA) We used the MIN6 cell line 
as a positive control to develop and prove the utility of the assay The 6 hour 
labelling time frame ensured that a significant percentage of newly synthesized 
insulin incorporated 35S-L-cysteine (mature murine insulin contains 6 cysteine 
residues) Initial experiments investigated a 1 hour ML time frame compared to a 
20 hour ML time frame Labelling for 20 hours compared to 1 hour required the 
use of a higher concentration of cold insulin competitor to compete with labelled 
insulin (Figure 3 111) In subsequent experiments, an ML time frame of 6 hours 
was chosen for technical reasons (i e ability to perform labelling step within a 1 
day period contributed to the user-friendliness of the assay) It was found that 
labelled insulin competed with similar concentrations of ‘cold5 insulin 
competitor m both the 20 hour and 6 hour ML experiments (Figure 3 1 11 B 
compared to Figure 3 1 12 B & C)
Total protein was extracted and the lysates were fractionated by ultra-filtration to 
remove larger proteins (> 50 kDa), including a large population of radio-labelled, 
‘sticky’ proteins We found that this step dramatically decreased the level of 
background signal in the subsequent MRIA and greatly improved assay 
performance (See Figure 3 1 12 A compared to Figure 3 1 12 B & C) It should 
be noted that this step also removes a small proportion (5 -10%) of preproinsulin 
(115 kDa) and insulin (6 kDa) due to the technical performance of the ultra- 
filtration membrane (data estimate from Centncon source) Wells on the ELISA 
plate were pre-blocked with non-labelled cell lysate, which decreased the noise 
in sampling i e standard deviation (See Figure 3 1 12 B compared to Figure 
3 1 12 C)
In the subsequent MRIA assay, radio-labelled insulin in the lysate was bound by 
the antibody coated on the ELISA plate, subsequently eluted by digestion with 
papain and the radioactive signal was measured by scintillation counting By 
including known, increasing concentrations of competitor substrate (unlabelled 
insulin) during binding, we were able to detect a drop in radio-labelled insulin
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bound to the antibody At low concentration of competitor (up to 2 5x10 
mg/ml) there was no change in the amount of labelled insulin bound to the 
antibody but as this increased (maximum 0 25 mg/ml) there was a sudden drop in 
counts from the plate (Figure 3 1 13 A) By plotting various dilutions of MIN6 
protein lysate (expressed in terms of total insulin measured by conventional 
ELISA) against the cpm (counts per minute) detected, we were able to generate a 
standard curve that could be used to determine the minimum detectable level of 
labelled insulin in the MIN6 sample (Figure 3 1 13 B) Applying the equation of 
the slope of the line we determined that the lowest theoretical concentration of de 
novo synthesised insulin detectable in this assay is 0 4 ng/ml However, this 
would be very close to background levels therefore using a cut-off of 3 X SD 
above this as a minimum would be more practical (SD = ± 12 for highest 
dilution) This gives a minimum detectable quantity of 0 71 ng/ml
Having successfully identified de novo insulin synthesis in the control MIN6 
cells we applied the assay to differentiated ES-D3 cells (stage 5), with untreated 
ES-D3 cells (stage 1) as a negative control First we measured the amount of 
total insulin in the lysates by conventional ELISA, including MIN6 as a positive 
control The control is included to account for inter-assay variations in specific 
activity of radioisotope, labelling efficiency, cell lysis, etc We also measured 
total protein content prior to ultra-filtration As can be seen in Table 3 13, there 
was a small but significant quantity of insulin detected by ELISA in the stage 5 
cells (88 ng/ml), similar to levels found previously When analysed using the 
competitive MRIA, the lysate from undifferentiated ES cells showed a low level 
of radioactive counts (~ 400 cpm) and there was no detectable decrease at high 
concentrations of competitor, as expected (Figure 3 1 14) The background signal 
was similar for the stage 5 cells but, significantly, high concentration competitor 
did not cause any drop in the signal demonstrating absence of detectable, bound, 
radio-labelled insulin This would suggest that the cells do not synthesize the 
majority of the 88 ng/ml insulin detected by standard ELISA
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M IN61hr labelling A
Competitor (mgfml)
MIN6 20hr labelling B
C o m p etito r (m g/m l)
Figure 3 111 Metabolic Labelling Times were asessed on MIN6 cells (A) 1 
hour time frame (B) 20 hour time frame Labelling for 20 hours compared to 1 
hour required the use of a higher concentration of cold insulin competitor to 
compete out labelled insulin A 6 hour labelling time frame was chosen for 
subsequent experiments
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Figure 3.1.12 35S labelled MIN6 competitive MRIA optimisation. Ultra-filtration 
of lysates decreased background levels and improved assay performance. See 
Figure A (without filtration) compared to Figure B &C (with filtration). A pre­
blocking step introduced to the assay reduced the noise in sampling (Standard 
Deviation, SD) in the MRIA step. See Figure B (no blocking) compared to 
Figure C (blocking included). Data represents mean ± SD from triplicate sample 
cpm readings.
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Figure 3.1.13 (A) Competitive binding of radio-labelled and non-labelled insulin 
to ELISA plate. Increasing the amount of ‘cold’ Competitor insulin from 0 to 
0.25 mg/ml in the well displaced bound MIN6-derived labelled insulin.
Metabolicly labelled MIN6 lysate diluted 1:10 (---------), 1:100 (------), 1:1000
( ). (B) Radioactive counts (cpm) versus total insulin concentration. A
standard curve was generated by plotting total bound cpm in non-competed, 
serial (10-fold) dilutions of MIN6 lysate against total insulin concentration as 
determined by ELISA. For very precise quantitation in any cell extract, a 
standard curve must be prepared as part of each experiment, due to inter-assay 
variations in labelling efficiency and specific activity. Data represents mean ± 
SD from triplicate sample cpm readings.
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Table 3.1.3 Detection of de novo insulin in cell lysates. Protein refers to total 
protein concentration prior to ultra-filtration. Total insulin concentration was 
determined by mouse (sensitive) ELISA. Cpm are those detected in diluted 
samples (1:5).
Protein
(mg/ml)
Total
lnsulin(ng/ml)
Insulin ng/mg 
Protein
Cpm* Cpm**
ES-D3 0.323 1.96 6.07 452 438 +/- 13
Stage 5 2.35 88 37.4 380 368 +/- 16
MIN6 0.341 2986 8757 2861 155+/-4
*cpm detected without addition of competitor **cpm detected after addition of 
high conc. competitor
Figure 3.1.14 Competitive MRIA: (A) MIN6 cells (---- ), stage 1 ES-D3 cells
(— ), stage 5 ES-derived differentiated cells ( ). All samples lysed in NaOH
and diluted 1:5. MIN6 showed a decrease in cpm with increasing competitor 
indicating de novo insulin synthesis (total insulin). ES-D3 and ES-derived stage 5 
differentiated cells did not show a decrease in cpm with increasing competitor 
despite the fact that the stage 5 ES-derived differentiated population contained 
approximately 45 times more total insulin (ng/ml) than the stage 1 ES-D3 
population measured by ELISA. Data represents mean ± SD from triplicate 
sample cpm readings.
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3 2 TWO-STAGE DIFFERENTIATION STUDIES
The derivation of definitive endoderm and in particular endocrine cell types from 
undifferentiated ES cells remains difficult to achieve Multi-step regulated 
differentiation protocols described for the derivation of pancreatic cell types are 
long, cumbersome, often involve the use of exogenous insulin and also result in 
low yields of insulin-producing cells The validity of these protocols has been 
questioned on the basis that ES-denved cells can absorb insulin from the feed 
media and may not produce insulin themselves (Section 3 1) In this study, we 
investigated the potential to regulate the differentiation of ES cells into 
endodermal derivatives (in particular insulin-producing cells) using extra-cellular 
factors previously associated with various aspects of pancreatic development
Previous studies, both in our laboratory and by others, have demonstrated that 
retinoic acid promotes both neuronal and endodermal differentiation (Section 
1 1 7 1 & 1 5 1) It has also been shown that similar elements control the 
development of both the pancreas and central nervous system (CNS) (Lumelsky 
et al, 2001) In this study, undifferentiated ES-D3 cells were removed from LIF 
and allowed to form EBs in the presence of retinoic acid (RA) (stage 1 
differentiation) (Section 3 2 1) The RA-treated EBs were subsequently exposed 
to one of the following Sodium Butyrate (SB), Betacellulin (BTC) and Activin 
A (AA) (stage 2 differentiation) (Figure 2 3 1) A comparative analysis was 
performed on these models of directed differentiation in parallel with a model of 
spontaneous differentiation Lineage differentiation was determined by profiling 
multi-lineage transcript expression (neuronal, glial, muscle, exocrine and 
endocrine pancreas, extra-embryonic and apoptotic) (Section 3 2 3) and 
subsequent protein expression within ES-denved cultures (Section 3 2 4)
Using the 2-stage differentiation protocols developed dunng this study, we 
successfully demonstrated the derivation of an intermediate multi-potential 
population (RA-treated EBs) from undifferentiated ES cells that preferentially 
gives rise to pancreatic endocrine insulin-expressing cell types in the presence of 
SB, and neuronal- and glial-like cell types in the presence of AA or BTC The 
short 2-stage RA SB protocol developed in this study does not require
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exogenous insulin for the derivation of insulin-positive cell types, indicating that 
any insulin expressed is de novo synthesized
3 2 1 Formation of Embryoid Bodies in the Presence of Retmoic Acid
Undifferentiated ES-D3 cells are seeded over-night in suspension culture prior to 
being treated with 100 nM RA After 3 days in suspension culture in the presence 
of RA the cells have formed tight rounded aggregates resembling EBs (Figure 
3 2 1)
A E
i
J
Figure 3 2 1 Formation of RA-treated EBs (A) ES-D3 grown in monolayer, 
scale bar = 200 ^m (B) RA-treated EBs grown in suspension, scale bar = 
100|4.m (A = 10X)(B = 20X)
3 2 2 Alkaline Phosphatase Activity in ES-D3 cells and 5 Day ES-denved 
Cultures
AP activity is a characteristic marker of undifferentiated plunpotent stem cells 
Down-regulation of AP activity is indicative of differentiation (Lumelsky et al, 
2001, Prelle et al, 2002, Bernll et al, 2004) Day 1 ES-D3 cells, day 5 control 
EBs (CO_5d) and day 5 RA-treated EBs were analysed for AP activity to 
ascertain the differentiation status of the cells both before and after stage 1 
differentiation EBs were plated onto a tissue culture surface prior to AP 
analysis Day 1 ES-D3 cells stained positive for AP activity (Figure 3 2 2 A & 
B) Day 5 RA-treated EBs (Figure 3 3 2 C & D) were distinctive in both 
morphology and staining pattern from CO_5d EBs (Figure 3 2 2 E & F) RA- 
treated EBs had neuronal like projections extending from the edge of the EBs 
that only stained weakly for AP activity and were larger in size than CO_5d EBs
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These neuronal like projections were most likely a result of differentiation. 
CO_5d EBs were predominately stained for AP activity (Figure 3.2.2 E & F). 
Intensity of staining decreased towards the outer layer of the EB suggesting that 
some of these cells may have started to differentiate.
Figure 3.2.2 AP expression in ES-D3 cells and 5 day ES-derived Cultures. ES- 
D3 cells stained intensely for AP expression (A & B). RA-treated EBs had 
neuronal like projections extending from the edge of the EBs that stained weakly 
for AP expression (C & D). CO_5d EBs predominately stained for AP 
expression (E & F). Intensity of AP staining decreased towards the outer layer of 
the CO_5d EBs suggesting that some of the outer cells may have started to 
differentiate. (A, C & E = 20X) (B, D & F = 40X)
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3.2 3 Analysis of Transcript Expression in ES-D3 and ES-derived 
Cultures
We evaluated the expression of multi-lineage marker transcripts (neuronal, glial, 
pancreatic exocrine & endocrine, extra-embyromc, muscle and apoptotic) in ES- 
derived cultures by semi-quantitive RT-PCR to characterize the cell types 
derived using the 2-stage differentiation protocols (Table 3 2 1 and Figure 3 2 3) 
Particular emphasis was placed on expression analysis of pancreatic endocrine (3 
cell markers qPCR was used to accurately determine the relative quantity of 
insulin I, insulin II and glut2 transcript expression in ES-denved samples (Figure 
3 2 4) Optimisation experiments were performed for the qPCR analysis as 
shown in Section 3 2 3 2 Two endogenous controls were tested by qPCR to 
ensure that the presence of extra-cellular factors had not affected the endogenous 
control expression thus affecting overall trends in target gene expression Both 
GAPDH and (3-actin resulted in similar trends in target gene expression (Figure 
3 2 5) PCR efficiency using insulin I, insulin II, GAPDH and P-actin primer and 
probe sets was checked on serial 10 fold dilutions of cDNA from a positive 
control cell line i e MIN6 (Figure 3 2 6) All primer and probe sets 
demonstrated an efficiency of > 90% (Table 3 2 3)
3 2 3.1 Summary of Results from Semi-Quantitive RT-PCR and qPCR 
Analysis of Multi-lineage Marker Expression in ES-D3 and ES-derived 
Cultures
ES-D3 cells cultured in the absence of feeder layers expressed early 
developmental markers (eg  nestin, islet-1, ngn3) indicating that initiation of 
differentiation takes place early in a feeder-free culture system (Figure 3 2 3 B, J, 
L) Spontaneously-formed 5-day control EBs (CO_5d) expressed a broad range 
of multi-lineage markers (Figures 3 2 3 & Figure 3 2 4) Addition of RA to the 
culture media during EB formation enhanced the expression of a subset of these 
markers (nestin, neurofilament-light (NF-L), myelin basic protein (MBP), islet-1, 
pax 6, pcsk2, alpha-fetoprotein (AFP), glut2) and induced the expression of some 
hedgehog (shh) and somatostatin (Table 3 2 1 and Figure 3 2 4) RA repressed 
expression of the skeletal muscle regulatory gene, myogenin (Figure 3 2 3 G) 
Transcript expression of p cell-specific insulin I and insulin II was marginally 
higher in the CO_5d culture compared to the RA culture (Figure 3 2 4 A, B),
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however, expression of pancreatic transcription factor Pdxl was greatly 
increased in the CO_5d culture (Figure 3 2 3 K)
The addition of differentiation-inducing agents to RA-treated EBs altered gene 
expression (Table 3 2 1 and Figure 3 2 4) SB promoted the mRNA expression 
of pancreatic transcription factors (Pdxl, nkx2 2, beta2), pancreatic endocrine 
hormones, pancreatic polypeptide (PP) and extra-embryonic markers, AFP 
between day 5 (RA) and day 9 (RA_SB) of the differentiation protocol SB also 
greatly induced expression of P cell mRNAs (pre-proinsulin, insulin I, insulin II 
and glut2) (Table 3 2 1 and Figure 3 2 4) SB repressed expression of the 
neuronal marker, NF-L, the transcription factors, shh, the 5 cell marker, 
somatostatin and the enzyme, pcsk2 (Table 3 2 1)
AA and BTC promoted the mRNA expression of the astrocyte marker, glial 
fibrillary acidic protein (GFAP) and shh, somatostatin and pcsk2 in differentiated 
9 day, RA_AA and RA_BTC cultures, respectively (Table 3 2 1) The 
oligodendrocyte marker, MBP, and neuronal markers, NF-L and P III tubulin, 
were also expressed within these cultures but their level of mRNA expression 
remained unchanged between day 5 and day 9 of the differentiation protocol 
Insulin I, insulin II and glut2 mRNA expression was repressed in RA_AA and 
RA_BTC cultures (Figure 3 2 4) Apoptotic marker expression i e bcl2- 
associated protein (bax) and caspase 3, remained unchanged between ES-D3 
cells and ES-denved EB cultures (Figure 3 2 3 Y, Z) Pax 4 (pancreatic 
transcription factor), glucagon (marker of pancreatic endocrine a cells) and 
amylase (marker of the exocrine pancreas) were undetected in ES-D3 and ES- 
denved cultures (Figure 3 2 3 O, U, W) There was no dramatic change in multi- 
lineage mRNA expression between spontaneously-formed EBs at day 5 (CO_5d) 
and day 9 (CO_9d) with exception to the muscle markers, both desmin and 
myogemn were expressed at higher levels in the CO_5d culture compared to the 
CO_9d culture (Table 3 2 1)
The range of transcript expression identified in the RA culture suggested a mixed 
population of multi-potential precursors Stage 2 differentiation of the RA culture 
in the presence of sodium butyrate encouraged pancreatic endocrine marker
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expression Stage 2 differentiation in the presence of AA or BTC promoted 
neuronal- and glial-specific transcript expression
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Table 3 2 1 Data is representative of the relative quantity (RQ) of gene 
expression in undifferentiated ES-D3 and ES-denved cultures Refer to Figure 
3 2 3 for gels and associated densitometry RQ was determined using 
densitometry analysis Target expression detected in the ES-D3 cells was set to 
1 In cases were there was no target detected m the ES-D3 cells, the sample 
expressing the lowest target level was set to 1 (A, Absent)
ES-D3 RA CO_ 5d CO_9d RA_AA R A SB RA_BTC
Markers
Differentiation -
Oct 4 1 0 788 0 867 0 839 0 790 0 584 0 827
Neuronal/Glial
NesUn 1 1 242 0 583 0 356 1 085 1 060 1 049
GFAP 1 A A A 2 342 A 0 956
NFL 1 1 339 0 653 0 814 1004 0 723 0 913
MBP 1 1257 0 893 0 930 0 740 0 840 0 834
P III Tubulin 1 1008 0 907 0 923 1032 0 942 0 973
Muscle
Myogenm 1 1 641 3 619 2 413 1 208 1 611 1 242
Desmin 1 1403 1426 0 582 1 085 1486 1443
Trancnption
Factors
Shh A 5 994 A A 4 599 1 4 284
Islet 1 1 2 069 0 638 0 694 0 421 0 701 0 521
Pdxl 1 2 780 5 941 4 547 2 527 4 072 2 829
Ngn3 1 1784 1 826 1 521 0 825 0 440 0 765
Beta2 1 0 746 0 845 0 796 0 794 1 149 0 732
Pax 6 1 1440 0 450 0 848 0 726 0 811 0 808
Pax 4 A A A A A A A
Nkx2 2 1 3 992 4 378 3 571 4 233 6 447 4 992
Endopeptidases
PCI 1 0 521 0 455 0 865 0 601 0 397 0 506
PC2 1 1 387 0 821 0 422 2 390 0 573 1 768
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Endocrine
Pancreas
Som 1 8 460 1 364 A 5 706 1 571 10 310
PP 1 1090 A 0 341 A 0 955 A
Glucagon A A A A A A A
PPI 1 2 396 5 862 2 905 1 111 13 383 2 451
Exocnne
Pancreas
Amylase A A A A A A A
Extra-
embryonic
AFP A 2 947 1 1 394 3 499 5 279 3 749
Apoptotic
Bax 1 1057 1050 1 063 0 897 0 986 0 893
Caspase 3 1 1 179 1 031 1 142 1 141 0 945 1036
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Table 3.2.2 Loading order for gels shown in Figure 3.2.3
Lane Sample
Marker
1 ES-D3
2 RA
3 CO_5d
4 CO_9d
5 R A A A
6 R A S B
7 R A B T C
8 Negative Control: H20
9 Positive Control: MIN6
Figure 3.2.3 Semi-quantitive RT-PCR analysis of differential gene expression 
in undifferentiated ES-D3 and ES-derived cultures. Individual transcript analysis 
labelled A-Z. See Table 3.2.2 for loading order of gels. RQ, relative quantity.
Di fferentiation Markers
GAPDH 
Oct 4
1 2 3 4 5 6 7 8
(A) Oct 4 mRNA expression 
was observed in ES-D3 cells 
and was down-regulated in all 
ES-derived cultures. The lowest 
level of Oct 4 expression was in 
the RA SB culture.
Oct4 Expression in ESD3 & ES-derived 
Cultures
1.25
1
0.75
0.5
0.25
0
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4
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Neuronal/Glial Markers
GAPDH
Nestin
Nestin Expression in ESD3 & ES-derived 
Cultures
■  Nest/GAP
Lanes
(B) Nestin mRNA expression 
was observed in ES-D3 cells. 
Nestin expression was up- 
regulated in the RA culture and 
subsequent treated EB cultures, 
but down-regulated in the 
spontaneously formed CO_5d 
and CO 9d cultures.
1 2 3 4 5 6 7
GFAP Expression in ESD3 & ES-derived 
Cultures
IGFAP/GAP
D A
1 2 3 4 5 6 7
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GFAP
GAPDH
(C) GFAP mRNA expression 
was observed in ES-D3 cells 
and down-regulated in all ES- 
derived cultures with the 
exception of the RA AA and 
RABTC cultures. GFAP 
expression was up-regulated in 
the RA AA culture.
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B-actin
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(D) NF-L mRNA expression 
was observed in ES-D3 cells 
and up-regulated in the RA 
culture. The level of NF-L 
expression was maintained in 
the presence of AA and BTC 
but was down-regulated in the 
presence of SB. NF-L 
expression was also down-regulated in control EBs (CO_5d and CO_9d).
GAPDH 
MBP
7 8
(E) MBP mRNA expression 
was observed in ES-D3 cells. 
MBP was up-regulated in the 
RA culture; however, there was 
no significant changes in 
expression in the other ES- 
derived cultures.
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MBP Expression in ESD3 & ES-derived 
Cultures
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GAPDH 
P III Tubulin
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(F) (3 III Tubulin mRNA was 
expressed at similar levels in 
ES-D3 cells and all ES-derived 
cultures.
Myogenic Markers
GAPDH 
Myogenin
1 2 3 4 5 6 7 8
(G) Low level myogenin 
mRNA expression was 
observed in ES-D3 cells and all 
ES-derived cultures. Myogenin 
expression was up-regulated in 
spontaneously formed control 
EBs (CO_5d and CO_9d).
Myogenin Expression ESD3 & ES-derived 
Cultures
■  Myo/GAP
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GAPDH 
Desmin
1 2 3 4 5 6 7 8
(H) Desmin mRNA expression 
was observed in ES-D3 cells 
and was up-regulated in all ES- 
derived cultures with the 
exception of the CO_9d culture.
Transcription Factor Markers
GAPDH
Shh
(I) Shh mRNA expression was 
induced in the RA culture and 
maintained in the RA AA and 
the RA_ BTC cultures; 
however, shh expression was 
down-regulated in the RA SB 
culture. Shh was not expressed 
in the control cultures (CO_5d 
and CO_9d).
Desmin Expression in ESD3 & ES-derived 
Cultures
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GAPDH 
Islet 1
Islet 1 Expression in ESD3 & ES-derived 
Cultures
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(J) Islet 1 mRNA expression 
was observed in ES-D3 and all 
ES-derived cultures. Islet 1 
expression was enhanced by the 
presence of retinoic acid.
GAPDH
1 2 3 6 7
Pdx1 Expression ESD3 & ES-derived Cultures
PDX1/GAP |
Pdxl
(K) Pdxl mRNA was expressed 
at a low level in ES-D3 cells, 
but up-regulated in all ES- 
derived cultures with the 
highest level observed in 
sponataneously-formed control 
EB cultures (CO_5d and 
CO_9d). Pdxl expression was 
up-regulated between the 5 day RA culture and the 9 day RA SB culture.
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(L) Ngn3 mRNA expression 
was observed in ES-D3 cells 
and up-regulated in the 5 day 
RA and the CO_5d culture. 
Ngn3 expression was down- 
regulated by secondary 
differentiation in the presence 
of AA, SB or BTC. High levels of ngn3 expression were maintained in the 
untreated, spontaneously-formed CO_9d culture.
GAPDH 
Beta 2
(M) Beta2 mRNA expression 
was observed in ES-D3 cells 
and all ES-derived cultures. An 
up-regulation in beta2 
expression was induced in the 
RA SB culture.
Beta2 Expression in ESD3 & ES-derived 
Cultures
I Beta2/GAP
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Ngn3 Expression ESD3 & ES-derived Cultures
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GAPDH 
Pax 6
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(N) Pax 6 mRNA expression 
was observed in ES-D3 cells 
and up-regulated in the RA 
culture. There was no change in 
pax 6 expression in other ES- 
derived cultures.
GAPDH 
Pax 4
1 2 3  4 5 6 7 8 9
(O) Pax 4 mRNA was not detected in ES-D3 cells or ES-derived cultures.
Pax6 Expression in ESD3 & ES-derived 
Cultures
■  Pax6/GAP
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GAPDH
Nkx2.2
Nkx2.2 Expression in ESD3 & ES-derived 
Cultures
INkx2.2/GAP
Lanes
(P) Low level nkx2.2 mRNA 
expression was observed in 
ES-D3 cells and up-regulated 
in all ES-derived cultures. 
The RA SB culture exhibited 
the highest level of nkx2.2 
expression.
Endopeptidases
GAPDH
PCI
(Q) PCI mRNA expression 
was observed in ES-D3 cells 
and down-regulated in ES- 
derived cultures with the 
exception of the CO_9d 
culture.
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(R) PC2 mRNA expression was 
observed in ES-D3 cells and up- 
regulated in the 5 day RA 
culture, the 9 day RA AA and 
RA BTC cultures.
Endocrine Pancreas Markers
GAPDH 
Som
8 9
(S) Somatostatin mRNA 
expression was induced in the 
RA culture. The induced 
expression level was maintained 
by subsequent treatment with 
AA and BTC, however 
expression levels were down-regulated by subsequent treatment with SB.
Expression of somatostatin was not observed in spontaneously formed CO_5d
and CO 9d cultures.
Somatostatin Expression in ESD3 and ES- 
derived Cultures
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GAPDH 
PP
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(T) Low level PP mRNA 
expression was detected in ES- 
D3 cells, the RA culture, the 
CO_9d culture and the RA SB 
culture
GAPDH 
Glucagon
1 2 3  4 5 6 7 8 9
(U) Glucagon mRNA was not expressed in ES-D3 cells or ES-derived cultures
8
PP Expression in ESD3 & ES-derived Cultures
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(V) PPI mRNA expression was 
detected at low levels in all ES- 
derived cultures with the 
exception of the R A S B  
culture. PPI expression was 
dramatically increased by 
secondary differentiation in the 
presence of SB.
Exocrine Pancreas Markers
Amylase 
GAPDH
1 2 3  4 5 6 7 8 9
(W) Amylase mRNA was not detected in ES-D3 cells or ES-derived cultures
PPI Expression in ESD3 & ES-derived 
Cultures
■  PPI/GAP
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Extra-Embryonic Markers
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Apoptotic Markers
1 2 3 4 5 6 7
GAPDH
(X) AFP mRNA expression was 
induced in all ES-derived 
cultures with highest levels 
observed in the RA SB culture.
GAPDH
Bax
Bax Expression in ESD3 & ES-derived 
Cultures
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(Y) Bax mRNA was expressed 
at similar levels in ES-D3 and 
ES-derived cultures
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Caspase3
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(Z) Caspase3 mRNA was 
expressed at similar levels in 
ES-D3 and ES-derived cultures.
Caspase3 Expression in ESD3 & ES-derived 
Cultures
084
111 UN
I Casp3/GAP
2 3 4 5 6
Lanes
148
3500 - 
2800 -
§ 2100 *
0
§  1400 -
1  700 J
o °'
B
30 i
Figure 3 2 4 (A -  C) qPCR analysis of (A) insulin I, (B) insulin II and (C) glut2, 
respectively Data presented (mean ± SD) is from two independent experiments, 
of which both sample sets were analysed in triplicate
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3.2.3.2 qPCR Optimisation Experiments
An endogenous control comparison was performed for qPCR analysis of ES-D3 
and ES-derived cell types to ensure that the presence of extra-cellular factors in 
the 2-stage differentiation studies hadn’t affected the endogenous control 
expression thus affecting overall trends in target gene expression. Both controls 
showed similar trends in expression (Figure 3.2.5). The efficiencies of insulin I, 
insulin II, P-actin and GAPDH probe and primer sets were also checked prior to 
the qPCR experiments (Figure 3.2.6). All primer and probe sets had an efficiency 
of > 90% (Table 3.2.3). The glut2 primer and probe set was an ‘assay on 
demand’ designed by ABI with guaranteed efficiency.
Figure 3.2.5 qPCR analysis on target expression in ESD3 & ES-derived cultures 
normalised by both p-actin and GAPDH. RQ, Relative Quantity. ES-D3 was set 
to an RQ of 1. Both GAPDH and P-actin resulted in similar trends in target gene 
expression.
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Figure 3.2.6 Plots used to determine the efficiency of insulin I (Ins I), insulin II 
(Ins II), P-actin and GAPDH probe and primer sets. 10-fold serial dilutions of 
MIN6 cDNA were prepared and used as test sample. The qPCR was performed 
with the gene of interest and control primers under standard conditions. The Ct 
was plotted against [10-fold serial dilutions of MIN6]. The efficiency was 
calculated using the following equation:
E = (10'1/slope-l)  x 100
Table 3.2.3 Data is representative of the slope of the lines shown in Figure 3.2.6 
The efficiency was calculated with these slopes using the equation shown above.
Primer & Probe sets Slope Efficiency
p-actin -3.5423 91.55%
GAPDH -3.5245 92.17%
Insulin 1 -3.5853 90.06%
Insulin II -3.5862 90.02%
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3 2 4 Analysis of Protein Expression in ES-D3 and ES-denved Cultures
In Section 3 2 3, qPCR and semi-quantitive RT-PCR analysis was used to profile 
multi-lineage marker mRNA expression in ES-D3 and ES-denved cultures In 
this section immunohistochemistry analysis was used to profile protein 
expression of a subset of these markers (1 e pluripotent, neuronal, glial, 
pancreatic and muscle markers) in ES-D3 and ES-denved cultures The analysis 
was preformed on random sections of paraffin embedded samples from two 
independent biological experiments (Figure 3 2 7 and Figure 3 2 8) The slides 
were scored by 2 independent observers (Table 3 2 4) (Immunohistochemistry 
analysis was performed in collaboration with Prof Michael Kasper)
Omission of the primary antibody was used as a technical negative control to test 
for the specificity of the individual antibodies involved Staining was not visible 
in any of the test samples after omission of the primary antibody (Section 7 1, 
appendix A) The variability in protein expression within the cultures tested 
allowed for positive and negative biological controls within test samples
3 2 4 1 Summary of Results Obtained from Immunohistochemistry Analysis 
of Multi-lineage Marker Expression
Oct 4, a charactenstic marker of pluripotent stem cells, was strongly expressed in 
the ES-D3 culture (Figure 3 2 7 A and Figure 3 2 8 A) Cells within this culture 
also expressed the muscle-specific transcription factor, myogenin and the 
pancreatic transcription factor, Pdxl (Figure 3 2 7 F, H and Figure 3 2 8 F, H) 
Low level expression of NF-L (neuronal marker), C-peptide 2 (bi-product of 
insulin II synthesis) and PP (endocrine hormone) were also detected in ES-D3 
cells (Figure 3 2 7 B, J, N and Figure 3 2 8 B, J, N)
The CO_5d culture expressed a broad range of markers i e NF_L, p III tubulin, 
myogenin, desmin, Pdxl, C-peptide 1, C-peptide 2, glut2, somatostatin and PP 
(Table 3 2 4) Formation of EBs in the presence of RA enhanced the expression 
of a subset of these markers (neuronal markers, NF-L and P III tubulin, p cell 
marker, Glut2) and induced expression of the multi-potential marker, nestin 
(Table 3 2 4) Stage 2 differentiation in the presence of BTC and AA further 
enhanced/induced nestin, GFAP (astrocyte marker), NF-L and P III tubulin
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expression (Table 3 2 4) Stage 2 differentiation in the presence of SB enhanced 
expression of the muscle marker, desmin, the P cell marker, glut2 and induced 
expression of the P cell hormone, insulin (Table 3 2 4) Pdxl, C-peptide 1 and C- 
peptide 2 were strongly expressed in the 5 day cultures (RA and CO_5d) (Table 
3 2 4) Stage 2 differentiation of the RA culture in the presence of SB did not 
enhance the overall expression of these markers, however, the RA_SB culture 
did contain subpopulations of cells that maintained a high level of Pdxl and C- 
peptide 2 expression (Figure 3 2 7 H, J and Figure 3 2 8 H, J) Expression of the 
pancreatic endocrine hormones, PP and somatostatin, was induced in all 
differentiated populations at both day 5 and day 9
These findings in combination with the results from Section 3 2 3 suggest that 
the intermediate RA culture consists of a mixed population of multi-potential 
precursors Stage 2 differentiation of the RA culture in the presence of SB 
promotes pancreatic endocrine differentiation, and in the presence of AA or 
BTC, promotes neuronal/glial differentiation
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Table 3.2.4 Summary of slide scores from immunohistochemistry analysis of protein expression in ES-D3 and ES-derived cultures. Slides were 
scored by two independent observers. The percentage of stained cells was graded as follows: A (<25%), B (25 -  50 %) or C (>50%). Intensity of 
staining was graded as follows: +1 (weak), +2 (moderate) or +3 (strong). Data is from 2 independent experiments: Repeat 1 in white column, 
Repeat 2 in blue column.
ES-D3 RA CO_5d R A A A RA_SB R A B T C CO_9d
Markers
D if fe re n t ia t io n
Oct 4 C+3 C+3 C+3 C+3 C+3 B+2; A+3 C+2 C+2 C+2; A+3 C+1; A+3 C+1 C+2; A+3 C+2 C+1
N e u ro n a l
NF-L B+1 A+1 C+2 C+2 B+2 B+1 C+2; A+3 B+2 C+2; A+3 C+2 C+2; A+3 B+2 C+1 C+1
GFAP Neg Neg Neg Neg Neg Neg A+3 A+3 Neg Neg A+3 A+3 Neg Neg
nestin Neg Neg A+1 Neg Neg Neg A+2 A+3 A+1 Neg A+2 A+3 Neg Neg
P III Tubulin Neg Neg A+3 A+3 A+1 A+1 B+3 A+3 A+2 A+2 B+3 B+3 A+2 A+1
M u s c le
myogenin A+1 C+1 C+2 C+2; A+3 C+3 C+2 C+1; A+2 C+1; A+2 A+2 A+2 Neg Neg A+2 C+1; A+2
desmin C+2 C+3 C+1; A+2 C+3 C+3 C+3 C+2; A+3 C+1; A+3 C+3 C+3 C+1; A+2 C+2; A+3 C+2 C+2; A+3
P a n c re a tic
Pdx1 B+2 C+3 C+3 C+3 C+3 C+3 C+2 C+2 C+1; A+3 C+2; A+3 C+2; A+3 C+2 C+1 C+2
C-peptide 1 Neg Neg B+2 B+2 C+3 B+3 B+1 C+1 A+1 B+1; A+2 C+1 ND A+1 B+1
C-peptide 2 A+1 Neg C+3 C+3 C+3 C+2 C+1 C+1; A+2 B+2 C+2; A+3 B+2 C+1; A+2 C+1; A+3 B+2
insulin Neg Neg Neg Neg Neg Neg Neg Neg A+3 A+1 Neg Neg Neg Neg
glut2 Neg Neg B+1;A+2 B+1;A+2 C+1 A+1 C+1;A+2 C+2 C+2;A+3 B+2;A+3 B+1 ;A+2 C+1; A+3 ND C+1
somatostatin Neg Neg A+3 B+1 A+2 A+2 C+2;A+3 B+1 ;A+2 B+2;A+3 C+2 B+2;A+3 A+2;A+3 Neg Neg
PP A+1 A+2 B+1 ;A+3 A+2 B+2 B+3 B+1 ;A+3 B+1;A+3 B+2;A+3 B+2;A+3 A+3 A+3 A+2 A+2
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Figure 3.2.7 (A) Immunohistochemistry analysis of Oct 4 protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
1 in Table 3.2.4. Images on left, scale bar = 100 ^m (20X). Images on right, scale 
bar = 50 ^m (40X).
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RA SB
The majority of cells in the ES-D3 and the 5 day cultures (RA and CO 5d) 
stained intensely for Oct 4; however the majority of cells in the 9 day cultures 
(RA AA, RA BTC, RA SB, CO_9d) stained moderately - weakly for Oct 4, 
indicating an overall down-regulation in Oct 4 protein expression between day 5 
and day 9. The RA BTC culture appeared to exhibit the lowest level of 
expression.
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Figure 3.2.7 (B) Immunohistochemistry analysis of NF-L protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
1 in Table 3.2.4. Images on left, scale bar = 100 |xm (20X). Images on right, scale 
bar = 50 [im (40X).
ES-D3 (Day 1)
157
C0_9d (Day 9)
(B) A subpopulation of ES-D3 cells stained weakly for NF-L where as a 
subpopulation of day 5 (RA and CO_5d) cultures stained moderately for NF-L, 
suggesting an up-regulation in NF-L protein expression between day 1 (ES-D3) 
and day 5 (RA and CO_5d). The RA culture contained a higher number of 
moderately stained cells than the CO_5d culture. Day 9 cultures which had been 
exposed to AA, SB and BTC all contained both moderately and intensely stained 
cells indicating an up-regulation in NF-L expression between the RA culture at 
day 5 and the treated cultures at day 9. Cells in the CO_9d culture stained weakly 
for NF-L, suggesting a down-regulation in NF-L expression between the CO_5d 
culture and the CO 9d culture.
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Figure 3.2.7 (C) Immunohistochemistry analysis of GFAP protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
1 in Table 3.2.4. Images on left, scale bar = 100 (im (20X). Images on right, scale 
bar = 50 i^m (40X).
ES-D3 (Day 1)
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GFAP protein expression was not detected in ES-D3 cells or in ES-derived 5 day 
cultures (RA and CO_5d). An intense distinctive staining pattern was observed in 
subpopulations of both the RA AA and RA BTC cultures at day 9S indicating 
that GFAP expression was induced within these cultures. Expression was not 
detected in the RA SB culture or the CO 9d culture
Figure 3.2.7 (D) Immunohistochemistry analysis of nestin protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
1 in Table 3.2.4. Images on left, scale bar = 100 ^m (20X). Images on right, scale 
bar = 50 \im (40X).
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RA BTC (Day 9)
C0_9d (Day 9)
Nestin protein expression was not detected in ES-D3 cells. A filamentous 
staining pattern was observed in the RA culture at day 5, indicating the induced 
expression of nestin within a subpopulation of this culture. The intensity of 
staining for nestin was maintained in the RA SB and increased in the RA AA 
and RA BTC cultures at day 9. Expression was not detected in spontaneously- 
formed CO_5d and CO_9d cultures.
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Figure 3.2.7 (E) Immunohistochemistry analysis of P III tubulin protein 
expression in ES-D3 and ES-derived cultures. The images shown are
representative of repeat 1 in Table 3.2.4. Images on left, scale bar = 100 (im 
(20X). Images on right, scale bar = 50 |am (40X).
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P III tubulin protein expression was not detected in ES-D3 cells. A subpopulation 
of the RA culture at day 5 stained positive for p III tubulin indicating that P III 
tubulin protein expression was induced within this culture. The percentage of 
staining was increased in the RA AA and RA BTC cultures at day 9 indicating 
an up-regulation in expression, p III tubulin expression was not detected in the 
spontaneously-formed CO_5d. A very small percentage of cells in the CO_9d 
culture stained weakly-moderately indicating low level expression of P III 
tubulin in a subpopulation of cells within this culture.
RA BTC
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Figure 3.2.7 (F) Immunohistochemistry analysis of myogenin protein expression 
in ES-D3 and ES-derived cultures. The images shown are representative of 
repeat 1 in Table 3.2.4. Images on left, scale bar = 100 jam (20X). Images on 
right, scale bar = 50 ^m (40X).
RA (Day 5)
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RA SB (Day 9)
R ABTC (Day 9)
A subpopulation of ES-D3 cells stained weakly for myogenin indicating low 
level expression of the protein within this culture. An increase in percentage and 
intensity of staining was observed in day 5 cultures indicating that myogenin 
expression was up-regulated in both the RA culture and CO_5d culture. 
Subsequent differentiation resulted in a decrease in the percentage and intensity 
of staining indicating a down-regulation of myogenin expression in 9 day 
cultures, including treated (RA AA, RA SB, RA BTC) and spontaneously- 
formed cultures (CO_9d).
166
Figure 3.2.7 (G) Immunohistochemistry analysis of desmin protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
1 in Table 3.2.4. Images on left, scale bar = 100 jam (20X). Images on right, scale 
bar = 50 ^m (40X).
ES-D3
RA (Day 5)
CO 5d
RA AA
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RA SB
CO 9d
ES-D3 and all ES-derived cultures stained positive for desmin expression. 
Increases in staining intensity in both the spontaneously formed CO_5d and 
CO_9d cultures suggested that desmin protein expression was up-regulated 
within these cultures. Desmin also appeared to be expressed at a high level in the 
RA SB culture.
(Day 9)
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Figure 3.2.7 (H) Immunohistochemistry analysis of Pdxl protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
1 in Table 3.2.4. Images on left, scale bar = 100 jim (20X). Images on right, scale 
bar = 50 |im (40X).
ES-D3 (Day 1)
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ES-D3 cells stained moderately for Pdxl protein expression. The RA culture and 
CO_5d cultures both stained intensely for pdxl expression indicating an up- 
regulation in expression between day 1 and day 5. A down-regulation in 
expression was observed between day 5 and day 9 cultures. The majority of cells 
in day 9 cultures (RA AA, RA BTC and CO_9d) exhibited moderate - weak 
staining for pdxl, with exception to the R A S B  culture. An intense distinct 
staining pattern within individual EBs was observed within the RA SB culture.
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Figure 3.2.7 (I) Immunohistochemistry analysis of C-peptide 1 protein 
expression in ES-D3 and ES-derived cultures. The images shown are 
representative of repeat 1 in Table 3.2.4. Images on left, scale bar = 100 ^m 
(20X). Images on right, scale bar = 50 ^m (40X).
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C-peptide 1 protein expression was not detected in ES-D3 cells Subpopulations 
of the RA and CO_5d culture stained positive for C-peptide 1 indicating induced 
expression of the C-peptide 1 protein within these cultures The weak staining 
pattern observed in day 9 cultures (RA AA, RA SB, RA BTC and CO_9d) 
indicated that stage 2 differentiation resulted in a down-regulation of C-peptide 1 
expression
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Figure 3.2.7 (J) Immunohistochemistry analysis of C-peptide 2 protein 
expression in ES-D3 and ES-derived cultures. The images shown are 
representative of repeat 1 in Table 3.2.4. Images on left, scale bar = 100 ^m 
(20X). Images on right, scale bar = 50 ^m (40X).
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A small subpopulation of ES-D3 cells stained weakly for C-peptide 2 indicating 
a low level expression of the protein in these cells The increase in percentage 
and intensity of staining in the RA and CO_5d cultures suggested an up- 
regulation of C-peptide 2 expression in these cultures Stage 2 differentiation 
appeared to down-regulate C-peptide 2 expression However, a strong staining 
intensity observed in subpopulations of the RA_SB and RA_BTC cultures 
indicated that these isolated cells still maintained a high level of c-peptide 2 
expression
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Figure 3.2.7 (K) Immunohistochemistry analysis of insulin protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
1 in Table 3.2.4. Images on left, scale bar = 100 jam (20X). Images on right, scale 
bar = 50 [im (40X).
ES-D3 (Day 1)
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Insulin protein was not detected in the ES-D3 cells or in ES-derived cultures with 
exception to the R A S B  culture. A subpopulation of the R A S B  culture stained 
intensely for insulin indicating induced expression of the insulin protein in 
isolated cells within this culture.
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Figure 3.2.7 (L) Immunohistochemistry analysis of glut2 protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
1 in Table 3.2.4. Images on left, scale bar = 100 (im (20X). Images on right, scale 
bar = 50 |im (40X).
RA (Day 5)
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C0_9d (Day 9) 
Not Determined
Glut2 protein expression was not detected in ES-D3 cells. The appearance of 
weak to moderately stained cells in the day 5 cultures (RA and CO_5d) indicated 
that glut2 protein expression was induced at a low level within these cultures. 
There was a noticeable increase in the percentage and intensity of staining within 
the R A S B  culture suggesting an up-regulation in glut2 protein expression 
between the RA culture at day 5 and the RA SB culture at day 9.
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Figure 3.2.7 (M) Immunohistochemistry analysis of somatostatin protein 
expression in ES-D3 and ES-derived cultures. The images shown are 
representative of repeat 1 in Table 3.2.4. Images on left, scale bar = 100 \im 
(20X). Images on right, scale bar = 50 (40X).
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Somatostatin protein expression was not detected in ES-D3 cells. The appearance 
of stained cells in the 5 day RA culture and to a lesser extent in the CO_5d 
culture indicated that somatostatin expression had been induced within these 
cultures. Subsequent differentiation in the presence of AA, SB and BTC 
increased the percentage and intensity of staining suggesting an up-regulation in 
somatostatin expression between the RA culture at day 5 and the treated cultures 
(RA-AA, RA SB, RA BTC) at day 9. The spontaneously-formed CO_ 9d 
culture does not appear to express somatostatin.
RA SB (Day 9)
180
Figure 3.2.7 (N) Immunohistochemistry analysis of PP protein expression in ES- 
D3 and ES-derived cultures. The images shown are representative of repeat 1 in 
Table 3.2.4. Images on left, scale bar = 100 (im (20X). Images on right, scale bar 
= 50 (im (40X).
ES-D3 (Day 1)
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The detection of a small subpopulation of weakly stained cells in the ES-D3 
culture indicated that PP protein expression was expressed at a low level within 
this culture. All differentiated ES-derived cultures contained subpopulations of 
moderately - intensely stained cells suggesting an induced up-regulation in 
protein expression upon differentiation.
(Day 9)
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Figure 3.2.8 (A) Immunohistochemistry analysis of Oct 4 protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
2 in Table 3.2.4. Images on left, scale bar = 100 |im (20X). Images on right, scale 
bar = 50 [im (40X).
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The majority of cells in the ES-D3 and the 5 day cultures (RA and CO_5d) 
stained intensely for Oct 4; however the majority of cells in the 9 day cultures 
(RA AA, RA BTC, RASB,  CO_9d) stained moderately - weakly for Oct 4, 
indicating an overall down-regulation in Oct 4 protein expression between day 5 
and day 9. The CO_9d culture appeared to exhibit the lowest level of expression.
184
Figure 3 2 8 (B) Immunohistochemistry analysis of NF-L protein expression in 
ES-D3 and ES-denved cultures The images shown are representative of repeat 
2 in Table 3 2 4 Images on left, scale bar = 100 [im (20X) Images on right, scale 
bar = 50 [im (40X)
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RA SB (Day 9)
I
RA BTC (Day 9)
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A subpopulation of ES-D3 cells stained weakly for NF-L where as a 
subpopulation of the day 5 RA culture stained moderately for NF-L, suggesting 
an up-regulation in NF-L protein expression m the RA culture Day 9 cultures 
which had been exposed to AA, SB and BTC all contained moderately stained 
cells indicating that NF-L expression levels had been maintained in these 
cultures The CO_5d culture and the CO_9d culture stained weakly for NF-L 
indicating low level of expression within these cultures
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Figure 3 2 8 (C) Immunohistochemistry analysis of GFAP protein expression in 
ES-D3 and ES-denved cultures The images shown are representative of repeat 
2 in Table 3 2 4 Images on left, scale bar = 100 pm (20X) Images on right, scale 
bar = 50 pm (40X)
ES-D3 (Day 1)
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CO_5d (Day 5)
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RA SB (Day 9)
RABTC (Day 9)
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GFAP protein expression was not detected in ES-D3 cells or in ES-derived 5 day 
cultures (RA and CO_5d). An intense distinctive staining pattern was observed in 
subpopulations of both the R A A A  and RA_BTC cultures at day 9, indicating 
that GFAP expression was induced within these cultures. Expression was not 
detected in the RA SB culture or the CO 9d culture.
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Figure 3.2.8 (D) Immunohistochemistry analysis of nestin protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
2 in Table 3.2.4. Images on left, scale bar = 100 (im (20X). Images on right, scale 
bar = 50 um (40X).
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Nestin protein expression was not detected in ES-D3 cells A filamentous 
staining pattern was observed in the RA AA and RAJBTC cultures, indicating 
the induced expression of nestin within subpopulations of this culture 
Expression was not detected in spontaneously-formed CO_5d, CO_9d cultures 
and the RA SB culture
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Figure 3.2.8 (E) Immunohistochemistry analysis of ß III tubulin protein 
expression in ES-D3 and ES-derived cultures. The images shown are 
representative of repeat 2 in Table 3.2.4. Images on left, scale bar = 100 jam 
(20X). Images on right, scale bar = 50 ^m (40X).
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P III tubulin protein expression was not detected in ES-D3 cells. A subpopulation 
of the RA culture at day 5 stained positive for p III tubulin indicating that p III 
tubulin protein expression was induced within this culture. The percentage of 
staining was increased in the RA AA and RA BTC cultures at day 9 indicating 
an up-regulation in expression, p III tubulin expression was not detected in the 
spontaneously-formed CO_5d. A very small subpopulation of cells in the CO_9d 
and RA SB culture stained weakly-moderately indicating low level expression 
of P III tubulin in subpopulations of cells within these cultures.
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Figure 3.2.8 (F) Immunohistochemistry analysis of myogenin protein expression 
in ES-D3 and ES-derived cultures. The images shown are representative of 
repeat 2 in Table 3.2.4. Images on left, scale bar = 100 jxm (20X). Images on 
right, scale bar = 50 [im (40X).
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A subpopulation of ES-D3 cells stained weakly for myogenin indicating low 
level expression of the protein within this culture An increase in percentage and 
intensity of staining was observed in day 5 cultures indicating that myogenin 
expression was up-regulated in both the RA culture and CO_5d culture 
However, the RA culture contained a subset of intensely stamed cells where as 
cells in the CO_5d culture were moderately stained Subsequent differentiation 
resulted in a decrease in the percentage and intensity of staining indicating a 
down-regulation of myogenin expression in 9 day cultures, including treated 
(RA AA, RASB,  RAJBTC) and spontaneously-formed cultures (CO_9d)
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Figure 3.2.8 (G) Immunohistochemistry analysis of desmin protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
2 in Table 3.2.4. Images on left, scale bar = 100 ¿im (20X). Images on right, scale 
bar = 50 \im (40X).
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ES-D3 cells and all ES-derived cultures stained positive for desmin expression. 
Decreases in staining intensity in both the spontaneously formed CO_9d culture 
and the RA AA and RA BTC culture suggested that desmin protein expression 
was down-regulated within these cultures.
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Figure 3.2.8 (H) Immunohistochemistry analysis of Pdxl protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
2 in Table 3.2.4. Images on left, scale bar = 100 i^m (20X). Images on right, scale 
bar = 50 jim (40X).
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ES-D3 cells (Day 1), the RA culture and C0_5d cultures (Day 5) stained 
intensely for Pdxl protein expression indicating. A down-regulation in 
expression was observed between day 5 and day 9 cultures. The majority of cells 
in day 9 cultures (RAAA,  RA BTC and CO_9d) exhibited moderate - weak 
staining for Pdxl, with exception to the R A S B  culture. An intense distinct 
staining pattern within individual EBs was observed within the RA SB culture.
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Figure 3.2.8 (I) Immunohistochemistry analysis of C-peptide 1 protein 
expression in ES-D3 and ES-derived cultures. The images shown are 
representative of repeat 2 in Table 3.2.4. Images on left, scale bar = 100 jim 
(20X). Images on right, scale bar = 50 i^m (40X).
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C-peptide 1 protein expression was not detected in ES-D3 cells Subpopulations 
of the RA and CO_5d culture stained positive for C-peptide 1 indicating induced 
expression of the c-peptide 1 protein within these cultures The weak staining 
pattern observed in day 9 cultures (RA AA, RA SB, RA BTC and CO_9d) 
indicated that stage 2 differentiation resulted in a down-regulation of C-peptide 1 
expression
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Figure 3.2.8 (J) Immunohistochemistry analysis of C-peptide 2 protein 
expression in ES-D3 and ES-derived cultures. The images shown are 
representative of repeat 2 in Table 3.2.4. Images on left, scale bar = 100 jim 
(20X). Images on right, scale bar = 50 (im (40X).
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C-peptide 2 protein expression was not detected in ES-D3 cells The appearance 
of stained cells in the RA and CO_5d cultures suggested an up-regulation of C- 
peptide 2 expression in these cultures The intensity of staining in the RA culture 
was stronger that that of the staining in the CO_5d culture Stage 2 differentiation 
appeared to down-regulate C-peptide 2 expression However, a strong staining 
intensity observed in subpopulations of the RA_SB and RA BTC cultures 
indicated that these isolated cells still maintained a high level of C-peptide 2 
expression
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Figure 3.2.8 (K) Immunohistochemistry analysis of insulin protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
2 in Table 3.2.4. Images on left, scale bar = 100 ^m (20X). Images on right, scale 
bar = 50 [im (40X).
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Insulin protein was not detected in the ES-D3 cells or in ES-derived cultures with 
exception to the R A S B  culture. A subpopulation of the R A S B  culture stained 
weakly for insulin indicating induced expression of the insulin protein in isolated 
cells within this culture.
Figure 3.2.8 (L) Immunohistochemistry analysis of glut2 protein expression in 
ES-D3 and ES-derived cultures. The images shown are representative of repeat 
2 in Table 3.2.4. Images on left, scale bar = 100 i^m (20X). Images on right, scale 
bar = 50 |im (40X).
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Glut2 protein expression was not detected in ES-D3 cells. The appearance of 
weak to moderately stained cells in the day 5 cultures (RA and CO_5d) indicated 
that glut2 protein expression was induced at a low level within these cultures. 
There was a noticeable increase in the percentage and intensity of staining within 
the R A S B  culture suggesting an up-regulation in glut2 protein expression 
between the RA culture at day 5 and the RA SB culture at day 9.
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Figure 3.2.8 (M) Immunohistochemistry analysis of somatostatin protein 
expression in ES-D3 and ES-derived cultures. The images shown are 
representative of repeat 2 in Table 3.2.4. Images on left, scale bar = 100 \im 
(20X). Images on right, scale bar = 50 i^m (40X).
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Somatostatin protein expression was not detected in ES-D3 cells. The appearance 
of stained cells in the 5 day RA culture and to a lesser extent in the CO_5d 
culture indicated that somatostatin expression had been induced within these 
cultures. Subsequent differentiation in the presence of A A, SB and BTC 
increased the percentage and intensity of staining suggesting an up-regulation in 
somatostatin expression between the RA culture at day 5 and the treated cultures 
(RA-AA, RA SB, RA BTC) at day 9. The spontaneously-formed CO_ 9d 
culture does not appear to express somatostatin.
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Figure 3.2.8 (N) Immunohistochemistry analysis of PP protein expression in ES- 
D3 and ES-derived cultures. The images shown are representative of repeat 2 in 
Table 3.2.4. Images on left, scale bar = 100 \im (20X). Images on right, scale bar 
= 50 jim (40X).
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The detection of a small subpopulation of moderately stained cells in the ES-D3 
culture indicated that PP protein expression was expressed within this culture. 
All differentiated ES-derived cultures contained subpopulations of moderately - 
intensely stained cells suggesting an induced up-regulation in protein expression 
upon differentiation.
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3 2 5 Immunofluorescence Analysis of Insulin/C-peptide Protein Expression 
in the R A S B  Culture
The 2-stage RA_SB differentiation protocol resulted in the derivation of insulin 
expressing cells (Section 3 2 4) To confirm these results we preformed 
immunofluorescence analysis on C-peptide and insulin expression within this 
culture At day 9 the entire RA SB culture was dissociated and the resulting cell 
suspension was plated onto poly-L-ornithine for immunofluoresence analysis 
Biological controls used in this study were ES-D3 cells and dissociated RA, 
CO_5d and CO_9d cultures MIN6 cells were used as a positive control
Initial screening of samples was preformed using a standard fluorescent 
microscope (Figure 3 2 9) MIN6 cells were positive for insulin (Figure 3 2 9 A) 
ES-D3, CO_5d, RA and CO_9d cultures were negative for insulin (Figure 3 2 9 
B -  E) A small number of insulin-positive cells were detected in the RA_SB 
culture (Figure 3 2 9 F - I) Insulin/C-peptide co-expression in RA SB cells 
versus CO_9d cells was analysed by LSCM (Figure 3 2 10) Strong insulin 
staining was detected in the RA_SB cells (Figure 3 2 10 A & B) but not in 
CO_9d cells (Figure 3 2 10 C & D), whereas C-peptide was detected in both the 
R A S B  cells and CO_9d cells (Figure 3 2 10 A -  D) Insulin expression in the 
RA_SB cells did not co-locahse with C-peptide 1 or C-peptide 2 expression 
(Figure 3 2 10 A & B), indicating a problem with C-peptide antibody specificity 
(previously addressed in Section 3 1)
These results verify previous findings reporting the derivation of msulin- 
expressing cells using the 2-stage RA SB differentiation protocol (Section 
3 2 4) These results also support previous findings questioning the specificity of 
the C-peptide antibodies used in immunofluorescent techniques (Section 3 1)
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Figure 3.2.9 Insulin expression analysis using a fluorescence microscope. MIN6 
(A) were positive for insulin: ES-D3 (B), CO_5d cells (C), RA-treated cells (D) 
and CO_9d cells (E) were negative for insulin. A small percentage of RA_SB 
cells (F & G) were positive for insulin. Enlarged view of the RA SB insulin- 
expressing cells (H & I). Scale bar = 50 (im (40X). Insulin, green; DAPI nuclear 
stain, blue.
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(A) R A S B
Insulin (green), C-peptide l(red), 
DAPI nuclear stain (blue) & 
C-peptide 1 overlaying DAPI (pink)
(B) RA SB
Insulin (green), C-peptide 2 (red), 
DAPI nuclear stain (blue) & 
C-peptide 2 overlaying DAPI (pink)
(C) CO_9d
Insulin (green), C-peptide 1 (red), 
DAPI nuclear stain (blue) & 
C-peptide 1 overlaying DAPI (pink)
(D) C0_9d
Insulin (green), C-peptide 2 (red), 
DAPI nuclear stain (blue) & 
C-peptide 2 overlaying DAPI (pink)
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Figure 3 2 10 Insulin/C-peptide co-localisation analysis of RA_SB cells and 
CO 9d cells using LSCM RA_SB cells are positive for insulin (A & B), C- 
peptide 1 (A) and C-peptide 2 (B) Insulin expression does not co-locahse with 
C-peptide expression CO_9d cells are negative for insulin (C & D) but positive 
for C-peptide 1 (C) and C-peptide 2 (D) Scale bar = 10
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3.2.6 Insulin ELISA on Lysed Cells
The overall aim of the 2-stage differentiation studies was to denve pancreatic 
endocrine cell types, in particular insulin-producing cells, from undifferentiated 
ES-D3 cells Insulin transcript (Section 3 2 3) and protein expression (Section 
3 2 4) were previously detected in differentiated RA SB cells Insulin ELISAs 
were preformed on lysates from both ES-D3 and ES-denved cell cultures to 
quantify insulin expression
Insulin content was assayed using a Mercodia mouse insulin ELISA All insulin 
readings were within the lower range of the standard curve on the ELISA plate 
and were considered non-specific background readings Insulin was not detected 
in any of the differentiated samples using the ELISA kit It was previously 
demonstrated by both immunohistochemistry (Section 3 2 4) and 
immunofluorescence (Section 3 2 5) analysis that only a small isolated number of 
cells within the entire RA_SB population contained insulin Therefore, the 
quantity of insulin per jal lysate may have been below the range of detection of 
the ELISA
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3 2 7 Growth Assay on the RA_SB and the CO_9d Culture
The RA SB differentiation protocol yielded interesting results in regard to the 
expression of pancreatic markers (Section 3 2 3, Section 3 2 4 and Section 3 2 5) 
However, it had been observed that the cell yield was extremely low in the 
RA_SB culture compared to the other ES-denved cultures A growth assay was 
preformed to ascertain the effects of the extra-cellular factors i e RA and SB on 
cell proliferation (Figure 3 2 11) The addition of RA to the culture medium 
resulted in a slight decrease in proliferation in the RA culture compared to the 
CO_5d culture The secondary treatment of RA-treated EBs with SB 
significantly reduced cell number (RA_SB) compared to spontaneously 
differentiated control EBs (CO_9d) at the same time-point The cell yield from 
the RA_SB culture was approx 7 fold lower than the cell yield attained from the 
CO_9d culture
Figure 3.2.11 Growth curves comparing the cell counts from the CO_9d culture 
and the R A S B  culture on day 1, day 5 and day 9 of the 2-stage differentiation 
protocol Data presented (mean ± SD) is from two independent experiments
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3 2 8 Time Course Assay on Insulin Transcript Expression in the RA_SB 
Culture
The derivation of insulin expressing cell types using the 2-stage RA_SB 
differentiation protocol was previously shown in Section 3 2 4 and Section 3 2 5 
It has also been shown that very low cell yields are attained from this protocol 
(Section 3 2 7) An alteration in protocol was necessary to improve cell yields 
and in turn increase the number of ES-denved insulin-expressing cells However, 
before altering the protocol it was necessary to identify the time-points at which 
insulin transcript expression is at its highest
A time course assay (2-day intervals) of insulin I and insulin II transcript 
expression was preformed on the RA_SB culture to determine at which point 
over the course of the differentiation protocol mduction/up-regulation and down- 
regulation of the insulin transcripts occur After the 9 day RA_SB differentiation 
protocol, the RA_SB culture was removed from supplemented medium and re­
fed with normal ES-D3 medium (-LIF) The culture was maintained under these 
conditions for a further 4 days Samples were taken at 2-day intervals i e day 11 
and day 13 to determine if the high transcript expression observed in RA_SB 
culture is maintained after removal from extra-cellular factors
The qPCR results demonstrated that both insulin I and II transcripts were up- 
regulated in cultures at day 7, day 9, day 11 and day 13 (Figure 3 2 12) Highest 
levels of expression were observed at day 9 and day 11 Shortening the 9 day 
RA SB protocol or withdrawing the cells from treatment agents to recover, may 
allow for an improved cell yield whilst maintaining a high insulin transcript 
expression Further analysis was carried out on alternative RA_SB protocols 
with a view to improving cell yields (Section 3 2 9)
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Figure 3.2.12 qPCR analysis of insulin I (A) and insulin II (B) transcript 
expression in ES-derived cells at 2-day intervals over the 9 day RA SB 
differentiation protocol and at 2-day intervals after removal from the 
differentiation agents. CO, Control.
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3 2 9 Investigation of Alternative R A S B  Differentiation Protocols
The 2-stage RA SB differentiation protocol yielded interesting results in terms 
of pancreatic differentiation (Section 3 2 3 - 3  2 5), however the cell yield from 
this treatment was very low (Section 3 2 7) The following adjustments were 
tested on the onginal RA_SB protocol in order to improve the cell yield
(a) shortening stage 2 of the differentiation protocol l e reducing the 
exposure time to SB (Section 3 2 8)
(b) omitting RA from stage 1 of the differentiation protocol
(c) culturing RA SB cells in nicotinamide after removal from the protocol
(d) introducing an alternative to SB in stage 2 of the differentiation protocol, 
PA and TSA are known to have similar effects as SB
The alternative RA SB differentiation protocols are outlined in Figure 2 3 2 The 
resulting ES-derived populations were analysed for protein content (Figure 
3 2 13) Protein content was representative of cell yields within cultures Insulin 
I and insulin II transcript expression was also analysed in the ES-denved 
populations (Figure 3 2 14)
Cultures exposed to SB only (SB EB ) had the highest amount of protein next to 
controls All other alternative treatments yielded similar amounts of protein to 
that of the RA SB treatment (Figure 3 2 13) RA SB cultures expressed high 
levels of insulin I transcript at day 9 whereas insulin II transcript expression was 
high at both day 7 and day 9 (Figure 3 2 14) RA_SB cultures which were 
removed from treatment at day 7 and transferred to media containing NIC 
exhibited the highest levels of insulin I transcript expression (Figure 3 2 14 A) 
The SB EB culture expressed the highest level of insulin II transcript (Figure 
3 2 14 B)
Ideally we had hoped that one of the alternative protocols would allow for 
improved cell yields as well as high levels of both insulin I and insulin II 
expression None of the protocols tested fulfilled the criteria The most promising 
protocol tested was the SB EB protocol This protocol allowed for improved cell 
yields as well as high insulin II transcript expression
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Figure 3.2.13 Data is representative of the protein derived from alternative 
R A S B  differentiation protocols outlined in Figure 2.3.2. Cultures were assayed 
for protein content at day 6, day 7 and day 9.
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Figure 3.2.14 qPCR analysis of insulin I (A) and insulin II (B) transcript 
expression in cultures derived from alternative RA_SB differentiation protocols 
outlined in Figure 2.3.2
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3 3 MICROARRAY STUDY COMPARING GENE EXPRESSION IN 
LOW PASSAGE MIN6 (GLUCOSE RESPONSIVE) TO HIGH PASSAGE 
MIN6 (GLUCOSE-NON-RESPONSIVE)
MIN6 cells have been used throughout this thesis as a positive control in the 
majority of ES experiments 1 e Competitive RIA, insulin secretion assays and 
RT-PCR analysis of p cell specific markers Previous studies have indicated that 
the glucose stimulated insulin secretion (GSIS) phenotype is relatively unstable 
in long-term culture (Section 1 3 4 2 3) The initial study performed in our 
laboratory, found that long-term culture was associated with changes in 
morphology, growth rate, alkaline phosphatase expression, as well as loss o f 
GSIS (Gammell, 2002, O Driscoll et al, 2004) We subsequently preformed three 
separate expression microarray experiments on glucose responsive low passage 
MIN6 (PI8) and glucose non-responsive high passage MIN6 (P40) A 
comparison of the differential gene expression between the two populations was 
used to elucidate the molecular mechanisms involved in loss of GSIS function in 
high passage MIN6 p cells
Loss/reduced levels in high passage cells of transcripts associated with the 
mature p cell coincided with increased expression of neuron-/glia- mRNAs 
These findings suggested that, with long-term culture, MIN6 cells may revert to a 
poorly differentiated precursor-like cell type This observation is supported by 
earlier findings demonstrating an increase in proliferation and an increase in 
expression of the embryonic stem cell marker, alkaline phosphatase in high 
passage MIN6 cells This de-differentiation model may be useful for the 
identification of crucial p cell markers and may also provide information relevant 
to the derivation of p-ltke cell types from ES cells It is not yet clear whether the 
functional de-differentiation of the MIN6 population is due to (a) de- 
differentiation of the population as a whole or (b) overgrowth by a faster growing 
poorly-differentiated sub-population
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3 31  Morphological Changes Associated with Continuous Culture of 
MIN6 Cells
Continuous culture of MIN6 cells resulted in an alteration in the typical MIN6 
morphology and growth pattern Low passage MIN6 cells grow in tight, multi­
layered localised clumps (Figure 3 3 1 A) As the passage number was increased, 
the cells no longer associated into clumps and were found to form even 
monolayers of stretched cells, some with extended protrusions resembling 
neuntes (Figure 3 3 1 B)
Figure 3 3 1 Low passage MIN6 cells associate into rounded multi-layered 
clumps (A) High passage MIN6 cells tend to form a monolayer and no longer 
form discrete colonies (B) In this experiment MIN6 cells were grown for 7 days 
with 1 re-feed Scale bar =100 |iM (A & B = 40X)
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The proliferation rates (doubling times) of the low and high passage MIN6 cells 
were determined by monitoring their growth rates over consecutive 24 hour 
periods Growth curves indicated that the rate of proliferation in high passage 
MIN6 cells was approximately 2-fold greater than that of low passage MIN6 
cells Continuous sub-culturing resulted in an increase in proliferation rate 
(Figure 3 3 2)
3 3 2 Proliferation Assays on Low and High Passage M1N6
Time (Hrs)
Figure 3 3 2 Proliferation data comparing MIN-6(L) (------) and (H) (------- )
Cells were cultured in 24 well plates and 3 wells were counted daily The 
experiment was repeated on > 3 independent cell populations The data presented 
equals mean cell number ± SD
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3 3 3 Alkaline Phosphatase Expression in Low and High Passage M1N6
AP activity is a characteristic of undifferentiated stem cells and can be seen to 
decrease following differentiation of the ES cells (Lumelsky et al, 2001, Prelie et 
al, 2002, Berill et al, 2004) Using BCIP as a substrate for alkaline phosphatase, 
Figure 3 3 3 (A & C) indicates that the extent of AP staining is much more 
widespread in the high passage MIN6 population (Figure 3 3 3 C) than in the low 
passage MIN6 population (Figure 3 3 3 A) At higher magnifications the 
intensity of the staining apparently also increased in high passage MIN6 cells 
(Figure 3 3 3 B & D)
Figure 3 3 3 MIN-6 cells stained for AP expression Low passage MIN6 cells (A 
& B) were found to have much less staining than high passage MIN6 cells (C & 
D) Scale bar = 50|im (See Gammell, 2002) ( A & C = 1 0 X ) ( B & D  = 20X)
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3 3 4 GSIS ELISA on Low and High passage MIN6
Each sample set (low and high MTN6) were analysed by GSIS ELISA prior to 
going onto the array The ELISA confirmed that low passage MIN6 cells 
demonstrated GSIS whereas high passage MIN6 cells had lost the ability to do so 
(Figure 3 3 4)
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Figure 3.3 4 (Pro)insulin secretion profiles with increasing glucose 
concentrations in low (white bars) and high passage MIN6 cells (black bars) 
Results are presented as pmol/ml/mg protein to allow for the increased growth 
rate of high passage MIN6 cells Results represent means ± SD from three 
experiments
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3.3 5 Analysis of Serially Passaged MIN6 cells by Microarray, 
Bioinformatics and qPCR
The results presented in Section 3 3 1 -  Section 3 3 4 clearly indicate that there is 
a change in the properties of MIN6 cells after long-term culture, most notably the 
loss of GSIS Gene expression changes associated with the loss of GSIS were 
investigated using microarray, bioinformatics and qPCR technologies Three 
separate microarray experiments were preformed on glucose responsive low 
passage MIN6 (PI8) and glucose non-responsive high passage MIN6 (P40)
Following data normalisation, gene lists were generated using a students t-test 
with a P value cut-off of 0 01, to identify genes that were statistically 
differentially expressed between the three high passage arrays and the low 
passage arrays (used as the reference/“control”) (Section 2 4 1 6 3) 
Approximately 4 % (500) of the transcripts on the microarray were significantly 
increased and approximately 3 5 % (461) were significantly decreased in three 
biological repeat studies of high passage MIN6 compared to low passage MIN6 
cells Eighty-eight genes were overexpressed 2-fold or more in high passage 
MIN6 cells, while 185 were down-regulated by this factor in high passage MIN6 
cells compared to low passage MIN6 cells The 2-fold cut-off gene lists are 
available in Table 3 3 1
Passaging of MIN6 cells resulted in many changes in gene expression, including 
both up-regulation and down-regulation of many transcripts associated with 
crucial aspects of p cell biology In order to validate the microarray results, 
qPCR was performed on a selection of chosen genes to demonstrate that the 
increase/decrease observed between high and low passage MIN6 were real 
expression changes
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Table 3 3 1 (A) Genes up-regulated 2-fold or more in high passage MIN6 cells 
compared to low passage MIN6 cells (B) Genes down-regulated 2-fold or more
in high passage MIN6 cells compared to low passage MIN6 cells
Probe Set 
ID
A Up-regulated Genes
Gene Title Gene Symbol Fold
100044_at claudin 11 Cldn11 3 791
100050_at inhibitor of DNA binding 1 Idb1 3 119
100465_i_at Clone IMAGE 3371572, mRNA — 2 752
100566_at insulin-like growth factor binding protein 5 IgfbpS 9 66
100946_at HLA-B-associated transcript 9 Bat9 2 799
101007_at MAP kinase-interacting senne/threomne kinase 2 Mknk2 2 137
101059_at necdin Ndn 2 307
101108_at nuclear autoantigemc sperm protein (histone-bindmg) Nasp 2 265
101135_at calcitonin receptor Calcr 3 144
10117 8_at
sema domain, immunoglobulin domain (Ig), short basic 
domain, secreted, (semaphorin) 3C Sema3c 8 671
101372_at thyroid hormone receptor interactor 13 Trip13 2 805
101526_at homeo box, msh-like 1 Msx1 2 792
101540_at thymine DNA glycosylase Tdg 2 108
101571_g_at insulin-like growth factor binding protein 4 Igfbp4 2 143
101631_at SRY-box containing gene 11 Sox11 6 347
102204_at
v-maf musculoaponeurotic fibrosarcoma oncogene family, 
protein B (avian) Mafb 12 491
102217_at G protein-coupled receptor kinase 5 Gprk5 2 643
102859_at DNA segment, Chr 6, ERATO Doi 253, expressed D6Ertd253e 6 088
103061_at glutamic acid decarboxylase 1 Gad1 8 446
103088_at cell adhesion molecule with homology to L1CAM Chl1 3 133
103212_at cDNA sequence BC006933 BC006933 2 221
103234_at neurofilament heavy polypeptide Nefh 2 645
103238_at wingless-related MMTV integration site 4 Wnt4 2 896
103452_at proline dehydrogenase (oxidase) 2 Prodh2 4 674
103460_at DNA-damage-inducible transcnpt 4 Ddit4 3 223
103504_at single-stranded DNA binding protein 2 Ssbp2 2 214
103549_at nestin Nes 4 217
103585_at 
103723_at
spastic paraplegia 4 homolog (human) 
interleukin 13 receptor, alpha 1
Spg4
H13ra1 2 346
104154_at transformation related protein 53 Trp53 2 074
104275_g_at transformation related protein 53 Trp53 2 103
160068_at sin3 associated polypeptide Sap30 2 24
160131_at angiomotin like 2 Amotl2 3 223
160135_at DNA segment, Chr 16, ERATO Doi 502, expressed D16Ertd502e 2 238
160227_s_at bystin-like Bysl 2 185
160246_at tumor necrosis factor, alpha-induced protein 8 Tnfaip8 4 35
160547_s_at thioredoxm interacting protein Txmp 2 494
160934_s_at — — 3 456
160965_at RAS p21 protein activator 4 Rasa4 4 644
161051_at hairy and enhancer of split 5 (Drosophila) Hes5 2 675
161077_f_at
SWI/SNF related, matnx associated, actin dependent 
regulator of chromatin, subfamily d member 2 y Smarcd2 2 178
161603_r_at erythrocyte protein band 4 1-like 4a Epb4 114a 6 405
92208_at C1q domain containing 1 C1qdc1 - 3 092
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92231_at erythrocyte protem band 4 1-like 4a Epb4 114a 4 35
92244_at exonuclease 1 Exo1 2 195
92266_at interleukin 11 1111 3 633
92697_at forkhead box A1 Foxal 3 809
92931_at delta-like 1 (Drosophila) DIM 5 132
92932_at cerebellin 1 precursor protein Cblnl 3 147
92995_at visinm-like 1 VsnM 2 629
93018_at interferon induced transmembrane protein 2 Ifitm2 2 548
93550_at cysteine and glycine-nch protein 2 Csrp2 5 067
93669J_at SRY-box containing gene 11 Sox11 6 216
94026_at pro-opiomelanocortin-alpha Pomcl 2 846
94429_at eukaryotic translation elongation factor 1 alpha 2 Eef1a2 2 032
94439_at oxysterol binding protein-like 11
DNA segment, Chr 13, Wayne State University 123,
Osbpl11 2 283
94451_at expressed
DNA segment Chr 13, Wayne State University 123,
D13Wsu123e 2 189
94452_g_at expressed D13Wsu123e 2 382
94477_at — — 3 494
94556_at sorting nexin 10
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-
Snx10 2 333
95064_at oxoacyl-Coenzyme A thiolase) Acaa2 2 126
95122_g_at polymerase (DNA-directed), epsilon 4 (p12 subunit) Pole4 2 057
95152_g_at RIKEN cDNA 2810052M02 gene 2810052M02Rik 3 873
95363_at granzyme M (lymphocyte met-ase 1) Gzmm 3 374
95471_at cyclin-dependent kinase inhibitor 1C (P57) Cdknlc 6 703
95550_at retinitis pigmentosa GTPase regulator Rpgr 2 05
95673_s_at brain abundant, membrane attached signal protein 1 Baspl 3 084
96244_at ubiquitin carboxy-terminal hydrolase L1 UchU 2 43
96598_at RIKEN cDNA D430039C20 gene
SWI/SNF related, matrix associated, actin dependent
D430039C20Rik 2 228
96651_at regulator of chromatin, subfamily e, member 1 Smarcel 2 487
96663_at surfeit gene 6 Surf6 2 246
96752_at intercellular adhesion molecule Icaml
96783_at mucin and cadhenn like Mucdhl 3 038
96804_at nucleolar protein 1
translocase of inner mitochondnal membrane 8 homolog a
Noll 2 361
96849_at (yeast) Timm8a 2 506
97203_at MARCKS-like protein Mlp 3 675
97426_at epithelial membrane protein 1 Emp1 2 202
97521_at argimnosuccinate synthetase 1 Ass1 2 46
97703_at brix domain containing 1 Bxdcl 2 226
97824_at nucleolar protein family A, member 2 Nola2 3 251
97890_at serum/glucocorticoid regulated kinase Sgk 4 32
98111_at heat shock protein 105 Hsp105 2 858
98122_at LIM domain only 4 Lmo4 2 169
98129_at M musculus mRNA for testis-specific thymosin beta-10 — 2 469
98446_s_at Eph receptor B4 Ephb4 2 342
98624_at RNA-binding region (RNP1, RRM) containing 1 Rnpcl 2 374
98839_at sine oculis-related homeobox 2 homolog (Drosophila) Six2 3 237
99328_at distal-less homeobox 3 Dlx3 9 246
99833_at calpain 9 (nCL-4) Capn9 3 025
99935_at tight junction protein 1 Tjp1 2 203
99956_at kit oncogene Kit 2 595
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Probe Set 
ID
B Down-regulated G enes
G ene Title G ene Symbol Fold
100131_at secretory granule neuroendocnne protein 1, 7B2 protein Sgnel -3 554
100136_at lysosomal membrane glycoprotein 2 Lamp2 -2 593
100303_at histocompatibility 2, M region locus 10 1
serine (or cysteine) proteinase inhibitor, clade A, member
H2-M10 1 -9 487
100329_at 1d Serpinald -2 485
100505_at Ras-like without CAAX 2 Rit2 -3 113
100513_at development and differentiation enhancing Ddefl -2 439
100572_at transmembrane 9 superfamily member 2 Tm9sf2 -2 169
100607_at phospholipase D3 Pld3 -2 299
100633_at RIKEN CDNA2810484M10 gene 2810484M10Rik -2 082
100771_at B-cell linker Blnk -11 91
100772_g_at B-cell linker Blnk -13 75
100931_at arylsulfatase A Arsa -2 009
100956_at klotho Kl -2 637
100962_at Ngfi-A binding protein 2 Nab2 -2 899
101001_at RIKEN cDNA 5031439A09 gene 5031439A09Rik -2 991
101055_at protective protein for beta-galactosidase Ppgb -2 356
101217__at
G protein-coupled receptor, family C, group 2, member A,
-- -3 042
101352_g_at related sequence 1 Gprc2a-rs1 -3 023
101384_at RIKEN cDNA 2210008A03 gene 2210008A03Rik -2 283
101389_at scavenger receptor class B, member 2 Scarb2 -2 302
101426_at ceramide kinase Cerk -2 259
101446_at tumor protein D52-like 1
serine (or cysteine) proteinase inhibitor, clade A, member
Tpd52l1 -2 351
101565_f_at 1a
serine (or cysteine) proteinase inhibitor, clade A member
Serpinala -2 139
101574_f_at 1a
serine (or cysteine) proteinase inhibitor, clade A, member
Serpmala -2 975
101575j_at 1a
serine (or cysteine) proteinase inhibitor, clade A member
Serpinala -2 92
101576_f_at 1a Serpmal a -2 518
101676_at glutathione peroxidase 3 Gpx3 -6 505
101681 J_at histocompatibility 2, blastocyst H2-BI -2 051
101735J_at angiogenm, nbonuclease A family, member 2 Ang2 -2 686
101851_at antigen identified by monoclonal antibody MRC OX-2 Mox2 -10 72
101887_at angiotensmogen Agt -5 079
101908_s_at CEA-related cell adhesion molecule 2 Ceacam2 -29 38
101918_at transforming growth factor, beta 1 Tgfbl -5 567
101975_at delta-like 1 homolog (Drosophila) Dlk1 -2 242
102064_at caspase 1 Caspi -2 099
102094_f_at — — -2 377
102161_f__at histocompatibility 2, D region locus 1 H2-D1 J -2 177
102163_at — — -2 622
102197_at nucleobindin 2 Nucb2 -4 534
102296_at proprotem convertase subtilisin/kexin type 2 Pcsk2 -2 555
102313_at GTP cyclohydrolase 1 Gch -2 399
102318_at sialyltransferase 8 (alpha-2, 8-sialyltransferase) D Siat8d -2 409
102370_at dehydrogenase/reductase (SDR family) member 8 Dhrs8 -6 895
102389_s_at growth associated protein 43 Gap43 -2 028
102414_i_at DnaJ (Hsp40) homolog, subfamily C, member 3 Dnajc3 -4 326
102415__r_at DnaJ (Hsp40) homolog, subfamily C, member 3 Dnajc3 -4 65
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102431_at microtubule-associated protein tau Mapt -5 619
102727_at brain denved neurotrophic factor Bdnf -4 25
102742_g_at microtubule-associated protein tau Mapt -5 243
102748_at coagulation factor V F5 -3 092
102784_at RIKEN cDNA 4632413K17 gene 4632413K17Rik -2 395
102804_at CEA-reiated cell adhesion molecule 2 Ceacam2 -6 734
102805_at CEA-related cell adhesion molecule 1 Ceacaml -25 39
102806_g_at CEA-related cell adhesion molecule 1 Ceacaml -17 71
102886_at glypican 4 Gpc4 -11 09
102905_at caspase 4, apoptosis-related cysteine protease Casp4 -4 072
102920_at RIKEN cDNA 9130422G05 gene
glial cell line derived neurotrophic factor family receptor
9130422G05Rik -2 352
102926_at alpha 3 Gfra3 -2 127
102960_at recombination activating gene 1 gene activation Rga -2 456
103235_at neuropeptide Y
membrane protein, palmitoylated 3 (MAGUK p55
Npy -23 98
103247_at subfamily member 3) Mpp3 -3 227
103394_at FXYD domain-containing ion transport regulator 5 FxydS -3 917
103456_at endothehn converting enzyme 1 Ece1 -2 322
103494_at transmembrane 4 superfamily member 3 Tm4sf3 -6 378
103562J_at — — -3 884
103637_at N-acetyl galactosamimdase, alpha Naga -2 256
103647_at galactosidase, beta 1 Glb1 -4 016
103671_at HIV-1 tat interactive protein 2, homolog (human) Htatip2 -3 795
103793_at major vault protein Mvp -2 245
103882_at carboxypeptidase N, polypeptide 1 Cpn1 -12 59
103933_at yolk sac gene 2
Similar to Lactase-phlonzin hydrolase precursor (Lactase-
Ysg2 -2 579
104018_at glycosylceramidase) (LOC226413), mRNA — -3 455
104065_at ER degradation enhancer, mannosidase alpha-like 1 Edemi -4 532
104066_at expressed sequence AW548124 AW548124 -2 478
104143_at coatomer protein complex, subunit zeta 2 Copz2 -3 039
104182_at hepatocyte growth factor activator Hgfac -5 285
104407_at activated leukocyte cell adhesion molecule Alcam -5 567
104422_at protein tyrosine phosphatase, receptor type, N Ptprn -2 16
104449_at glycine receptor, beta subunit Glrb -2 158
104564_at secretogramn III Scg3 -3 456
104680_at receptor (calcitonin) activity modifying protein 1 Rampi -2 885
104686_at glutamate receptor, lonotropic, NMDA1 (zeta 1) 
DNA segment, Chr 14, Wayne State University 89,
Gnn1 -3 303
104714_at expressed
hydroxy-delta-5-steroid dehydrogenase 3 beta- and
D14Wsu89e -2 139
160104_at steroid delta-isomerase 7 Hsd3b7 -5 018
160108_at nuclear protein 1 Nuprl -47 94
160127_at cyclin G1 Ccngl -2 28
160139_at heat shock 27kDa protein 8 Hspb8 -2 021
160181_at synaptophysin Syp -2 263
160270_at lectin, mannose-bmding, 1 Lmanl -2 112
160428_at succinate-Coenzyme A ligase, GDP-forming, beta subunit Suclg2 -2 369
160461_f_at RIKEN cDNA2310057H16 gene 2310057H16Rik -6 736
160516_at glucosidase, alpha, acid Gaa -2 847
160580__at mannosidase 1, alpha Mania -8 397
160611_at cytochrome P450 family 4, subfamily v, polypeptide 3 Cyp4v3 -4 593
160711_at 2,4-dienoyl CoA reductase 1, mitochondrial Decrl -3 328
160732_at aminopeptidase-like 1 NpepH -12 22
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160767_at sterol O-acyltransferase 1
Transcribed sequence with moderate similarity to protein 
pirA47643 (M musculus) A47643 hypothetical protein -
Soatl -2 157
160799_at mouse — -5 915
160819_at N-myc downstream regulated gene 4 Ndrg4 -2 119
160899_at Purkinje cell protein 4 Pcp4 -2 828
160968_at alanine and arginine nch domain containing protein Aard -1019
160971_at expressed sequence AI842353 AI842353 -2 436
160977_at Rho guanine nucleotide exchange factor (GEF) 5 ArhgefS -2 781
160991_at NFKB inhibitor interacting Ras-like protein 1 Nkirasl -2 054
161132_at scielim Seel -4 541
161139_f_at development and differentiation enhancing Ddefl -2 407
161294_f_at clusterin Clu -6 402
161754_f_at galactosidase, beta 1 Glb1 -2 298
161987_at prodynorphin Pdyn -6 189
162108_f_at salivary protein 1 Spt1 -15 25
162237_f_at secretogramn III Scg3 -2 615
162275J_at UPF3 regulator of nonsense transcnpts homolog B (yeast) Upf3b -2 067
92271_at paired box gene 6
protein tyrosine phosphatase, receptor type Z, polypeptide
Pax6 -2 171
92378_at 1
sialyltransferase 7 ((alpha-N-acetylneuraminyl 2,3- 
betagalactosyl-1,3)-N-acetyl galactosammide alpha-2,6-
Ptprzl -16 22
92403_at sialyltransferase) E Siat7e -4 12
92426_at transmembrane 4 superfamily member 9 Tm4sf9 -2 696
92474_at phospholipase D1 Pld1 -4 065
92475_g_at phospholipase D1 Pld1 -2 666
92730_at diphtheria toxin receptor Dtr -4 019
92793_at tumor necrosis factor receptor superfamily, member 1a Tnfrsfla -2 934
92806_at RIKEN cDNA 1110004D19 gene 1110004D19Rik -2 08
92841_f_at chromogramn B Chgb -2 961
92880_at milk fat globule-EGF factor 8 protein Mfge8 -9 964
92936_at contactm 1 Cntnl -23 68
93009_at glutathione S-transferase, mu 2 Gstm2 -4 464
93039_at plasma glutamate carboxypeptidase Pgcp -5 807
93066_at granulin Grn -2 634
93083_at annexin A5
serine (or cysteine) proteinase inhibitor, clade A, member
Anxa5 -2 277
93109_f_at 1a Serpinala -3 069
93120_f_at histocompatibility 2, K1, K region 
gamma-aminobutyric acid (GABA-A) receptor, subunit
H2-K1 -2 383
93163_at gamma 2 Gabrg2 -4 631
93240_f_at UPF3 regulator of nonsense transcripts homolog B (yeast) Upf3b -2 039
93285_at dual specificity phosphatase 6 Dusp6 -6 373
93373_at alpha-N-acetylglucosamimdase (Sanfilippo disease IIIB) Naglu -2 013
93451_at LIM domain only 7 Lmo7 -5 068
93568j_at RIKEN cDNA 2610042L04 gene 2610042L04Rik -7 439
93569_f_at RIKEN cDNA 2610042L04 gene 2610042L04Rik -7 723
93575_at gamma-glutamyl hydrolase Ggh -4 232
93605_r_at immunoglobulin superfamily, member 4A Igsf4a -2 235
93606_s_at immunoglobulin superfamily, member 4A Igsf4a -3 603
93626_at ATP-bindmg cassette sub-family G (WHITE) member 2 Abcg2 -5 508
93714_f_at histocompatibility 2, K1, K region H2-K1 -2 136
93731_at FK506 binding protein 9 Fkbp9 -2 799
93736_at transcobalamin 2 Tcn2 -2 889
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93842_at death-associated protein Dap -2 383
94047_at RIKEN cDNA 0610031J06 gene 0610031J06Rik -2 346
94152_at salivary protein 1 Spt1 -7 313
94153_g_at salivary protein 1 Spt1 -9 954
94247_at RIKEN cDNA 5730453H04 gene 5730453H04Rik -2 392
94270_at keratin complex 1, acidic, gene 18 Krt1-18 -2 004
94284_at diaphorase 1 (NADH) Dia1 -2 209
94350_f_at NAD(P)H dehydrogenase, qumone 1 Nqo1 -2 426
94351_r_at NAD(P)H dehydrogenase, quinone 1 Nqo1 -3 413
94366_at RIKEN cDNA 2310079N02 gene 2310079N02Rik -2 042
94392_f_at angiogenm, nbonuclease A family, member 1 Angl -3 176
94515_at sulfide quinone reductase-like (yeast) Sqrdl -5 559
94545_at reticulon 1 Rtn1 -4 232
94633_at glucagon
ATP-bmding cassette, sub-family B (MDR/TAP), member
Gcg -3 041
94733_at 4 Abcb4 -3 318
94840_at hexosaminidase A Hexa -3 057
94872_at sphingomyelin phosphodiesterase, acid-like 3A Smpdl3a -3 453
94906_at alcohol dehydrogenase 1 (class I) Adh1 -2 073
95052_at RIKEN cDNA 1110035L05 gene 1110035L05Rik -2 464
95102_at scotin gene Scotin -2 411
95104_at syndecan 2 Sdc2 -3 123
95286_at clusterm Clu -3 691
95290_at corticotropin releasing hormone receptor 1 Crhrl -3 608
95330_at glucose-6-phosphatase, catalytic, 2 G6pc2 -3 3
95436_at somatostatin Sst -16 82
95453_f_at S100 calcium binding protein A1 S100a1 -2 07
95465_s_at protein distantly related to to the gamma subunit family Pr1 -2 713
95520_at RIKEN cDNA 2310061B02 gene 2310061 B02Rik -3 274
95552_at deiodinase, lodothyronme, type I Dio1 -5 582
95557_at bone morphogenetic protein 1 Bmp1 -2 232
95620_at dehydrogenase/reductase (SDR family) member 7 Dhrs7 -2 549
95661_at CD9 antigen Cd9 -13 26
95709_at vitamin K epoxide reductase complex, subunit 1 Vkorcl -2 279
95885_at RIKEN cDNA 1200009F10 gene 1200009F10Rik -2 218
96047_at retinol binding protein 4, plasma Rbp4 -4 986
96055_at cholecystokimn Cck -6 531
96114_at protein phosphatase 1, regulatory (inhibitor) subunit 1A Ppp1r1a -2 279
96115_at deleted in polyposis 1
glycine amidinotransferase (L-argimne glycine
Dpi -2 36
96336_at amidinotransferase) Gatm -9 755
96346_at cysteine dioxygenase 1 cytosolic Cdo1 -2 492
96426_at thymosin, beta 4, X chromosome Tmsb4x -3 979
96591_at reel in Rein -4 396
96603_at quiescin Q6 Qscn6 -2 477
96605_at RIKEN cDNA 0610011104 gene 0610011l04Rik -2 233
96634_at RIKEN cDNA 5730469M10 gene 5730469M10Rik -4 054
96653_at nbonuclease T2 Rnaset2 -2 639
96657_at spermidine/spermine N1-acetyl transferase 1 Sat1 -2 146
96672_at homeobox only domain Hod -4 655
96708_at RIKEN cDNA 1200002G13 gene 1200002G13Rik -2 525
96767_at membrane bound C2 domain containing protein Mbc2 -2 677
96948_at quinmoid dihydroptendine reductase Qdpr -2 18
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97125_f_at histocompatibility 2, K1, K region H2-K1 -2 091
97197_r_at — — -2 011
97206_at serine protease inhibitor, Kunitz type 1 Spinti -2 08
97255_at CUGtnplet repeat,RNA binding protein 2 Cugbp2 -2 467
97415_at RAB3D, member RAS oncogene family Rab3d -3 024
97498_at four and a half LIM domains 1 Fhl1 -4 38
97520_s_at neuronatin Nnat -2 732
97540_f_at histocompatibility 2, D region locus 1 H2-D1 -2 243
97811_at ADP-nbosylation factor GTPase activating protein 3 Arfgap3 -2 026
97964_at FK506 binding protein 11 Fkbp11 -3 584
97980_at lymphotoxm B receptor Ltbr -3 598
98059_s_at lamin A Lmna -2 026
98133_at calbmdin-28K Calbl -6 052
98316_at cysteme-nch hydrophobic domain 1 Chid -3 382
98398_s_at apolipoprotein B editing complex 1 Apobed -5 727
98435_at adenylosuccinate synthetase, muscle Ad ss -2 104
98472_at RIKEN cDNA C920025E04 gene C920025E04Rik -2 18
98579_at early growth response 1 Egri -5 545
98588_at fumarylacetoacetate hydrolase Fah -2 537
98931__at glucosamine (N-acetyl)-6-sulfatase Gns -2 128
99062_at poliovirus receptor-related 3 Pvrl3 -2 336
99065_at casein kappa Csnk -7 343
99197_at group specific component Gc -18 19
99390_at wingless-related MMTV integration site 5A Wnt5a -2 207
99444_at receptor (calcitonin) activity modifying protein 2 Ramp2 -3 858
99475_at suppressor of cytokine signaling 2 Socs2 -2 577
99494_at serine (or cysteine) proteinase inhibitor, clade I, member 1 SerpinM -2 115
99580_s_at UDP-glucuronosyltransferase 1 family, member 2 Ugt1a2 -19 18
99584_at kangai 1 (suppression of tumongemcity 6, prostate) Kail -6 293
99840_at prodynorphin Pdyn -8 344
99902_at hyperpolarization-activated, cyclic nucleotide-gated K+ 1 Hcn1 -2 566
99972_at tryptophan hydroxylase 1 Tph1 -4 225
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3.3.5.1 Quality Control Clustering using the Spearman Correlation
The spearman correlation is a non-parametric test for analysis of data i.e. it 
makes no assumptions about data to determine the strength of the relationship 
between pairs of variables. Spearman correlation analysis of gene lists 
(normalised using PLIER algorithm, Section 2.4.1.6.2.1) from the 6 samples 
making up the “control” (low passage MIN6) and the “test” (high passage 
MIN6), were used to make a condition tree investigating their similarity. 
Through the careful standardisation of the culture conditions used for MIN6 
cells, good concordance between biological repeats were obtained (Figure 3.3.5 
A). The overall comparison of the genes flagged present in high passage MIN6 
cells compared to low passage MIN6 cells indicated that these cells lines are 
very different (Figure 3.3.5 B).
I
1 2 3 1 2 3
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A B
Figure 3.3.5 (A) Spearman correlation analysis of the 6 samples making up the 
“control” (low passage MIN6) and “test” samples (high passage MIN6) indicates 
the high quality and reproducibility of the biological replicates, as indicated by 
the close clustering of the test and control samples into two discrete groups 
illustrated in the condition tree above. Up- and down-regulated genes are 
represented by red and blue, respectively. R (Spearman correlation co-efficient) 
between triplicate low passage MIN6 is 0.991; between triplicate high passage 
MIN6 is 0.986; and between low and high passage MIN6 is 0.96. (B) 
Hierarchical clustering analysis of the 6,605 genes flagged ‘Present’ in this 
analysis (where each vertical line is a gene) clearly demonstrates the large 
differences in global gene expression upon serial passaging of MIN6 cells.
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3 3 5 2 Categories of Gene Transcripts Changed after the Serial Passage of 
MIN6 cells
The 2-fold up-regulated/down-regulated genes (Table 3 3 1) were classified into 
the following categories metabolism, growth proliferation, differentiation, 
regulation of transcription, signal transduction, protein transport secretion, cell 
adhesion, apoptosis, defense/immunity, proteolysis/peptidolysis, development, 
hormone, other (includes cytoskeletal, stress, RNA and protein binding), 
unknown (includes RIKEN cDNAs and newly discovered gene products that 
have not yet been assigned functions)
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Figure 3.3 6 Representations of the overall categories of gene transcripts that 
were either up-regulated (A) or down-regulated (B) in high passage MIN6 cells 
compared to low passage MIN6 cells
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In order to validate the gene lists and to demonstrate that the increase/decrease 
observed were real expression changes, a set of genes were selected for qPCR 
analysis from the gene lists generated (Table 3 3 1) Genes of interest included 
those involved in the categories listed in Figure 3 3 6 Primers were designed for 
these genes using Primer Express Software 2 0 (Table 3 3 3) qPCR analysis was 
preformed on the three MIN6 sample sets (Table 3 3 2) In the majority of cases 
the results confirmed the trends observed in the microarray experiment (Table 
3 3 3)
3 3 5 3 qPCR Confirmation Analysis of Genes Detected on Microarray
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Table 3 3 2 RQ of transcript expression in the three MIN6 samples sets as 
determined by qPCR RQ of low passage MIN6 was set to 1 MIN6-L, low 
passage MIN6, MIN6-H, high passage MIN6 RQ, relative quantity
Genes MIN6-L RQ MIN6-H RQ SD
Repeat 1 Repeat 2 Repeat 3 Repeat 1 Repeat 2 Repeat 3
Up regulated
glut2 1 1 1 2 366 1741 7 674 3 260
dill 1 1 1 1 613 1387 1 144 0 235
claudinll 1 1 1 3 594 6 925 10 069 3 238
Gck 1 1 1 1212 1 029 1217 0 107
trp53 1 1 1 2 005 2 199 1 248 0 502
tJP 1 1 1 1 449 2 027 1 13 0 455
nestin 1 1 1 2 427 2 354 1 37 0 590
Down- regulated
egrl 1 1 1 0 172 0 094 0 191 0 051
sgnel 1 1 I 0 094 0 163 0 166 0 041
GAP43 1 1 I 0 173 0 242 0 294 0 061
PC2 1 1 1 0 121 0 187 0 144 0 033
pldl 1 1 1 0 074 0 221 0 134 0 074
PPI 1 1 1 0 433 0 401 0 43 0018
npy 1 1 1 0 082 0 005 0 187 0 091
scg3 1 1 1 0 176 0 222 0 15 0 036
chgb 1 1 1 0 054 0 039 0 04 0 008
Pdxl 1 1 1 0 446 0 363 0 348 0 053
Isll 1 1 1 0 338 1 009 0 766 0 340
nkx2 2 1 1 1 0 374 0 593 0 453 0 111
beta2 1 1 1 0 546 0 496 0 457 0 045
ODC 1 1 1 0718 0 726 0 733 0 007
CEACAM1 1 I 1 0 027 0 038 0 036 0 006
insulin I 1 1 1 0 t 0 269 0 36 0 132
insulin II 1 1 1 0 386 0 379 051 0 074
pax 6 1 1 1 03 03 0 402 0 059
Ihh 1 1 I 1 002 0 37 0 255 0 402
cck P P P A A A 0
pax 4 1 1 I 0 959 1 018 0711 0 163
Genes not in 
agreement with 
array
dlkl A A A P P P 0
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Table 3 3.3 Validation of microarray data (induced/up-regulated and down-regulated) by qPCR
Induced/Un-Regulated Function/Physiological Role Pnmer Sequence (5’ to 3*) Microarrava Real-time
Secretion
gck
glut2
Adhesion
tJP
claudin 11
phosphorylation of glucose to G-6-P
facultative glucose transporter
paracellular permeability barrier
interacts with extracellular matrix at tight junctions
Differentiation
nestrn marker of neuronal-like cells (16)
gatgctggatgacagagccaggatg
agatgcactcagagatgtagtcga
Taqman
acgacaaaacgctctacagg
gagaatggactggcttagca
caagagtgcccatgtctaag
tgggcattaactgagctaga
ggctacatacaggattctgctgg
caggaaagccaagagaagcct
(fold) PCR-
ifold)
NS 1 03-1 22
NS 1 74-7 67
2 2 1 13-2 03
3 8 3 59-10 07
4 2 1 37-2 43
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dll 1 controls development of neurons
trp53 has been found to negatively impact terminal differentiation
Down-Regulated
Secretion
egrl elicited by glucose secretagogues
pldl regulates GSIS
scg3 associated with secretory granule membrane
chgb islet secretory glycoprotein
sgnel (7B2 protem) required for PC2 activation
agccctccatacagactctc 513
cagaacacagagcaaccttc 
agctttgaggttcgtgtttg 2 1
ggaacatctcgaagcgttta
atggacaactaccccaaact 5 54
attcagagcgatgtcagaaa 
tcttatcccttcctgctacc 4 07
ccaccttgttgaacacaact
ggatactggtgttggtgctc 3 45
tttctgttattgccctcagc
atccaagtccagtgttccaa 2 96
tctcattgcctaccttcgtc
ctgggtagtcatgttctgga
ttcagtgaggatcaaggcta 3 55
1 14-161
1 23-2 20
5 2-10 6
4 5-13 5
4 5-6 7
18 5-25 6
6-10 6
PC2 processes proinsulin to mature insulin
cck stimulates insulin secretion from p cells
Proliferation
dlkl P cell autocrme/proliferation factor
Adhesion
CEACAMld cell adhesion & proliferation suppressor
ODC inhibition may prevent polyamine-regulated P cell rephcation
Differentiation
pax 6 expression required for islet cell development, facilitates GSIS
pax 4 transcription factor mvolved m pancreatic development
cacagatgactggttcaaca
tcacagttgcagtcatcgta
gatggcagtcctagctgctg
ccaggctctgcaggttctta
Taqman Probe
aatctgcccctggcgcttggagcc
aaatcgcacagtcgcctgagtacg
ctgccacatccttgatgaag
cgttactggcagcatacttg
aagagtggcgactccagaagt
accatacctgtattcttgcttcagg
tggcttcctgtccttctgtgagg
tccaagacacctgtgcggtagtag
2 56 5 3-8 2
6 53 A
22 P
25 4 26 3-37
1 92 1 36-1 39
2 17 2 5-3 3
NS 0 9-1 4
Pdx 1 essential for pancreatic development and insulin secretion
Isll development of the dorsal pancreatic bud and aU endocrine
islet cells
nkx2 2 pancreatic cell & neuron development
beta2^NeuroD pancreatic, hippocampus & cerebellum development
npy mduced m insulin* cells at islet formation
Ihh hedgehog signalling required during pancreas development
GAP43 neunte outgrowth & synaptic plasticity
Insulin
PPI
ggtggagctggcagtgatgtt
accgcccccactcggggtcccgc
acgtctgatttccctgtgtgttgg
tcgatgtggtacaccttagagcgg
cggagaaaggtatggaggtgac
ctgggcgttgtactgcatgtgctg
cttggccaagaactacatctgg
ggagtagggatgcaccgggaa
tgaccctcgctctatctctg
aagggtcttcaagccttgtt
aaggcccacgtgcattgctct
tgtccgcaatgaagagcaggtg
gctgctaaagctaccactga
taggtttggcttc gtctaca
agcgtggcttcttctacacacc
ggtgcagcactgatccaccatg
NS 2 2-2 9
1 47 1-2 9
NS 1 7-2 7
NS 1 8-2 2
23 98 5 3-200
A 1-3 9
2 03 3 4-5 8
NA 2 3-2 5
insulin 1 tagtgaccagctataatcagag NS 2 8-10
acgccaaggtctgaaggtcc
insulin II ccctgctggccctgctctt NS 19-2 6
aggtctgaaggtcacctgct
p Actin p-actin was co-amphfied with other cDNAs as gaaatcgtgcgtgacattaaggagaagct
endogenous control, annealing temperature (temp) tcaggaggagcaatgatcttga
used was as relevant for cDNA of mterest & Taqman
Note qPCR = quantitative/real-time PCR,a = mean of 3 microairay experiments, b= range of fold changed detected by (n=3) qPCR, P = induced in MIN-6(H) from absent in MTN-6(L), A = 
present in M1N-6(L) but absent from MIN-6(H)5 NA -  not represented on array, NS = Not Significantly Changed
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Section 4.0: Discussion
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4.1 General Introduction
The global incidence of insulin dependant diabetes mellitus (IDDM) in children and 
adolescents is increasing with an estimated overall annual increase of around 3%. 
(http://www.eatlas. idf.org/Incidence/) IDDM can be managed through insulin injections; 
however, the poor control in glucose fluctuations associated with this therapy leads to 
severe long-term complications such as blindness, kidney failure, heart disease, stroke 
and amputations. The Diabetes Control and Complications Trial (DCCT) has shown that 
rigid control of glucose levels can diminish longterm complications 
(http://diabetes.niddk. nih. gov/dm/pubs/control/). Over the past decade, several 
researchers have achieved varying degrees of success at using whole pancreas and islet 
transplantations as a therapy for IDDM; however, the demand for donor tissue greatly 
outweighs its availability. Investigators are now looking for alternative sources of donor 
tissue. One possible solution being investigated is the derivation of p/islet cells from ES 
cells using genetic modification and directed differentiation (Berna et al, 2001; Soria et 
al, 2001a).
Many of the ES differentiation studies reported to date have been carried out on mouse 
models. Mouse ES cells were the first to be characterised and are also more readily 
available to laboratories than human ES cells (Pedersen, 1999). Ethical concerns are a 
limiting factor when it comes to human ES cell research thus emphasising the importance 
of non-human primate ES cells as relevant models in studying human development 
(Jacobson et al, 2001). ES-D3 is a pluripotent ES cell line derived from a mouse 129/Sv 
blastocyst (Doetschman et al, 1985). It is used as an ES model within this thesis. Studies 
performed over the past 15 years have shown that the ES-D3 cell line is suitable for use 
in differentiation studies using both genetic and culture based techniques (Section 
1. 1.6. 1).
Several publications in recent years have described differentiation protocols (both 
genetic- and culture-based) for the derivation of insulin-expressing cell types (Lumelsky 
et al, 2001; Hori et al, 2002; Blyszczuk et al, 2003; Moritoh et al, 2003; Miyazaki et al, 
2004; Shi et al, 2005). These multi-step regulated differentiation protocols described for
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the derivation of pancreatic cell types are long, cumbersome, often involve the use of 
exogenous insulin and also result in low yields of insulin-producing cell The success of 
these protocols in generating authentic P cells has been questioned due in part to 
uncertainty regarding cell lineage (Kama et al, 2004, Milne et al, 2005) but also due to 
the controversy regarding de novo insulin synthesis (Rajagopal et al, 2003, Hansson et al, 
2004) In an attempt to address the latter, we designed a novel assay that can identify de 
novo insulin synthesis The method is based on metabolic labelling combined with a 
modified radio-immunoassay (MRIA) We also presented means of quantifying C- 
peptide expression These assays, in combination with more commonly used techniques, 
including Western blotting to detect and quantify C-peptide 2, were employed to 
characterise the ES-derived populations generated using an adapted version of the 
controversial protocol published by Lumelsky et al in 2001 (Section 3 1)
Limited numbers of pancreatic P-like cells have also been successfully derived from ES 
cells by spontaneous differentiation (Kahan et al, 2003) Whilst this is an important 
finding in this field, it is recognised that a more controlled differentiation is necessary to 
maximise the number of ES cells successfully differentiated to islet-like cell types 
However, the regulated multi-step protocols discussed previously appear to be 
suboptimal for use We investigated the potential of extra-cellular factors in inducing 
endocrine pancreas differentiation - without the use of exogenous insulin - in order to 
improve on existing protocols or to establish a novel, simplified protocol for the 
derivation of pancreatic endocrine cell types Using a 2-stage differentiation protocol 
developed during this study, we successfully demonstrated the derivation of an 
intermediate multi-potential population (RAEBs) from undifferentiated ES cells that 
preferentially gives rise to pancreatic endocrine msulin-expressing cell types in the 
presence of SB, and neuronal- and glia 1-1 ike cell types in the presence of AA or BTC 
(Section 3 2)
Previous MIN6 studies, by both ourselves and others, have indicated that the GSIS 
phenotype is relatively unstable, in long-term culture This loss in functional GSIS 
correlated with changes in morphology, increased proliferation and increased AP activity,
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suggesting that the loss of GSIS may be due to de-differentiation of the high passage 
MIN6 cells (Kayo et al, 1996, Gammell, 2002, O’ Driscoll et al, 2004a) In this study, we 
used microarray, bioinformatics and qPCR technologies to investigate the gene 
expression changes associated with this loss of GSIS Lossed/reduced levels of certain 
transcripts associated with the mature (3 cell, in high passage cells, together with 
increased levels of neuron-/glia- associated mRNAs, are suggesting that, with time in 
culture, MIN6 cells may revert to an early, poorly-differentiated, “precusor-like” cell 
type This observation is supported by increased expression of the stem cell marker, 
alkaline phosphatase The MIN6 cells (low and high passage) were therefore considered a 
potential model for (a) identifying crucial (3 cell markers and (b) studying the molecular 
mechanisms involved in loss of GSIS and hypothetical P cell de-differentiation (Section 
3 3)
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4 2 Feeder-free Culture of Mouse ES Cells
The in vitro differentiation process begins with a non-differentiated, pluripotent ES cell 
line Generally in vitro studies with mouse ES cells include maintenance on feeder layers 
(mouse embryonic fibroblasts) However, some groups have demonstrated that inclusion 
of LIF at high concentrations can maintain pluripotency of ES cells in the absence of 
feeder layers (Smith et al, 1988, Nichols et al, 1990, Burdon et al, 1999)
In this study ES-D3 cells were cultured on gelatin, in the absence of feeder layers and in 
the presence of 1400 units/ml (700 pM) LIF It has been shown previously that long-term 
culture of mouse ES cells at > 50 pM LIF, allows for a more homogenous, stable 
population of ES cells (Berrill et al, 2004) The ES-D3 cells exhibited characteristics of 
pluripotency i e growth in tight multi-layered colonies (Figure 3 1 2 A & B), expression 
of alkaline phosphatase activity (Figure 3 1 3 A and Figure 3 2 2 A & B) and expression 
of Oct 4 (Figure 3 2 7 A and Figure 3 2 8 A) (Prelle et al, 2002) However, these cells 
also express a broad range of mRNAs for developmental markers (nestin, islet 1, pax 6) 
and lineage specific markers (p III tubulin, MBP) (Figure 3 14 and Figure 3 2 3) The 
presence of pancreatic markers in undifferentiated cells has previously been reported by 
Lumelsky et al (2001), who demonstrated that removal of ES cells from feeder layers in 
the presence of LIF triggered expression of Pdxl mRNA, and Soria et al (2001b), who 
demonstrated that somatostatin and glucagon mRNAs may be detected in undifferentiated 
ES cell cultures Ward et al (2004) also demonstrated that the neuronal marker, NF-L is 
expressed in a variety of undifferentiated ES cell lines Directed differentiation, therefore, 
requires the repression of inappropriately expressed genes, in addition to the induction of 
lineage specific markers
Upon removal of LIF and formation of EBs, there is a decrease observed in alkaline 
phosphatase activity in the cells constituting the outer layer of the EB, indicating the 
initiation of differentiation (Section 3 1 2 and Section 3 2 2) Previous work (Berrill et al, 
2004, Sandstorm et al, 2000) showed a direct correlation between alkaline phosphatase 
activity and increasing LIF concentrations
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4 3 Charactenzation of the Insulin-Con taming Cells Denved using an Adapted 
Version of the Original Lumelsky-based Protocol
ES-derived cell types generated in recent protocols (Lumelsky et al, 2001, Hori et al, 
2002, Blyszczuk et al, 2003, Montoh et al, 2003, Miyazaki et al, 2004, Shi et al, 2005) 
have remained largely uncharacterised, apart from the identification of a small proportion 
of msulin/C-peptide positive cells within isolated sub-populations Some of these 
protocols have reported the derivation of neuronal phenotypes (Lumelsky et al, 2001, 
Hori et al, 2002, Miyazaki et al, 2004, Rajagopal et al, 2003, Sipione et al, 2004, 
Hansson et al, 2004) within differentiated populations whereas a more recent publication 
has suggested that ES-derived insulin positive cells are actually extra-embyronic in origin 
(Milne et al, 2005) In light of these findings we investigated the nature of the cells as 
well as developing another means of establishing the presence of de novo synthesized 
insulin (Section 3 1)
4 3.1 Multi-lineage Transcnpt Expression in Stage 5 Clusters
We found that the ES-derived stage 5 clusters expressed markers representative of 
neuronal/glial lineage (GFAP, MBP, P III Tubulin), extra-embyronic lineage (GATA 4, 
AFP, Pdxl) and pancreatic endocrine lineage (pax 4, insulin I, insulin II, glut2) indicating 
the presence of multiple cell types in stage 5 clusters (Section 3 13) The derivation of 
such a complex culture may be a result of the nestin selection at stage 3 of the protocol 
(serum-free, ITSFn-supplemented medium) Nestin has been accepted as a marker of 
neuronal progenitor cells, however the cumulative data from recent studies suggest that 
nestin expression in ES-derived progeny represents a property of multi-lineage 
progenitors that have the potential to develop into neuroectodermal, endodermal and 
mesodermal lineages (Wiese et al, 2004) The initial Lumelsky study had reported the 
derivation of cells expressing all endocrine hormones (Lumelsky et al, 2001), however, 
both the present study and others (Sipione et al, 2004) failed to detect PP or glucagon 
mRNA expression in the stage 5 ES-derived cultures This may be due to slight variations 
in the protocols such as lack of feeder cells, handling (trypsimzation at certain stages), 
cell type
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4 3 2 Stage 5 Clusters May Con tarn Cells of an Extra-Embryonic Lineage
Many of the published differentiation protocols rely on the expression of endodermal 
markers in determining pancreatic P cell differentiation However, it must be kept in 
mind that extra-embyromc structures such as the yolk sac are also derived from the 
endoderm (Milne et al, 2005) High expression levels of markers such as Pdxl and PPI in 
ES-derived cells (as observed in this and other studies) are common to both extra- 
embryonic and pancreatic p cell differentiation In addition to these markers we observed 
an increase in extra-embryonic markers (AFP and GAT A 4) and p cell markers (insulin I 
and glut2) in the stage 5 clusters indicating the presence of both lineages within 
differentiated cultures (Section 3 1 3) Insulin I is considered a more definitive marker of 
the P cell than insulin n , the reason being that insulin I expression is restricted to p cells 
whereas insulin II expression is more widespread (Kahan et al, 2003) If extra-embryonic 
differentiation was dominating over that of pancreatic differentiation we would expect to 
see an increase in Oct 4 expression rather than a decrease between stage 1 and stage 5 of 
the differentiation protocol Oct 4 is expressed at increased levels in the primitive 
endoderm compared to undifferentiated cells (Milne et al, 2005)
4 3 3 Stage 5 Clusters Contain cells of a Neuronal/Glial lineage
After ITSFn nestin-positive selection at stage 3 of the differentiation protocol, neuronal- 
like projections become visible in the stage 4 and stage 5 cultures (Section 3 11) These 
morphological changes coincided with an up-regulation in oligodendrocyte marker, MBP 
and astrocyte marker, GFAP transcript expression Neuron-specific p ID tubulin was also 
expressed m these cultures (Section 3 13) The occurrence of neuronal-like phenotypes at 
this time point of the differentiation protocol was previously reported by Lumelsky et al 
(2001) and Sipione et al (2004) It was suggested that the introduction of ITSFn (stage 
3) and FGF-2 (stage 4) induced the commitment of ES-derived cells to a neuronal fate 
and that any further processes to induce pancreatic differentiation after this time-point 
activated apoptotic pathways (Kama et al, 2004)
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4 3 4 Stage 5 Clusters Lack Evidence Supporting Apoptosis
ES-derived cells did not show any sign of apoptosis RT-PCR analysis demonstrated that 
there was no change in bax or caspase 3 mRNA expression between stage 1 and stage 5 
(Section 3 1 3) Stage 5 cell nuclei were round and robust rather than small and 
fragmented (as would be expected during apoptosis) (Section 3 14) This finding 
contradicted that of recent publications (Sipione et al, 2004, Hansson et al, 2004) The 
discrepancy may be due to a modification in protocol at the end of stage 3 In this 
protocol all cells present at the end of stage 3 were maintained in culture without 
disruption and carried through to stage 4 In other studies (Lumelsky et al, 2001, Sipione 
et al, 2004, Hansson et al, 2004), cell cultures were dissociated at this point and allowed 
to reattach before entering stage 4, perhaps putting the cells under stress and inducing 
apoptosis or perhaps selecting for a subpopulation which becomes apoptotic
4.3 5 Insulin/C-peptide Protein Expression in Stage 5 Cultures
The identification of a p cell phenotype within differentiated populations has proven to be 
a challenge to all research groups Commonly used supplements such as B27 and N2 
include a high insulin content contributing to an overall insulin concentration in the 
culture medium exceeding that of physiological circulating levels by 1000-fold 
(Rajagopal et al, 2003) It is therefore difficult to ascertain whether insulin-positive cells 
are a direct result of insulin uptake or genuine de novo synthesis and secretion
Immunoreactivrty to C-peptide (Rajagopal et al, 2003) as well as assaying C-peptide 
release (Hansson et al, 2004), in conjunction with that of insulin, have subsequently been 
employed as a more definitive means of demonstrating authentic p cell function 
However, m the present study we found that the polyclonal C-peptide antibodies (i e 
anti-C-peptide 1 and 2) detected C-peptide expression in all ES-derived cells (Figure 
3 1 7 and Figure 3 1 8), whereas insulin protein expression was only detected in an 
isolated population of cells (Figure 3 16) Using the same antibodies, Kahan et al had 
found that the anti-C-peptide antibodies detected significantly more positive cells in a 
region than either of two monoclonal antibodies to insulin (Kahan et al, 2003)
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In the present study we drew our conclusions from immunofluorescence (IF) data on the 
pattern and localization of staining, including positive and negative biological controls 
We found that C-peptide 1 and C-peptide 2 staining in stage 5 ES-derived cells was not 
indicative of granular insulin staining as observed in the positive control phenotype, 
MIN6 (Figure 3 17 and Figure 3 18) The anti-C-peptide antibodies also significantly 
stained ‘negative’ control cell lines, i e stage 1 ES-D3 and mouse mammary 4TI cells 
Western blot analysis confirmed that the C-peptide 2 antibody recognised a specific band 
for C-peptide 2 at the expected size (3 kDa) in the MIN6 cell line (Figure 3 1 8 E), 
however, did not detect a 3 kDa band for C-peptide 2 in negative control cell lines or 
stage 5 ES-derived cells (Figure 3 1 8 F) The C-peptide 2 antibody does not detect 
proinsulin by western blot analysis, therefore positive IF staining is not due to 
unprocessed proinsulin This C-peptide 2 antibody is therefore useful in western blot 
analysis where one can distinguish between specific and non-specific bands based on 
molecular weight (Figure 3 1 8 E), however more caution is required for IF/IHC analysis 
It is our belief, based on these findings, that stage 5 ES-derived cells did not express C- 
peptide 2 (at a significant level to be detected by western blot) and that apparent C- 
peptide 2 positivity in this IF study and perhaps in other published IF/IHC studies may be 
overrepresented significantly in relation to actual levels in ES-derived cell populations
4 3 6 Intracellular Insulin Content of Stage 5 Cultures and In Vitro GSIS
We detected approximately 36 ng insulin per mg of protein in stage 5 cultures using a 
mouse ultra-sensitive insulin ELISA (Figure 3 19) This quantity varied from one 
biological repeat to another Insulin was released from stage 5 cells but not in a glucose 
dependant manner (Figure 3 1 10) The original Lumelsky protocol reported the 
derivation of cells containing 145 ng insulin per mg protein These cells were also 
reported to have secreted insulin in response to glucose in a dose dependant manner, 
however, subsequent studies using both the original protocol (Sipione et al, 2004) and a 
modified version of the protocol (Miyazaki et al, 2004) were unable to demonstrate 
functional GSIS by ES-derived cells
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Hansson et al (2004) demonstrated that ES-derived cells generated using the Lumelsky 
protocol released insulin in the presence of glucose However, the insulin release was 
variable and did not follow the release kinetics associated with genuine P cells It was 
also found that C-peptide, a bi-product of insulin synthesis was not secreted along with 
insulin, indicating that any insulin released was not de novo synthesised
4 3 7 Lack of Evidence Supporting De Novo Insulin Synthesis in Stage 5 Clusters
In a further effort to definitively identify de novo insulin biosynthesis in cultured cells, 
we developed a novel assay based on metabolic labelling (ML) followed by a modified 
radio-immunoassay (MRIA) In summary, the ML step radioactively labels all newly 
translated, cysteine-containing proteins (6 residues in insulin) by inclusion of 35S-L- 
cysteine in the culture medium The subsequent MRIA specifically binds insulin present 
in the cell lysate - both labelled and unlabelled -  the former of which is detected by 
scintillation counting
To develop and test the MRIA we used the mouse insulinoma cell line, MIN6, which 
actively synthesizes and secretes insulia We were particularly interested in determining 
the sensitivity limits of the assay given its intended use on ES cell-derived cultures that 
would be expected to synthesize very small quantities, if any, of the hormone We first 
established that 6 hours was sufficient time for the ML step (Section 3 1 6 and Figure 
3 1 11) It should be noted that this is based on results generated using MIN6 cells and 
that insulin synthesis and turnover (secretion) rates are likely to be different depending on 
cell type A second concern addressed was the specificity of the MRIA Although the 
assay uses a commercial insulin ELISA plate for insulin capture (immunosorption), it 
does not include binding of the secondary insulin-specific, enzyme-linked antibody To 
discount the possibility of non-specific protein-antibody interaction, we opted to include 
a titration step based on competitive antigen binding using non-labelled (cold) insulin By 
increasing the amount of cold competitor m the binding solution we demonstrated 
concentration-dependent reduction in the radioactive signal bound to the plate (Figure 
3 1 12 B & C and Figure 3 1 13 A) This also served the purpose of establishing the 
background radioactive signal resulting from non-specific protem-plate binding events
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Initial experiments revealed two further challenges in successful implementation of the 
MRIA Firstly, the background measurement was too high for sensitive applications This 
was most likely caused by non-specific binding of ‘sticky’ proteins, such as albumin, to 
the plate Secondly, there was a large standard deviation across replicate sample 
measurements Both these problems were overcome by incorporating an ultra-fihration 
step to remove proteins greater than 50 kDa from the sample lysates and by pre-blocking 
the wells with non-labelled cell lysate (Section 3 1 6 and Figure 3 112)
To investigate the sensitivity of the MRIA (and further confirm the insulm-specificity), a 
standard curve was generated by measuring the bound signal (cpm) detected in dilutions 
of labelled MIN6 lysate and plotting this against the concentration of total insulin in this 
dilution series (Figure 3 1 13 B) Having established the utility of the assay in detecting 
insulin biosynthesis in MIN6 cells routinely down to levels below 0 71 ng/ml, we were 
unable to detect de novo synthesis in lysate from stage 5 cells that contained 88 ng/ml 
insulin (as determined by standard commercial ELISA) (Figure 3 114) Although it could 
be argued that the rate of insulin translation may be very low in these cells, it is unlikely 
to account for the high concentrations indicated by ELISA and the failure to detect any 
reduction in radioactive counts at high concentrations of competitor in the MRIA This is 
further supported by the IF results that reveal a very small number of msulin-positive 
cells with a punctate staining pattern indicative of p cell granules for storage of protein 
(and possibly lower turnover) The IF analysis also reveals a large amount of feint, more 
diffuse, non-granular insulin staining, not usually associated with a P cell phenotype 
Taking these separate pieces of evidence together we propose that the diffuse staining 
seen in IF analyses is responsible for the high levels of insulin detected in stage 5 cell 
lysates by ELISA, but it is not cell-derived as it is not detected by MRIA These findings 
are in agreement with previous reports suggesting an insulin uptake from the culture 
medium to be responsible for the high insulin content in cells exposed to similar 5 stage 
differentiation protocols
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4 3 71 Factors Affecting the Overall Performance of the MRIA
The percentage of radio-labelled versus unlabelled insulin present in the cell lysates is 
unknown, therefore, the MRIA assay does not facilitate absolute quantification of 
labelled de novo synthesised insulin in cell cultures Determination of a limit of detection 
for the MIN6 sample required a standard curve (as shown with the MIN6 dilution series, 
Figure 3 113) Inter-assay variations necessitate the generation of a new standard curve 
with each independent assay These inter-assay variations, which affected assay 
performance were as follows
• Specific activity of the labelled amino acid substrate
• Cell line to cell line variations such as protein turnover
• Lysis efficiency
• Exposure time to the 35S-L-cysteine/metabolic labelling time
Irrespective of these variables it is possible to identify de novo insulin synthesis using the 
MRIA assay based on competition between labelled insulin and cold competitor (Figure 
3 1 14)
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4 4 Two-Stage Differentiation Protocols
Induced differentiation of endoderm-derivatives from ES cells has proved more difficult 
than the induced differentiation of ecto- and meso-dermal lineages (Schuldiner et al, 
2000, Mfopou et al, 2005) Thus, the application of candidate inductive signalling 
compounds in ES differentiation cultures to enrich for endoderm derivatives is of current 
interest In this study, a number of compounds previously linked to endocrine 
differentiation or functional enhancement of P cells were introduced to the culture 
medium of differentiating ES-D3-derived EBs (Section 3 2) We used an in vitro 3- 
dimensional EB differentiation system, which in many respects mimics the early stages 
of development (Schuldiner et al, 2001, Czyz & Wobus, 2001), to investigate the effects 
of these compounds on temporal gene expression and lineage specification Models of 
directed differentiation were developed and investigated in parallel with a model of 
spontaneous differentiation, with particular emphasis placed on the successful derivation 
of pancreatic endocrine cell types within complex differentiated cultures (see schematic, 
Figure 4 4 1)
ESD3 cells maintained in feeder 
free culture system (+UF)
+ Retinoc Acid 
(RA) LIF
RA 
S Day EBs
+ Actvin A + Betacell uim + Sodium 
(AA) (BTC) Butyrate
(SB)
R AAA RA_BTC RA_SB 
9 Day EBs
Figure 4 4 1 Two-stage differentiation protocol used in differentiation studies LIF, 
leukaemia inhibitory factor, CO, control, RA, retmoic acid, AA, activin A, BTC, 
betacellulin, SB, sodium butyrate, EBs, embryoid bodies (Repeat of Figure 2 3 1)
i
LIF
CO_5d 
5 Day EBs
COj9d
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4 4.1 Formation of EBs in the presence of Retinoic Acid
Differentiation of mouse ES cells m the presence of retinoic acid has previously been 
shown to induce both neuronal/glial differentiation (Bain et al, 1995, Schuldmer et al 
2001, Tang et al, 2002) and endodermal differentiation (Vetere et al, 2003, O Driscoll et 
al 2004, Micallef et al, 2005) The concentration of RA, the time-point of introduction 
and the culture type 1 e monolayer versus suspension, varied from one study to another 
In the present study, ES-D3 cells were seeded overnight in suspension culture prior to 
being exposed to 100 nM RA for 72 hours (stage 1 differentiation) (Section 3 2 1) 
Previous results within our laboratory had demonstrated that these conditions were 
suitable for induction of endodermal differentiation (Gammell et al, 2002)
At day 5, after 72 hours in the presence of RA, neuronal-like projections extended from 
the edge of RA-treated EBs when plated These outer cells appeared to have a decrease 
in alkaline phosphatase activity when compared to the inner cells of the RA-treated EBs 
The outer layer of EBs in the untreated CO_5d culture also appeared to have a decrease 
m alkaline phosphatase activity but not to the same extent as that observed in the RA- 
treated EBs The pattern of staining in both cultures indicated that the cells constituting 
the outer EB layer had started to differentiate (Section 3 2 2)
4 4 2 Multi-lineage Marker Expression in ES-derived cultures
In vitro cultivation of ES cells as EBs results in derivatives representative of all three 
primary germ layers (Doetschman et al, 1985, Rohwedel et al, 1996) Given the 
possibility of a broad range of lineage outcomes and the fact that many markers are 
expressed in multiple lineages, specific combinations of marker mRNAs expected to be 
expressed or not expressed, were evaluated at various time points in our 2-stage 
differentiation models, to determine differentiation towards a specific lineage (D’Amour 
et al, 2005) The choice of markers for the analysis of such regulated differentiation of 
cells was based on the outcome of previous studies which demonstrated that ES cells 
spontaneously differentiate into pancreatic endocrine (Kahan et al, 2003), extra- 
embryonic (Milne et al, 2005), neuronal (Wiese et al, 2004) and myogenic cell types
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(Karbanova et al, 2002) Apoptotic marker expression was also assessed to determine the 
effect of extra-cellular compounds on cell viability (Section 3 2 3)
4 4 2 1 Multi-lineage Marker Expression in the CO_d5 Culture and the RA culture 
after Stage 1 Differentiation
Oct 4, a characteristic marker of pluripotent stem cells, was strongly expressed at both an 
mRNA level and protein level in the ES-D3 culture (Section 3 2 3 and Section 3 2 4) 
After stage 1 differentiation, the transcript level was down-regulated slightly in both the 
CO _5d culture and the RA culture, however, there was no visible sign of down- 
regulation at a protein level This minimal reduction in Oct 4 expression was not 
surprising as it had been previously shown that Oct 4 mRNA levels in ES cells are only 
partially diminished in LIF free conditions after 5 - 6  weeks culture (Berrill et al, 2004)
The CO_5d culture expressed a broad range of markers at both mRNA level (Nestin, NF- 
L, MBP, p HI Tubulin, myogenin, desmin, islet 1, Pdxl, ngn3, beta2, pax 6, nkx2 2, PCI, 
PC2, somatostatin, PPI, AFP, bax and caspase 3) (Table 3 2 1) and protein level (NF_L, P 
HI tubulin, myogenin, desmin, Pdxl, glut2, somatostatin and PP) (Table 3 2 4) Primary 
differentiation in the presence of RA enhanced expression of the multi-potential marker, 
nestin (Zulewski et al, 2001, Wiese et al, 2004), at both RNA and protein level, early 
transcription factors common to both neuronal/glial and pancreatic development (pax 6 
and islet 1) at mRNA level (Hunziker et al, 2000, Kama et al, 2004, Moritoh et al, 2003), 
the oligodendrocyte marker, MBP, at mRNA level, the neuronal markers, NF-L, at both 
mRNA and protein level, and p El Tubulin, at protein level, the proinsulin processing 
enzyme, PC2 at an mRNA level, and the glucose transporter, glut 2, at mRNA and 
protein level
RA slightly repressed expression of P cell markers (insulin 1, insulin II and Pdxl) at 
mRNA level only (Section 3 2 3 1) The repression of Pdxl coincided with the induced 
expression of Shh mRNA (a known inhibitor of pancreas induction (Soria et al, 2001b, 
Mfopou et al, 2005)) The difference in our findings compared to Micallef et al (who 
reported that RA induced Pdxl-positive endoderm expression in differentiating mouse ES
259
cells) (Micallef et al, 2005), is possibly due to variations in RA concentration, timing of 
its addition to the culture medium, and the use of a different mouse ES cell line A high 
level of ngn3 mRNA expression was detected in both the RA culture and the CO_5d 
culture Ngn3 is a pancreatic transcription factor expressed at an early stage in cells 
differentiating toward an endocrine fate (Habener et al, 2005) The range of transcript and 
protein expression identified in the RA culture would suggest a mixed population of 
multi-potential precursors Elevated Pdxl and PPI mRNA expression in the 
spontaneously formed CO_5d culture would suggest the presence of endodermal cell 
types, however, unregulated secondary differentiation of the CO_5d cultures did not 
result in the derivation of endocrine cell types (CO_9d)
Secondary differentiation of the RA culture in the presence of other compounds altered 
the specification of lineage fate, resulting in neuronal- and glial-specific transcript 
expression prevailing in the presence of AA or BTC (Section 4 4 2 2) and pancreatic 
endocrine marker expression dominating in the presence of SB (Section 4 4 2 3) These 
findings support those reported by Seaberg et al (2004) who identified the presence of a 
multi-potential population in the adult pancreas, that can generate both neural and 
pancreatic lineages
4 4 2 2 Preferential Differentiation of the RA culture along a Neuronal/Glial Lineage 
in the Presence of AA or BTC
Neuronal and glial differentiation is characterized by the development of nestin- 
expressing precursor cells in the RA culture and subsequent down-regulation of nestin 
expression in the RA_AA and the RABTC cultures, coinciding with an up-regulation of 
the astrocyte-specific transcript, GFAP (Section 3 2 3) The co-expression of the nestin 
protein (in a small percentage of both the RA_AA and the RA_BTC cultures) with the 
lineage-specific proteins, GFAP, P III tubulin and NF-L, is known to occur at time points 
that define the onset of cell lineage specification preceding terminal differentiation in 
vitro (Section 3 2 4) (Wiese et al, 2004) The profile of somatostatin mRNA expression 
was similar to that of neuronal and glial markers in that it was expressed at an 
intermediate stage in the RA culture and maintained at a high level of expression in the
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RA AA and the RA_BTC cultures (Section 3 2 3) Somatostatin protein was detected in 
subpopulations of both these cultures (Section 3 2 4) Somatostatin is most commonly 
known as a marker of the endocrine islet 5-cell type (Soria et al, 2001b) but is also 
expressed m the brain (Hokfelt et al, 1975, Johansson et al, 1978, Jarvi et al, 1987)
AA and BTC have previously been identified as inducers of P cell differentiation 
(Mashima et al, 1996, Huotari et al, 1998, Miyagawa et al, 1999), however, given the 
substantial phenotypic similarity between pancreatic and neuronal/glial cell types it is 
understandable that the same compounds may regulate both developmental pathways 
(Lumelsky et al, 2004, Stoffel et al, 2004) (Section 14 5) In the present study, it would 
seem that in combination with RA, both AA and BTC independently gave rise to 
neuronal- and glial-like phenotypes
4 4 2 3 Preferential Differentiation of the RA culture along a Pancreatic Endocrine 
Lineage in the Presence of SB
SB is known to induce P cell differentiation (Otonkoski et al, 1997) and increase insulin 
content (Philippe et al, 1987, Bartholomeusz et al, 1989), but in turn, induce cell death 
(Soria et al, 2001) In this study, pancreatic differentiation in the R A SB culture is 
characterized by the expression of pancreatic developmental control genes at day 5 
(Pdxl, ngn3, beta 2, pax 6, nkx2 2), followed by the up-regulation of P cell specific genes 
(insulin I, insulin II and glut2) at day 9 (Section 3 2 3) The down-regulation of ngn3 
between the RA culture at day 5 and the R A S B  culture at day 9 was indicative of islet 
cell differentiation Ngn3 initiates the islet differentiation program but its expression is 
diminished before terminal differentiation of endocrine cells (Smith et al, 2005) Semi- 
quantitive PCR demonstrated an induced expression of PPI mRNA in the 9 day RA_SB 
culture (Figure 3 2 3 V), however, qPCR was much more effective at quantifying the 
dramatic induction of insulin I, insulin II and glut2 mRNA expression within this culture 
(Figure 3 2 4) Shh expression was repressed in the R A S B  culture, which in turn 
promoted Pdxl expression (Section 3 2 3) Pdxl is known to play a role in pancreas 
maturation, P cell fate specification and insulin gene expression (Soria et al, 2001b) 
Subsequent IHC analysis of the R A S B culture demonstrated that Pdxl, glut2 and insulin
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mRNAs were translated into protein over the course of our 2-stage differentiation 
protocol (Section 3 2 4)
Markers characteristic of the y and 5 endocrine islet cells were also detected in the 
RA_SB culture mRNA expression of PP was detected in the early stages of 
differentiation (RA culture) and its expression was maintained in the presence of SB 
(RA_SB culture) (Section 3 2 3) Both PP and somatostatin proteins were detected in 
subpopulations of the RA_SB culture by IHC analysis (Section 3 2 4) The expression 
levels of these proteins in ES-derived cultures do not correlate with transcript expression 
For instance, somatostatin was detected at protein level m the RA_SB culture, however, 
it was not detected at mRNA level There are two possible explanations for these results 
(i) low level transcript expression of both genes may not have been detected in specific 
samples by RT-PCR or (u) the individual antibody molecules recognised epitopes that 
may be shared among different proteins
The transcription factor, pax 4 and the endocrine a cell hormone, glucagon were not 
detected at mRNA level at any point over the 2-stage RAJSB differentiation protocol 
(Section 3 2 3) Although we do not know the reason for this, we speculate that the 
exogenous RA_SB treatment can prime pancreatic progenitors during EB formation, but 
may suppress some endocrine specific genes at the latter stages of differentiation Pax 4 
appears m the final stages of the cascade of transcription factors thought to be involved in 
the endocrine pancreas differentiation programme (Figure 1 2 2)
In the present study, it would appear that in combination with RA, SB gave rise to 
pancreatic endocrine-like cell types, including insulin-positive cells This novel 2-stage 
differentiation protocol warranted further investigation (Section 4 4 3 -  Section 4 4 6)
4 4 2 4 C-peptide 1 and C-peptide 2 Expression in ES-D3 and ES-derived Cultures
Immunoreactivity to C-peptide, in conjunction to that of insulin, has been used as a 
definitive means of proving de novo insulin synthesis in ES-derived cells (Kahan et al, 
2003, Miyazaki et al, 2004, Segev et al, 2004) In this study, C-peptide 2 expression was
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detected in ES-D3 cells C-peptide 1 and C-peptide 2 expression was detected in both the 
RA and CO_5d cultures after stage 1 differentiation The expression of both these 
proteins appeared to be down-regulated in the 9 day cultures including the RAJSB 
culture Despite C-peptide being a product of insulin bio-synthesis, the trend in C-peptide 
1 and C-peptide 2 expression did not correlate with the trend in insulin expression 
(Section 3 2 4)
Insulin/C-peptide co-localization analysis was performed on cells from the R A S B  
culture (Section 3 2 5) The cells were shown to express insulin, C-peptide 1 and C- 
peptide 2, however, the C-peptide staining did not co-localize with that of insulin C- 
peptide 1 and C-peptide 2 were also detected in the majority of cells in the CO_9d 
culture, however these cells were negative for insulin These IF results verify previous 
findings in Section 3 1 demonstrating that these C-peptide antibodies, when used for 
immuno-analysis, over-exaggerate actual protein levels
Taking both the IF (Section 3 14 and Section 3 2 5) and IHC (Section 3 2 4) results into 
account it is apparent that immuno-analysis using these particular antibodies is unreliable 
for determining de novo insulin synthesis
4 4 3 De Novo Insulin Synthesis in the ES-denved RA SB Culture
Other protocols used for the derivation of insulin-expressing cell types have been long, 
complex (Lumelsky et al, 2004, Hori et al, 2002), often require genetic modification 
(Blyszczuk et al, 2003, Miyazaki et al, 2004), the addition of exogenous insulin to the 
culture medium (Lumelsky et al, 2004, Hon et al, 2002, Blyszczuk et al, 2003, Miyazaki 
et al, 2004) and result in the derivation of apoptotic bodies (Rajagopal et al, 2003) The 
insulin-positive cells derived from such protocols may be a direct result of insulin uptake 
upon apoptosis rather than de novo synthesis (Rajagopal et al, 2003, Hansson et al, 2004) 
The short 2-stage RA_SB differentiation protocol developed in this study did not require 
exogenous insulin for the derivation of insulin-positive cell types, indicating that any 
insulin expressed was de novo synthesized (Figure 3 2 10) LSCM analysis of RA_SB
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insulin-positive cells demonstrated a punctate staining pattern indicative of p cell 
granules
4 4 4 Lineage Specification of Insulin-Positive cells in the R A S B  Culture
Milne et al has suggested that insulin-positive cells derived from ES cells are extra- 
embryonic in origin (Milne et al, 2005) Extra-embryonic endodermal cells express 
elevated levels of Oct 4 and AFP mRNA In our study, the RA_SB culture containing 
insulin-positive cells had an elevated level of AFP mRNA expression, however, a 
decrease in Oct 4 mRNA was observed between undifferentiated ES-D3 and the RA_SB 
culture coinciding with an increase in insulin I, insulin II and glut2 mRNA (Figure 3 2 4), 
which is more consistent with p cell differentiation than extra-embryonic lineage 
specification
4 4 5 Apoptotic Bodies Are Not Detected in the RA SB Culture
As differentiation proceeded and cells within the RA_SB culture became committed to an 
endocrine pancreatic fate, we observed a decrease in proliferation capacity (as illustrated 
by cell counts, Figure 3 2 11) Previous studies have suggested that SB induces apoptosis 
(Soria et al, 2001), however, in the present study there was no change observed in 
apoptotic marker expression (Figure 3 2 3) and no sign of small fragmented nuclei (a 
characteristic of apoptosis) in the RA_SB culture (Figure 3 2 10), suggesting that the 
reduced cell number in this culture compared to the CO_9d culture was not related to 
apoptosis induced by extra-cellular compounds The low cell number in the RA_SB 
culture was most likely due to the inhibition of DNA synthesis and cell division by SB 
(Hagopian et al, 1977) In general, a reduction in proliferation is inversely proportional to 
differentiation (Soria et al, 2001b)
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4.4.6 An Investigation of Alternative R A S B  Differentiation Protocols
The cell yield in the RA SB culture was approximately 7-fold lower than the cell yield 
attained from the CO_9d culture. An alteration in protocol (Figure 4.4.2) was necessary 
to improve cell yields and in turn increase the number of ES-derived insulin-expressing 
cells.
Undifferentiated ESD3 (Day 1)
Media (-LIF)
EB
Day 5
+ Media (-LIF) + SB
CO_EB SB_EB
Day 6 Day 6
J I
CO_EB SB_EE
Day 7 Day 7
1
+ SB
RA (10-7 M)
I
RA_EB
Day 5
PA + TSA
RA_SB_EB RA_PA_EB RA_TSA_EB
Day 6
I J I
RA_SB_EB RA_PA_EB RA_TSA_EB
Day 7 Day 7
NIC
RA_SB_EB
Day 9
Figure 4.4.2 Alternative RA SB differentiation protocols. LIF, leukaemia inhibitory 
factor; CO, control; RA, retinoic acid; SB, sodium butyrate; EBs, embryoid bodies; PA, 
pentanoic acid; TSA trichostatin A. (Repeat of Figure 2.3.2)
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4 4 6 1 Tertiary Treatment with Nicotinamide
It was established that insulin I and insulin II transcripts were increased > 30-fold by day 
7 of the 2-stage RA_SB differentiation protocol (Figure 3 2 12) It was also demonstrated 
that transcript expression was maintained for at least four days after removal from the 
stage 2 differentiation treatment Based on these results it was hypothesized that (a) 
removal of the R A S B  culture from SB supplemented media by day 7 of the protocol and
(b) introduction of the culture to a tertiary treatment such as nicotinamide, may allow for 
an overall improvement in cell yield and may also encourage translation of the insulin 
transcripts, allowing for higher insulin protein expression (see schematic, Figure 4 4 2)
Nicotinamide was chosen as a tertiary treatment based on a previous study demonstrating 
that a combination of SB and NIC increased insulin content of islet-like cell clusters by 
90-fold (Otonkoski et al, 1999) However in the same study, the presence of SB caused a 
severe reduction in cell number Independently, NIC was found to enhance insulin 
content and encourage (3 cell differentiation without affecting cell number (Sjoholm et al, 
1994, Otonkoski et al, 1999)
In the present study, there was no improvement in cell yield observed in the R A S B N I C  
culture (Figure 3 2 13) However, insulin I transcript expression was twice that observed 
in the original RA_SB culture and insulin II transcript expression was also noticeably 
higher (Figure 3 2 14)
4 4 6 2 Omission of RA from Stage 1 Differentiation
It was previously noted that (a) the CO_5d culture had a higher level of Pdxl transcript 
expression than the RA culture (Figure 3 2 3) (b) the RA culture consisted of a mixed 
population (Section 3 2 3) (c) cell numbers were lower m the RA culture compared to the 
CO_5d culture (Section 3 2 7) It was therefore hypothesized that the omission of RA 
from stage 1 differentiation may allow for a higher percentage of endodermal cell types at
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day 5 thus increasing the percentage of cells that would commit to a pancreatic endocrine 
fate in the presence of SB (stage 2 differentiation) See schematic, Figure 4 4 2
The omission of RA from stage 1 differentiation allowed for a dramatic increase in cell 
yield (Figure 3 2 13) as well as a dramatic increase in insulin II transcript expression 
(Figure 3 2 14 B) However, insulin I transcript expression was extremely low in these 
cultures (Figure 3 2 14 A) These results demonstrated that the low cell yield observed in 
the original RA_SB protocol (Section 3 2 7) was due to the combined effect of RA and 
SB, not SB alone
4 4 6 3 Pentanoic Acid or TSA as Alternatives to SB
Pentanoic acid and TSA were chosen as alternatives to replace SB in stage 2 of the 
differentiation protocol (Figure 4 4 2) It was thought that these two agents may induce 
pancreatic endocrine differentiation in a similar manner to SB without inhibiting growth 
rate (to the same extent as SB)
TSA is similar to SB in that it is a HDAC inhibitor This class of compounds inhibit 
hist one deacetylase allowing histone hyperacetylation to occur Hyperacetylation leads to 
chromatin relaxation and modulation of gene expression resulting in high transcription of 
DNA and protein biosynthesis (Philippe et al, 1987, Gan et al, 2005) Pentanoic acid is 
similar to SB in that it is a short chain carboxylic acid Liu et al (2001) demonstrated that 
pentanoic acid had a similar effect to SB on protein biosynthesis whilst having less of an 
effect on growth suppression
TSA and PA did not improve cell yields (Figure 3 2 13) nor did they improve insulin II 
transcript expression (Figure 3 2 14 B) However, TSA did allow for an insulin I 
transcript expression level similar to that observed in the original RA_SB culture (Figure 
3 2 14 A)
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The alterations in the RA_SB differentiation protocol discussed in Section 4 4 6 1 -  
Section 4 4 6 3 were not suitable for improving the original RA_SB differentiation 
protocol
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4 5 The MIN6 Cell Line as a Potential Model for Studying 0 Cell De-differentiation
Great advancements have been made in the study of p cell biology by the development of 
cultured p cell lines (Poitout et al, 1996) These lines are preferable over isolated islet 
material in that they offer a pure population with which to work One of the most 
commonly studied clonal P cell lines is MIN6 This cell line maintains accurate P cell 
function at early passages i e the cells respond synchronously and physiologically to 
changes in glucose concentration (Webb et al, 2000)
Previous MIN6 studies, by ourselves (O’ Driscoll et al, 2004a) and others (Miyazaki et 
al, 1990, Ishihara et al, 1995, Kayo et al, 1996), have indicated that the GSIS phenotype 
is relatively unstable in long-term culture Loss of GSIS function in MIN6 cells has been 
accompanied by a decrease in the insulin processing enzyme pcsk2 (PC2) and an increase 
in fur in These changes were considered indicative of a de-differentiating system i e well 
differentiated P cells were directed to a poorly differentiated state by fur in cleaved bio- 
active proteins (Kayo et al, 1996) It is also possible that the loss of differentiation in 
MIN6 cells is attributed to the overgrowth of a rapidly proliferating, poorly differentiated 
population such as those identified by Minami et al, 2000
In investigating potential factors associated with the loss of the GSIS phenotype it should 
be considered that optimised conditions for culturing P cells are typically supra- 
physiological i e MIN6, 25mmol/l (Miyazaki et la, 1990, Lilia et al, 2003, O’ Driscoll et 
al, 2004a) Continuous exposure to high glucose has wide ranging effects such as 
increased rates of insulin secretion at low glucose, glycogen deposition and increased 
proliferation These changes are correlated with changes in the expression of genes 
associated with differentiation, glucose regulation, insulin processing, proliferation and 
transcription of islet specific hormones (Kayo et al, 1996, Roche et al, 1997, Roche et al, 
1998, Jonas et al, 1999, Itkm-Ansari et al, 2000)
The MIN6 system, i e glucose responsive low passage cells versus glucose non- 
responsive high passage cells, has the potential to highlight crucial pathways/systems in P 
cell development It is of utmost importance to identify a means of preserving p cell
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function, 1 e GSIS while in culture, for possible future applications involving the use of 
cultured replacement tissue To investigate this, a study was performed in our laboratory 
on MIN6 cells with respect to their GSIS capability and their proliferation rates Upon 
reaching the proposed ‘less differentiated state’ (glucose non-responsive), microarray, 
bio informatics and qPCR techniques were employed to compare gene expression profiles 
of fully functional MIN6 cells (glucose-responsive) and the proposed ‘poorly- 
different rated’ MIN6
4 5 1 Loss of GSIS in MIN6 Cells After Long-term Culture
PI8 MIN6 cells respond to changes in glucose concentrations, producing an approximate 
6-fold GSIS in response over the glucose range tested (0 -  26 7 mmol/1) After 
continuous culture to passage 40 this GSIS was no longer present (Section 3 3 4) These 
findings were consistent with other reports such as those by Miyazaki et al (1990), 
Ishihara et al (1995) and Kayo et al (1996) There is an increase in mature 
insulin/proinsulin secretion observed at 0 mM glucose This may be attributed in part to 
the progressive loss of pcsk2 (PC2) with increasing passage, allowing for an increase in 
unprocessed pro insulin which in turn increases constitutive secretion (Simpson et al, 
1995, Kayo et al, 1996) It is also possible that the high passage cells are unable to store 
insulin in granules as efficiently as low passage cells This theory is supported by 
findings by Kayo et al, who reported the down-regulation in chromogranin A expression 
in high passage MIN6 cells Chromogranin A is a matrix constituent of secretory granules 
in neuroendocrine cells (Zimmer et al, 1999) In the present study scg3, a granin family 
member, also associated with secretory granules, was down-regulated in high passage 
MIN6 cells along with other transcripts associated with insulin processing and secretion 
(Section 45 3 1) Human islets show a marked decrease in storage granules when 
cultured at high glucose levels for prolonged periods (Bjorklund & Grill, 1999)
4 5 2 Phenotypic Changes Correlating with the Loss in GSIS After Long-term 
Culture
Low passage glucose-responsive cells typically grow in multilayered clumps facilitating 
cell-to-cell interactions and formation of gap junctions High passage glucose non-
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responsive cells do not form clumps They grow in a more conventional monolayer 
pattern resulting in a loss in cell-to-cell contact (Section 3 3 1) Previous studies have 
reported disruptions in GSIS when MIN6 cells are unable to interact and form gap 
junctions (Lmzel et al, 1988, Meda et al, 1991, Vozzi et al, 1995)
Glucose non-responsive high passage MIN6 cells proliferate at almost double the rate of 
glucose responsive low passage cells The low passage cells reach a plateau after 6 days 
at which point the clumps have reached their maximum size However, high passage cells 
continue to grow until the entire tissue culture surface is covered (Section 3 3 2) Other 
studies have found that in general, differentiation is inversely proportional to proliferation 
i e differentiated cells exhibit a lower proliferate capacity than undifferentiated cells 
(Soria et al, 2001b) A study by Zimmer et al (1999) indicated that growth arrest of a 
proliferating p cell line stimulated the expression of genes associated with p cell function 
and resulted in a phenotype that more closely resembled that of the mature terminally 
differentiated, P cell
High passage glucose non-responsive MIN6 cells were found to express a considerable 
amount of alkaline phosphatase compared to their low passage counterparts (Section
3 3 3) The difference in alkaline phophatase activity in the two cell populations is 
indicative of variable differentiation status In stem cell studies, a high level of alkaline 
phosphatase expression is characteristic of undifferentiated pluripotent stem cells, 
whereas a decrease in this expression is consistent with differentiation (Lumelsky et al, 
2001, Bemll et al, 2004) In the case of MIN6 cells, the increase in alkaline phosphatase 
activity after long-term culture suggests a de-differentiating process
4 5 3 Microarray Profiling of Gene Expression in High (glucose non-responsive) and 
Low (glucose responsive) MIN6
Microarray techniques allow for large scale gene expression profiling, something which 
is not possible with conventional PCR techniques Gene expression profiles can be 
compared to phenotypic changes and the resulting information can be used to identify 
novel pathways that warrant further investigation Microarray technology has previously
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been used in the field of p cell research to demonstrate the glucose regulation of secretory 
and metabolic genes (Webb et al, 2000) and the effect of growth arrest on cultured P cells 
(Zimmer et al, 1999)
In this study almost 1000 genes were considered significantly, differentially expressed 
(P<0 01) in high passage MIN6 compared to low passage MIN6 Eighty-eight of these 
genes were over-expressed 2-fold or more in the high passage MIN6 cells whereas 185 
genes were down-regulated by the same factor in the high passage compared to the low 
passage MIN6 Genes involved in regulated secretion, proliferation, adhesion and 
development were among those affected (Figure 3 3 6)
Minami et al (2000) reported 10 genes to be differentially expressed in a glucose non- 
responsive clonal population (ml4) compared to a glucose responsive population (m9) 
Glucokmase (involved in glucose phosphorylation), stanniocalcin/STC (involved in 
calcium regulation) and dlk/Pref-l(involved in differentiation and growth) were 
expressed at higher levels in glucose responsive cells Lilia et al (2003) also reported the 
differential expression of genes involved in metabolism, intracellular signalling and 
adhesion in glucose responsive (Bl) and non-responsive (C3) populations
4 5 31 Reduced Levels of Transcripts Associated with Insulin Processing and 
Secretion
It was hypothesized in Section 4 5 1 that a combination of both ineffective processing 
and depleted storage granules might be responsible for increased constitutive proinsulin 
secretion by high passage MIN6 cells in glucose-free conditions Kayo et al previously 
reported the loss of gene transcripts involved in insulin processing and regulated 
secretion with increased passage number (Kayo et al, 1996) Our microarray analysis 
indicated that gene products associated with vesicle formation/transportation and 
secretion were expressed at a significantly lower level in high passage MIN6 compared to 
low passage MIN6 (Table 3 3 3) These down-regulated genes are discussed in further 
detail below
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Egrl is specifically associated with insulin secretion The induction of egrl by glucose in 
MIN6 cells was inhibited by EDTA suggesting a dependence on influx of extra cellular 
Ca2+ (Josefsen et al, 1999) Egrl was down-regulated 5 5-fold in high passage MIN6 
cells Pldl is known to regulate secretagogue-stimulated insulin release in P cells It was 
also established that pldl activity is required for both the first and the second phase of 
glucose-stimulated insulin release (Hughes et al, 2004) Pldl was down-regulated 4-fold 
in high passage MIN6 cells Scg3 is transported to the secretory granules in 
neuroendocrine cells This protein and the other gramn family members are important for 
condensing secretory proteins to secretory granules with co-aggregation (Hosaka et al, 
2004) Scg3 was down-regulated 3 45-fold in high passage MIN6 cells Chgb is an acidic 
glycoprotein present m neuroendocrine tissue and localised to intragranular components 
in the RINm5F insulinoma cell line It was previously shown that chgb plays a regulatory 
role in IAPP and insulin secretion (Bargsten, 2004) Chgb was down-regulated 2 96-fold 
in high passage MIN6 cells Sgnel is a neuroendocrine protein necessary for PC2 activity 
(Lee et al, 2006) PC2 processes proinsulin to mature insulin (Smeekens et al, 1992) 
Sgnel was down-regulated 3 55-fold in high passage MIN6 cells Cck is a 
gastrointestinal hormone and a pancreatic neuropeptide It has been shown to activate cck 
receptors on the P cell and stimulate insulin secretion (Simonsson et al, 1998) Cck was 
down-regulated 6 53-fold in high passage MEN6 cells
Our microarray analysis indicated that transcript expression levels for the ‘glucose 
sensory components’ such as glut2 and gck where not significantly affected by long-term 
culture These findings are in agreement with Minami et al (2000) who reported that 
glut2 expression was similar in a glucose responsive and glucose non-responsive 
population
4 5 3 2 Changes in Transcripts Associated with Cell Adhesion and Proliferation
As previously discussed in Section 4 5 2, cell-cell interaction is extremely important for 
GSIS function A comparison of insulin levels, secretion rates and GSIS capabilities of 
intact islets, dispersed islets, and re-aggregated islets revealed that the dispersed cells and
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re-aggregated cells had impaired response to glucose (Lmzel et al, 1988) Intracellular 
contacts in islets are established through adherens junctions, gap and tight junctions
In the present microarray study, transcript levels of a number of cell adhesion molecules 
including CEACAM-1, CE AC AM-2, contactin 1 and E-cadhenn were reduced after 
long-term culture The down-regulation in these genes coincided with the up-regulation 
of tight junction protein (tjp) and claudin 11 (tight junction transmembrane protein 
(Hashizume et al, 2004)) The loss of E-cadherin (1 6-fold) in non-responsive P cells is in 
agreement with a similar observation by Lilia et al (2003) in a non-glucose responsive 
MIN6 clone (C3) and its association with undifferentiated pancreatic progenitor cells 
(Jensen et al, 2005) Reelin, known to be involved in cell-cell interactions in the brain, 
was down-regulated (4 4-fold) in high passage MIN6 cells (Lilia et al, 2003)
The absence of connexins (components of cell-cell communication in islets) from the 
microarray study may reflect a limitation of microarray technology where probe selection 
can exclude important transcripts from final gene lists, our experience has been that 
present calls on the microarray are generally confirmed by RT-PCR Exceptions to this 
are glut2 (where semi-quantitative RT-PCR, but not qPCR, confirmed microarray results) 
and dlkl (where triplicate microarrays indicated > 2-fold down-regulation in high 
passage MIN6 compared to low, but qPCR suggested an “absent” to “present” call, in this 
comparison These limited conflicting results between microarrays and qPCR are likely 
to reflect differing locations of microarray probes and qPCR primers on dlkl gene 
transcripts (Table 3 3 2 and Table 3 3 3)
CEACAM1 may have an additional role in the loss of differentiation state and GSIS in 
cultured MIN6 separate from its role in adhesion, as it can act as a suppressor of cellular 
proliferation (Singer et al, 2000), thus, its absence at high passages may in fact promote 
growth Other proliferation related genes were found to be altered in high passage MIN6 
including increased (1 96-fold) levels of cdk4 (cyclin-dependant kinase 4) mRNA
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expression and decreased levels of dlkl mRNA, which, respectively, promote (Marzo et 
a l , 2004) and attenuate (Fnedrichsen et al, 2003) proliferation of P cells This loss of 
dlkl in non-responsive cells is in agreement with a study by Minami et al (2000)
The increase in cdk4 (1 96-fold) in high passage MIN6 cells coincided with a decrease m 
TGFpl (5 6-fold) Growth arrest has been induced by TGFpi in several cell types, which 
perhaps explains its down-regulation in the rapidly proliferating high passage MIN6 cells 
It has been suggested that the inhibitory action of TGFpi is mediated by the deactivation 
of kinase complexes l e cdk4, which may also explain why cdk4 is only up-regulated in 
the high passage MIN6 when TGFpl is decreased (Herrera et al, 1996)
Ornithine decarboxylase (ODC) is a rate limiting enzyme in polyamine metabolism ODC 
is thought to play a role in polyamine-regulated p cell replication and growth of 
pancreatic tissue during early development (Morisset & Grondin, 1987, Sjoholm et al, 
1994) It may also play a role in pancreatic tissue regeneration (Hayakawa, 1996) It is 
not surprising to find ODC expressed at a high level in low passage MIN6 cells and 
down-regulated (1 92-fold) in high passage cells that are thought to have de-differentiated 
towards a precursor-like cell type
4 5 3 3 Changes in Transcripts Associated with P cell Development and Function
qPCR analysis demonstrated that genes specifically expressed during terminal p cell 
differentiation and in the mature p cell are down-regulated m high passage MIN6 cells 
Examples of such genes are pax 4, a transcription factor that is necessary for the 
specification of p cell fate (Chakrabarti & Raghavendra, 2003, Chae et al, 2004) (Section 
1 2 3 5), Pdxl, a transcription factor which plays a role in pancreas maturation, p cell 
specification and insulin gene expression (Soria et al, 2001), insulin I, the insulin 
transcript which is specifically expressed in p cells, insulin n, the insulin transcript which 
is expressed in p cells as well as other tissues (Kahan et al, 2003)
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Lilia et al (2003) previously reported that Pdxl expression is 2 5-fold higher in a non­
glucose responsive population (C3) compared to a glucose responsive population (Bl) 
These findings are contrary to what is reported in the present study 1 e Pdxl expression 
was > 2-fold lower in the glucose non-responsive high passage MIN6 cells compared to 
the glucose responsive low passage MIN6 as determined by qPCR Earlier studies in our 
laboratory had determined by semi-quantitive PCR that insulin transcript expression was 
unaffected by long-term culture (O’ Driscoll et al, 2004a), however, in the present study 
we demonstrate by qPCR that PPI (23 - 2 5  fold), insulin I (2 8 -  10 fold) and insulin II 
(1 9-2 6 fold) are down-regulated in high passage MIN6 cells qPCR is much more 
effective in accurately quantifying expression levels
4 5.3 4 De-differentiation and/or Emergence of a Poorly Differentiated Sub- 
Population
The loss of GSIS coupled with increased proliferation, the morphological changes 
observed, and the increase in the level of the stem cell marker alkaline phosphatase 
(Section 4 5 2) are all indicative of a major transition occurring within serially passaged 
MIN6 cells These changes involve functional de-differentiation of the cell population, 
but whether this is due to de-differentiation of the population as a whole, or over-growth 
by a faster growing poorly-differentiated sub-population, remains unclear It must be 
remembered that MIN6 is a transformed cell line, not a completely normal p cell Studies 
by Lilia et al (pers comm) showing that clones with a high and stable level of GSIS do 
eventually lose this phenotype suggests a model in which fast-growing poorly- 
differentiated cells arise, perhaps by mutation, these cells may then over-grow and 
eventually dominate the differentiated populations Less differentiated P cells, such as 
RINm5F, have higher proliferative rates than more differentiated P cells This effect has 
previously been linked to the increased expression of furin in less differentiated p cells 
However, it is important to note that furin levels were not significantly different in low 
and high passage MIN6
276
The reduction in pax 6 levels, coupled with the appearance of nestin, correlates with the 
less differentiated state of the high passage cells Nestin has been used as a marker of 
cells that can differentiate towards a P cell-like cell type (Lumelsky et al, 2001) and has 
more recently been described as a marker of multi-potential precursor cells (Zulewski et 
al, 2001, Wiese et al, 2004) The increased mRNA levels of other neural markers tend to 
agree with the hypothesis that the higher passage MIN6 cells may be reverting to a more 
primitive neuroendocrine-like cell type i e delta-like 1 (dill) which is essential for proper 
migration and differentiation of neural crest cells (De Bellard et al, 2002) and involved in 
controlling development of neurons/glia from neural stem cells (Grandbarbe et al, 2003), 
cerebellin-1, which is widely distributed in the CNS (Albertin et al, 2000), junctophilin 
type 3, which is specifically expressed in neurons of the brain (Nishi et al, 2002), and 
necdin, suggested to mediate terminal differentiation and survival of nerve growth factor- 
dependent dorsal root ganglion neurons In fact, most of the “development” associated 
genes in the 2-fold up-regulated genelist (Figure 3 3 6) are actually involved in 
neurogenesis and brain development
The origins of pancreatic cells and neurons have many crucial transcription factors in 
common including ngn3, Isll, NeuroDl/beta 2, pax 6 and nkx2 2 (Edlund, 1999, Kama et 
al, 2004, Moritoh et al, 2003), many of which are differentially expressed in low and high 
passage MIN6 cells (Table 3 3 2 and Table 3 3 3) Furthermore, brain tumours have been 
identified that express insulin and promsulm, resulting in severe hypoglycaemia for the 
patient (Nakamura et al, 2001) This suggests that both neuronal and p cells may have 
similar progenitor cells and that it is these cell types to which de-differentiatmg MIN6 
cells are reverting This hypothesis is strongly supported by two recent reports Seaberg 
et al (2004) suggested a novel endodermal/ectodermal multi-potential precusor in 
embryonic development that persists in adult pancreas, Burns et al found that rat neural 
stem cells differentiated in vitro, into an insulin-expressing phenotype, showed functional 
responses typical of pancreatic p cells (Burns et al, 2005)
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The increased expression of nestin and Baspl (brain acid soluble protein 1) mRNA in 
parallel with decreased levels (2-fold) of GAP43 (growth associated protein 43) gene 
transcript expression in high passage MIN6, compared to low passage MIN6, may 
indicate that TGFpi has at least a partial role in the de-differentiation towards a 
“neuroendocrine precusor” cell type (Figure 4.4.3). TGFpi levels are lower in high 
passage MIN6 cells, and under normal circumstances, would have a negative effect (Loo 
et al, 1995) on nestin levels (4.2-fold up-regulated) and a positive effect on GAP43 levels 
(2-fold down-regulated). While Baspl and GAP43 can functionally substitute for one 
another, GAP43 negatively affects Baspl expression (Frey et al, 2000) which may 
explain why Baspl levels are 3-fold up-regulated in high passage MIN6. As TGFpi 
positively regulates clusterin levels (Jin & Howe, 1997), the reduction in TGFpi (5.6- 
fold) may also explain the unexpected decrease in clusterin levels (6.4-fold), which 
would possibly have been expected to be elevated in more rapidly proliferating high 
passage MIN6 cells (Kim et al, 2001). The reduced levels of TGFpi are also in keeping 
with the more rapidly proliferating phenotype of high passage MIN6 as TGFpi is a 
potent growth inhibitor. Early reports by Kim et al (2001) suggested clusterin was 
involved in pancreatic islet formation during early development as well as islet 
regeneration and a recent study by the same group demonstrated that the over-expression 
of clusterin induced differentiation of pancreatic duct lining cells into insulin-secreting 
cells (Kim et al, 2006). It is therefore not surprising that in our study clusterin is down- 
regulated in high passage MIN6 cells that have lost P cell function.
jm
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Figure 4 4 3 TGF01 exerts an effect on Nestin (NES), GAP43 and Baspl expression
4 5 3 5 Summary of Changes in Gene Expression
Several genes that are involved in crucial p cell function are down-regulated in high 
passage glucose non-responsive cells Loss/reduced levels of these transcripts together 
with the increased levels of neuron-/glia- associated mRNAs may suggest, that after long­
term culture, MIN6 cells revert to a poorly-differentlated, precursor-like population
279
Section 5.0: Conclusions and Future Work
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5 1 Conclusions
5 11 Feeder-Free Culture of Mouse ES Cells
• Undifferentiated ES-D3 cells cultured on gelatin, in the absence of feeder layers, 
and in the presence of LIF exhibit characteristics associated with pluripotency 
However, these cells also express a range of developmental markers, which may 
suggest that some of the cells are in the early stages of differentiation
5 12 An Investigation into the Derivation of Insulin-Expressing Cell Types using an 
Adapted Version of the Original Lumelsky Protocol
• Stage 5 differentiated clusters derived from ES-D3 cells using a modified version 
of the original Lumelsky protocol expressed markers representative of the 
neuronal/glial lineage (GFAP, MBP, (3 III tubulin), extra-embyromc lineage 
(GATA 4, AFP, Pdxl) and pancreatic endocrine lineage (pax 4, insulin I, insulin 
II, glut2) indicating the presence of multiple cell types in these clusters
• The appearance of neuronal striations in cultures at stages 4 and 5 correlated with 
an increase in neuronal/glial transcript expression supporting a previous 
suggestion by Kama et al (2004) that the stage 3, nestin-selection step promotes 
neuronal/glial differentiation
• Endocrine pancreatic differentiation appeared to dominate over extra-embryonic 
differentiation during the 5 stages of the modified Lumelsky protocol An increase 
in (3 cell marker transcripts i e insulin I, insulin II, pax 4 and glut2 was observed 
in the stage 5 culture whereas Oct 4 expression was down-regulated An increase 
in Oct 4 expression is usually associated with extra-embryonic differentiation
• Stage 5, ES-derived cells did not show any sign of apoptosis There was no 
change in apoptotic marker transcript expression between stage 1 and stage 5 
Stage 5 cell nuclei were round and robust rather than small and fragmented (as 
would be expected during apoptosis)
• C-peptide 1 and C-peptide 2 expression detected by IF/IHC analysis over­
represented actual C-peptide protein levels in the stage 5, ES-derived culture A
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C-peptide western blot optimised in our laboratory demonstrated that stage 5 
clusters did not express C-peptide 2 at a significant level for detection
• IF analysis demonstrated that an isolated subpopulation of the stage 5, ES-derived 
culture expressed granular staining indicative of insulin staining An insulin 
content of 88 ng/ml was detected in lysates from this culture by ELISA Stage 5 
cultures also released insulin, but not in a glucose dependent manner
• A novel MRIA assay developed during the course of this study was used to 
identify de novo insulin synthesis (down to a level of 0 71 ng/ml) in the MIN6 
insulinoma cell line The same assay was applied to the stage 5, ES-derived 
culture (containing 88 ng/ml insulin measured by ELISA) The assay was unable 
to detect any de novo insulin synthesis in the ES-derived culture
• Using both the novel MRIA assay and the C-peptide 2 western blot developed 
during the course of this study, we were unable to find evidence, which would 
support de novo insulin synthesis in the stage 5, ES-derived culture These 
findings are in agreement with previous reports suggesting that insulin uptake 
from the culture medium is responsible for the high insulin content in cells 
exposed to similar 5 stage differentiation protocols
5 13  Two-Stage Differentiation Studies
• Formation of EBs in the presence of RA resulted in a mixed population 
expressing a range of multi-lineage transcripts (neuronal/glial, pancreatic 
endocrine, transcription factor, apoptotic, extra-embryonic, endoprotease and 
muscle) and proteins (neuronal/ghal, pancreatic endocrine, muscle) suggesting the 
presence of a multi-potential precursor population
• Secondary differentiation of the RA culture by the presence of other compounds 
altered the specification of lineage fate, resulting in neuronal- and glial-specific 
marker expression prevailing in the presence of AA or BTC and pancreatic 
endocrine marker expression dominating in the presence of SB
• Neuronal/ghal differentiation was characterized by the development of nestin- 
expressing precursor cells in the RA culture and subsequent down-regulation of 
nestin expression in the RA AA and the RA_BTC cultures, coinciding with an
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up-regulation in GFAP P HI tubulin, GFAP and NF-L proteins were expressed in 
subpopulations of both the RA_AA and RA_BTC culture
• Pancreatic differentiation in the RA_SB culture was characterized by the 
expression of pancreatic developmental control genes at day 5 (Pdxl, ngn3, beta 
2, pax 6, nkx2 2), followed by the up-regulation of p cell specific genes (insulin I, 
insulin II and glut2) at day 9 Pdxl, glut2 and insulin proteins were expressed m 
subpopulations of the RA_SB culture
• The short 2-stage RAJSB differentiation protocol developed in this study did not 
require exogenous insulin for the derivation of insulin-positive cell types, 
indicating that any insulin expressed was de novo synthesized LSCM analysis of 
RA_SB insulin-positive cells demonstrated a punctate staining pattern indicative 
of P cell granules containing insulin
• Insulin staining in the RA SB cells did not co-localize with C-peptide 1 or C- 
peptide 2 staining C-peptide 1 and C-peptide 2 protein expression was detected in 
the majority of cells in the CO_9d culture, however these cells were negative for 
insulin These IF results verify previous findings in Section 3 1 demonstrating that 
these C-peptide antibodies, when used for immuno-analysis, over-exaggerate 
actual protein levels
• The trend in transcript expression observed over the 2-stage RA_SB 
differentiation protocol indicated that the RA_SB population was of a pancreatic 
endocrine lineage more so than an extra-embryonic lineage An increase in 
pancreatic endocrine marker transcripts, and a decrease in Oct 4 expression was 
observed between the untreated ES-D3 culture and the RA_SB culture
• The decrease in proliferation capacity observed in the 2-stage RA_SB 
differentiation protocol did not appear to be related to apoptosis There was no 
change in apoptotic marker expression between undifferentiated ES-D3 cells and 
RA_SB cells Small fragmented nuclei were not observed in the RA SB culture 
(as would be expected with apoptosis)
• Further studies investigating alternative RA_SB protocols (Section 3 2 7 -  
Section 3 2 9) were not successful at improving cell yields
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• The combinations of extra-cellular factors described in this study may be of value 
in future protocols for directed differentiation of stem cells to neuronal, glial and 
pancreatic endocrine cell types
• Spontaneous formation of EBs did not appear to encourage lineage specific 
differentiation and did not result in the derivation of insulin expressing cell types
5 14  MLN6 Microarray Study
• PI 8 MIN6 cells respond to changes in glucose concentrations, producing an 
approximate 6-fold GSIS in response over the glucose range tested (0 -  26 7 
mmol/1) After continuous culture to passage 40, this GSIS was no longer present
• The loss in functional GSIS after continuous culture correlated with phenotypic 
changes including an increased proliferation rate, an increase m AP activity and a 
change in cell morphology
• The difference in AP activity and proliferation rates between the two cell 
populations (Le PI8 MIN6 and P40 MIN6) is indicative of de-differentiatioa
• Microarray and qPCR analysis demonstrated that mRNAs involved in secretion, 
adhesion, proliferation and p cell development were affected by continuous 
culture
• The reduced expression of transcripts associated with the mature P cell in high 
passage cells (P40) compared to low passage cells (PI 8), together with the 
increased level of neuron-/glia- associated mRNAs, suggested that with time in 
culture, MIN6 cells reverted to a less differentiated ‘precursor-like’ population
• This observation was supported by (a) the elevated level of AP activity in high 
passage cells compared to low passage cells and (b) the suggestion by Kayo et al 
(1996) that well differentiated MIN6 cells were directed to a poorly differentiated 
state at higher passage numbers by furin cleaved bioactive proteins
• The phenotypic and gene expression changes observed between low and high 
passage MIN6 involve functional de-differentiation of the cell population, but 
whether this is due to de-differentiation of the population as a whole, or over­
growth by a faster growing poorly-differentiated sub-population, remains unclear
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5 2 Future Work
• Culture conditions and marker expression in undifferentiated ES cells vary from 
one study to another Therefore, one can assume that the differentiation status of 
these ES cells also varies from one study to the next This is an issue that needs to 
be addressed A comparative analysis of multi-lineage marker transcript 
expression (including pluripotent markers) by qPCR, in ES cells cultured both in 
the absence and presence of feeder layers, would determine if these varying 
culture conditions were affecting the overall undifferentiated status of the cells
• ES lines express high levels of Oct 4 and precise levels of this gene are critical in 
maintaining the ES cell state (Rao, 2004, Berill et al, 2004) It has been observed 
both in this study and in others (Berill et al, 2004) that Oct 4 mRNA expression 
levels are only slightly diminished after 5 - 6  weeks in culture lacking LIF Future 
work could investigate the effects of Oct 4 down-regulation using SiRNA 
technology on differentiation Down-regulation of Oct 4 in combination with 
some of the treatments investigated in Section 3 2 may improve on the derivation 
of lineage specific cell types
• Alternative RA SB differentiation protocols investigated in Section 3 2 
demonstrated that NIC and SB are both potent enhancers of insulin transcript 
expression It may be interesting to study the effects of these extra-cellular 
factors on differentiation and maturation of ductal stem cells
• Future studies on MIN6 cells could focus on determining specific passage 
numbers at which GSIS is lost GSIS analysis and microarray analysis of serial 
passage numbers may yield more information on the molecular mechanisms 
associated with the loss of GSIS function
• The prevention of the loss of functional GSIS with continuous culture is the mam 
aim in MIN6 studies A study by Zimmer et al (1999) demonstrated that growth 
arrest correlated with increased levels of secretory granule genes including 
chromogranin A and insulin In the present study, genes associated with 
proliferation where among those significantly affected by continuous culture 
These genes i e dlkl, cdk4, CEACAM1 are potential targets for future functional
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studies (1 e s l R N A  knockdown or cDNA transfections) to identify whether de- 
differentiation can be prevented by controlling proliferation
• A study by Bouckenooghe et al (2003) demonstrated that SB induced P cell gene 
(re)expression after expansion and de-differentiation of human pancreatic islets It 
may be interesting to investigate whether sodium butyrate has a similar effect on 
gene expression in high passage MIN6 cells which are also thought to have de­
differentiated to a precursor-like cell type
• This study by Bouckenooghe et al (2003) proposed that the expansion of human 
pancreatic islets represented a de-differentiating system It may be interesting to 
study this system in parallel to our MIN6 model (low and high passage cells) 
which is also thought to represent a de-differentiating system, using both micro- 
array and proteomics technologies
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